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ABSTRACT 
 
Purpose: Cataracts are a key feature of type 1 myotonic dystrophy (DM1), 
however, little is known about the mechanisms which underlie their development. 
This project aims to verify the suitability of lens cell lines derived from DM1 
patients as a model for the disease and to use these to investigate the mechanisms 
which lead to cataract development.  
Methods: Experiments were conducted using four DM1 and four control cell 
lines derived by SV40 transformation of human lens epithelial cells (LECs). The 
DM1 cell lines were characterised by measuring gene expression using QRT-PCR 
and identifying foci formation of triplet repeat RNA via FISH. Activation of 
signalling pathways was analysed using Western blotting. Active signalling 
pathways were inhibited to examine their roles in cell growth, death and apoptosis 
which were measured using BCA, LDH and TUNEL assays respectively.  
Results: Human LECs expressed DMPK and transcripts formed foci in the nuclei 
of DM1 cells; however, no evidence of alternative splicing was found. DM1 LECs 
had significantly longer population doubling times and a shorter lifespan 
compared to controls. Serum deprivation led to increased levels of apoptotic cell 
death in DM1 LECs. DM1 LECs released autocrine signalling factors which 
activated the Akt pathway in the non-virally transformed lens cell line FHL124. 
Levels of pAkt and pJNK were subsequently shown to be elevated in the DM1 
cell line, DMCat1. However, levels of Akt activity declined during the culture 
period. Inhibition of the PI3K/Akt pathway in DMCat1 led to increased levels of 
apoptotic cell death. 
Conclusions: DM1 LECs require signalling via the PI3K/Akt pathway for 
survival. Sustained activation of JNK and decreasing activation of Akt could be 
responsible for the longer population doubling times and shorter lifespan of DM1 
LECs. Increased LEC death could underlie cataract formation through a loss of 
homeostatic control in DM1 lenses. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 The human eye 
 
 The eye is a highly specialised organ which detects and interprets photic 
stimuli to allow us to perceive vision. The eye detects light energy and converts it 
into electrical signals which are sent to the brain and processed so that we can 
visualise our surrounding environment. The individual structures within the eye 
(see figure 1.1) are either involved in the transmission and focusing of light and 
generation of signals, or in the nourishment and support of the tissues within the 
eye (Forrester et al., 2002). 
 The adult human eye is roughly spherical with a diameter of around 24 
mm; it has an average volume of 6.5 ml and a mass of 7.5 g and is separated into 
anterior and posterior segments. The smaller anterior segment consists of the 
conjunctiva, cornea, iris, lens and aqueous humour. This segment is separated into 
the anterior and posterior chambers by the iris, but the chambers remain 
connected via the pupil. The anterior chamber is the space between the cornea and 
iris and the posterior chamber is the space between the iris and the lens; both 
chambers are filled with aqueous humour. The larger posterior segment consists 
of the sclera, choroid, retina and vitreous humour (Forrester et al., 2002).  
The outermost layer of the posterior segment is the sclera and this joins the 
transparent cornea and conjunctiva which form the outermost layer of the anterior 
segment. Together these form a layer called the fibrous coat which protects the 
eye. Beneath the fibrous coat are two further layers, the first of which is known as 
the vascular coat and is made up of the choroid, ciliary body and iris. The choroid 
is highly vascularised to nourish the outer layers of the retina and is pigmented to 
reduce light scatter within the eye. The ciliary body holds the lens in place and 
produces aqueous humour, which bathes the lens and fills the anterior segment. 
The iris is the coloured part of the eye and contains sphincter and dilator muscles 
that control the size of the pupil and therefore the amount of light that enters the 
eye. The innermost layer of the posterior segment is known as the neural coat 
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which consists of the retina. The retina has a highly complex, layered structure 
which contains the photoreceptor cells known as rods and cones. The region of the 
retina known as the macula is responsible for high visual acuity and contains a pit 
called the fovea where light rays are focused. The retina is responsible for turning 
light into electrical signals that are passed to the brain via neurones in the optic 
nerve which exits the retina at the blind spot (Forrester et al., 2002). 
 
 
 
 
Figure 1.1 – A diagrammatic representation of the human eye, showing the main structures 
and their relative positions within the eye. The eye consists of three outer coats: the fibrous 
coat (sclera and cornea); the vascular coat (choroid and iris); and neural coat (retina), which 
encase the remaining structures of the eye, including the lens. The vitreous and aqueous 
humours provide nourishment and support and maintain the shape of the eye (image from 
http://en.wikipedia.org/wiki/Eye). 
 
 
The three layers surround and house the remaining components that make 
up the eye. These include the lens, which is responsible for focusing light on to 
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the retina; the aqueous humour, which supports and nourishes the structures of the 
anterior segment of the eye; and the vitreous humour, which supports the 
structures of the posterior segment of the eye.   
 
1.1.2 The passage of light through the eye 
Light of wavelengths that are visible to the human eye is found in a 
relatively small region of the electromagnetic spectrum between 400 and 700 nm 
and corresponds to a colour range of violet to red. Light with wavelengths below 
400 nm, such as ultraviolet (UV) light, is filtered out by the cornea and lens as its 
high energy would be damaging to the retina (Yanoff & Duker, 2009). Light 
enters the eye through the conjunctiva and cornea which are the transparent 
coverings of the eye. The cornea is responsible for two-thirds of the eye’s 
refractive power, but unlike the lens its focus is fixed (Forrester et al., 2002). The 
light passes through the clear aqueous humour and the amount of light that can 
pass through the pupil is determined by the muscles of the iris. The iris contracts 
or dilates to enable more or less light to pass towards the back of the eye 
depending on lighting conditions. In low light the iris dilates to allow more light 
to enter the eye and in bright light the iris contracts to restrict the amount of light 
that enters the eye. 
Light passes through the lens which is a transparent structure responsible 
for the remaining refractive power of the eye. Unlike the cornea, the lens is 
capable of altering its shape, and therefore refractive power, in order to bring light 
from varying distances to focus on the same point of the retina. The light then 
passes into the vitreous humour, a clear gelatinous material, which fills the space 
between the lens and the retina. The vitreous humour consists mainly of water 
(over 98%) and a matrix of type II collagen fibres and hyaluronic acid, which 
increases its viscosity to 2-4 times that of water alone (Forrester et al., 2002). This 
enables it to fulfil its role of maintaining the shape of the eye.  
When focused light reaches the retina it is directed to the macula region 
and particularly the pit of the fovea. The retina is the photosensitive part of the 
eye and consists of ten distinct layers containing many different cell types (see 
figure 1.2). The retina is responsible for turning light energy into electrical signals 
which can be interpreted by the brain. Light passes through several layers of 
retinal cells before reaching the photoreceptor cells at the back of the retina. The 
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outermost layer of the retina (situated nearer the back of the eye) consists of 
retinal pigment epithelial (RPE) cells which contain pigment (melanin) and are 
responsible for capturing stray light to avoid light scatter within the eye. Other 
roles of the RPE cells include: the phagocytosis of outer segments of the 
photoreceptor cells; the turnover of vitamin A required for the production of 
photopigment; and the provision of a barrier between the blood vessels of the 
choroid and the retina.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 – A diagrammatic representation of the structure of the retina. The retina is made 
up of a pigmented epithelial cell layer and several layers of neuronal cells connected by 
synapses. The cells convert light energy into electrical signals which are passed to the brain 
via the ganglion cell axons which exit the eye at the blind spot and form the optic nerve 
(image from http://psych.hanover.edu/Presentations/VoiceFound/images/retina2.jpg). 
 
 
Most of the light that passes through the layers of the retina is captured by 
the two types of photoreceptor cell known as rods and cones. Rod cells are highly 
sensitive and can be activated by a single photon of light. For this reason they are 
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mainly used for vision in low light intensity. Cone cells are less sensitive to light 
but allow the perception of colour. There are three types of cone cell, each being 
sensitive to a different part of the visible light spectrum. The photoreceptor cells 
contain photopigments which are activated by different wavelengths of light, 
causing the closure of Na+ channels, hyperpolarisation and the reduction of tonic 
release of the neurotransmitter glutamate onto bipolar and horizontal cells. The 
bipolar cells pass the signal via a graded potential to either amacrine cells or 
directly to ganglion cells which fire action potentials when stimulated. The 
ganglion cells have long axons which exit the eye at the optic disk and form the 
optic nerve which goes to the lateral geniculate nucleus situated in the thalamus of 
the brain. The lateral geniculate nucleus is the processing centre for visual 
information and sends the signals via the optic radiation to the visual cortex where 
further analysis and interpretation occurs. 
 
1.2 The human lens 
 
 The lens is derived from surface ectoderm which overlies the optic vesicle 
and forms the lens placode during development. The mature lens is a transparent, 
avascular tissue situated behind the iris and in front of the vitreous body in the 
anterior segment of the eye. The lens has an ellipsoid, biconvex shape with the 
anterior surface being less curved than the posterior. The adult human lens is 
approximately 10 mm in diameter and has a width of around 4 mm (Forrester et 
al., 2002). It is held in place by the zonule fibres which are attached to the lens 
capsule (just in front of the equatorial line) at one end and the ciliary body at the 
other. The lens is nourished by vitreous humour on its posterior surface and 
aqueous humour on its anterior surface. As the lens does not have its own blood 
supply, all of the nutrients it receives come from the surrounding humours. 
 The function of the lens is to focus light onto the retina. In order to focus 
light from varying distances at the same point the lens is able to alter its shape by 
a process known as accommodation. When the ciliary muscle contracts, tension in 
the zonules is reduced and the lens relaxes to a more spherical shape to focus light 
from near objects. At rest (relaxed), the lens has a refractive power of 
approximately 15 dioptres, which is altered when it changes shape. When the 
ciliary muscle relaxes the converse is true and tension in the zonules increases to 
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flatten the lens enabling light from distant objects to be focused. Ciliary muscle 
contraction is activated by the parasympathetic nervous system via the oculomotor 
nerve and relaxation is under the control of the sympathetic nervous system. 
 Structurally the lens has three main components: the capsule; the anterior 
epithelium; and the fibres (see figure 1.3). All three components have a structure 
that has evolved to maintain transparency of the lens.  
 
 
 
Figure 1.3 – A diagrammatic representation of the human lens. A layer of metabolically 
active epithelial cells (blue) are found on the anterior surface of the lens. Some of these cells, 
known as the germinative cells (pink), continually divide throughout life. They elongate (red) 
and migrate, forming new fibre cells (yellow) that become part of the fibre mass. The 
original embryonic fibres form the nucleus (pale yellow) of the lens. The lens is surrounded 
by the lens capsule (grey) (image from Maidment et al. (2004)). 
 
 
1.2.1 The lens capsule  
The lens capsule is a transparent, smooth, basement membrane that 
surrounds the entire lens and protects it from infectious viruses and bacteria. The 
lens capsule acts as a reservoir of growth factors and provides epitopes for lens 
cell surface receptors which encourage cell survival, growth and migration 
(Danysh & Duncan, 2009). The membrane also acts as a selectively permeable 
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barrier to allow the movement of metabolic substrates and waste between the lens 
and the humours of the eye due to the lack of blood vessels that would usually 
perform this task. The lens epithelial cells slowly produce and turnover the matrix 
material of the thick, elastic lens capsule. The capsule is mainly composed of 
laminin and type IV collagen, but also contains nidogen and several heparan 
sulphate proteoglycans (Danysh & Duncan, 2009). The thickness of the adult lens 
capsule varies from around 2 µm at the posterior pole to around 30 µm at the 
anterior pole. 
 
1.2.2 The lens epithelium 
 The lens epithelium is a monolayer of tightly packed cuboidal epithelial 
cells which cover the anterior surface of the lens. The epithelium is divided into 
three parts: the non-dividing epithelial cells situated in the central anterior region; 
the germinative dividing cells which surround them; and the differentiating cells 
which elongate into new fibre cells at the equatorial region. The cells in the 
germinative zone grow throughout life, resulting in new fibre cells being added to 
the fibre cell mass which increases in size with age.  
 The lens epithelial cells (LECs) are responsible for maintenance of 
homeostatic control of the lens. The LECs regulate levels of ions, nutrients and 
water and maintain the osmolarity and volume of the lens. A gradient of sodium 
ions (Na+) and potassium ions (K+) exists across the lens with high levels of Na+ 
at the posterior where it enters by diffusion and high K+ at the anterior. The LECs 
contain Na+/K+ ATPase pumps which pump Na+ out into the aqueous humour and 
K+ ions in. This results in a negative resting potential which enables the cells to 
maintain their volume (Bhat, 2001). A concentration gradient of calcium ions 
(Ca2+) is also necessary for normal lens cell function with the intracellular levels 
being over 1000-fold lower than extracellular levels (Paterson & Delamere, 2004). 
The gradient is maintained via plasma membrane Ca2+-ATPase (PMCA) and 
Na+/Ca2+ exchangers (NCX), which pump Ca2+ out of the cell and 
sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) pumps, which pump 
Ca2+ into the endoplasmic reticulum (ER) calcium store (Rhodes & Sanderson, 
2009). 
 LECs produce the antioxidant glutathione to protect against oxidative 
insults which can inhibit the pumps that maintain the ion gradients and therefore 
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lead to a loss of homeostasis within the lens (Delamere & Tamiya, 2004; Marian 
et al., 2007). 
 
1.2.3 The lens fibres 
 The lens fibres constitute the overwhelming bulk of the lens. Mature fibre 
cells are long and thin in shape, stretching from the anterior to the posterior pole 
of the lens, reaching up to 12 mm in length, but with a diameter of only 4-7 µm. 
The ends of mature fibre cells meet anteriorly at the lens epithelium or posteriorly 
at the capsule where they overlap at the anterior and posterior sutures, forming a 
new growth shell. The fibre cells are tightly packed in layers, called laminae, and 
linked to each other laterally by many gap junctions and channels formed by 
connexins and major intrinsic protein 26 (MIP26). The gap junctions allow rapid 
communication between the cells of the lens, allowing solute and ionic transfer 
from cell to cell. Neighbouring fibre cells are also joined by ball-and-socket 
junctions and membranous interdigitations along their lateral edges which provide 
stability and structure (Forrester et al., 2002). MIP26 acts as a water channel and 
also plays a role in the formation of gap junctions, the organisation of the lens 
protein γ-crystallin and in cell to cell adhesion to limit inter-fibre space 
(Golestaneh et al., 2004). The highly ordered arrangement of the fibre cells and 
the lack of extracellular space ensures the transparency of the lens (Forrester et al., 
2002).  
Fibre cells differentiate and elongate from the dividing LECs at the 
equator of the lens. The equatorial cells continue to divide and new fibres are 
continually added to the fibre mass, leading to an increase in lens size throughout 
life. Since all cells are retained by the lens, fibre cells laid down in the embryo 
and foetus are still found in the adult lens and form the central, denser nucleus. 
  As the fibre cells differentiate and mature they synthesise crystallins, 
water channel and gap junctional proteins and gradually dismantle their organelles 
(Rao & Maddala, 2006). The lens fibres become packed with crystallins, which 
are water soluble proteins that increase the refractive index of the lens and 
maintain transparency. The main crystallins found in the human eye are α-, β-, 
and γ-crystallins. The α-crystallins are members of the small heat shock protein 
family and also have roles as molecular chaperones, which may be of importance 
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in protecting lens proteins and preventing their precipitation during ageing 
(Andley, 2007).  
The organisation of the proteins that maintain transparency is dependent 
on the fibre cell cytoskeleton, which performs a scaffolding role. Further roles of 
the cytoskeleton include regulation of fibre cell shape, elongation and migration. 
The cytoskeleton consists of actin, vimentin and spectrin microfilaments, 
microtubules and intermediate filaments, as well as lens specific beaded filaments 
(Forrester et al., 2002; Rao & Maddala, 2006). 
 The highly ordered structure of the components of the lens is crucial to its 
transparency. Loss of homeostasis in levels of ions and water and the loss of the 
tightly packed structure of the lens fibres can lead to a loss of transparency due to 
light scatter. 
 
1.2.4 The ageing lens 
 As the human lens ages, several changes occur which can impact on vision. 
The most common changes that occur in the ageing human lens are increases in 
stiffness, colouring and light scatter (Vrensen, 2009). The refractive power of the 
lens decreases with age from 15 dioptres during youth to 6-8 at around 40 years of 
age and 2-0 at around 60 years of age (Forrester et al., 2002; Yanoff & Duker, 
2009). 
The condition presbyopia is the inability to focus on near objects, which 
arises due to a loss of elasticity of the lens with age; in particular the hardening of 
the nucleus of the lens. The decrease in lens elasticity is also accompanied by 
atrophy of the ciliary muscle fibres (Forrester et al., 2002). Reading glasses are 
then required in order to view close objects in focus. The level of α-crystallin also 
decreases with age, which coincides with an increase in stiffness. During ageing, 
the level of free α-crystallin decreases as it binds to degraded proteins to prevent 
them from precipitating. At around 40 years of age no free α-crystallin is found in 
the lens and after this point the level of stiffness in the lens increases dramatically 
(Truscott, 2009). With no free α-crystallin to act as a molecular chaperone, levels 
of insoluble proteins that cause light scatter begin to increase. 
The lens becomes increasingly yellow with age due to increased 
absorption of light at the blue end of the spectrum and increased light scattering as 
the cells begin to lose their highly ordered structure. The UV light filter, 3-
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hydroxykynurenine-3-O-β-glucoside (3-HKG), becomes covalently bound to lens 
proteins during ageing, producing a yellow pigment which contributes to 
colouration and also to the development of age-related nuclear cataract (Yanoff & 
Duker, 2009). 
The formation of both nuclear and cortical cataracts has been linked to 
ageing. The hardening of the lens could alter the flow of water, ions and anti-
oxidants through the fluid cell membranes by affecting the activity of membrane 
bound proteins involved in their transport. This could result in a loss of 
homeostasis and an increase in reactive oxygen species, leading to nuclear 
cataract. Also the hardening of the lens nucleus could result in shearing and 
ruptures between the hard nucleus and the softer cortex during attempts to focus 
and accommodate, leading to cortical cataract (Truscott, 2009). 
The density of the LEC layer decreases with age as the surface of the lens 
increases and the proliferative capacity of the germinative cells decreases. As a 
result the epithelial cells flatten to maintain coverage of the lens (Yanoff & Duker, 
2009). The LEC layer is responsible for the maintenance of homeostasis of ion 
and water levels within the lens. A thinning epithelial cell layer is likely to 
contribute to cataract formation due to a loss of homeostasis (Li et al., 1995). 
 
1.3 Cataract 
 
 Cataract is an opacity in the lens which obstructs the passage of light and 
causes light scattering (see figure 1.4). The lens becomes cloudy and opaque, 
resulting in a loss of visual acuity and contrast sensitivity. Cataract can result in 
varying degrees of visual impairment, ranging from blurred vision to blindness. 
 Cataract is the leading cause of blindness worldwide, responsible for 
almost 50% of cases, and it is estimated that 17 million people are currently 
rendered blind due to the condition (Javitt et al., 1996). In developed countries the 
prevalence of blindness due to cataract is low. In most developing countries, 
however, prevalence is much higher, as treatment is not readily available. The 
incidence of cataract increases with age and studies have shown that the risk of 
developing cataracts increases with every decade of life after 40 years of age 
(McCarty et al., 1999; Klein et al., 2002). A study by McCarty et al. (1999) 
showed that 2-3% of people tested had cataract between the ages of 40-49, which 
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increased to 100% in people tested over the age of 90. A similar study by Klein et 
al. (2002) showed that the incidence of cataract over a 10-year period between the 
ages of 43-54 was between 14-19%, compared to 84-90% of those studied over 
the age of 75. The impact of this data becomes apparent when the continual 
increase in life expectancy, and therefore an ageing population, is taken into 
account. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 – Image of a cataractous lens. Cataract is an opacity of the lens, which obstructs 
the passage of light, causing scattering. This results in a cloudy appearance to the lens which 
can be seen behind the pupil of the eye (indicated by the arrow) (image from 
http://www.aapos.org/client_data/files/182_cataract1.jpg). 
 
 
Although the greatest risk factor for developing cataract is age, many 
others have been indentified including: environmental stresses, such as exposure 
to UV light, oxidative stress and radiation; genetic changes, such as mutations in 
crystallin genes; physical trauma; toxic substances, such as selenite; and certain 
medical conditions, such as diabetes. With an ageing population the prevalence of 
cataract is increasing and with no current cure, the only treatment is surgical 
removal.  
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Figure 1.5 – A schematic diagram of the human lens, showing the relative positions of the 
various types of cataract. Nuclear cataracts (NC) are located in the nucleus of the lens. 
Cortical cataracts can either be anterior (ACC) or posterior (PCC). Posterior subcapsular 
cataracts (PSC) are located at the posterior of the lens (image from Das Gupta et al. (2004)). 
 
 
 Cataracts are classified by their position in the lens and are normally 
regarded as either nuclear, cortical, posterior subcapsular, or a mixture of these 
(see figure 1.5). Nuclear cataract affects the nucleus of the lens and is most often 
associated with oxidative damage and age-related changes, such as the 
accumulation of large high molecular weight protein aggregates. Cortical cataracts 
are also most commonly age-related and occur in the cortical fibres of the lens as 
the result of degeneration and liquefaction of the fibres. A breakdown in ion 
homeostasis leads to an influx of Ca2+ and Na+ ions, with the increase in 
intracellular Ca2+ resulting in activation of Ca-activated proteases (calpains) 
which break down the fibre cell protein. Cortical spokes form when groups of 
fibre cells are affected (Naumann et al., 2008). Posterior subcapsular cataracts 
(PSC) form near the posterior edge of the lens and lead to high levels of glare. 
PSCs are the result of the appearance of granular material and vacuoles in the lens, 
but are often associated with other types of cataract, leading to a classification of 
mixed cataract. The development of PSCs has been linked to age, diabetes 
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mellitus, intraocular inflammation, smoking and use of corticosteroids (Hodge et 
al., 1995; Delcourt et al., 2000; Hennis et al., 2004).  
 
1.3.1 Cataract surgery 
Surgical removal of cataracts is the most common operation performed by 
the National Health Service (NHS) in the UK. Around 300 000 are performed 
every year, and with each operation costing around £700 to £1200, this is an 
incredible financial burden on the NHS. 
Cataract surgery lasts around 15 minutes and is performed under local 
anaesthetic. The most common method is extra-capsular cataract extraction 
(ECCE), which removes the fibre mass, but leaves the capsular bag (lens capsule) 
in place to house an artificial intraocular lens (IOL) (see figure 1.6a and b). The 
cataract operation can be briefly described as follows: small incisions are made in 
the front of the eye to enable access to the lens and a viscoelastic substance is 
injected into the anterior chamber to maintain space and pressure during the 
procedure. A capsulorhexis is performed on the lens, where a circular piece of 
tissue is removed from the anterior surface, which contains the anterior epithelial 
cells attached to the lens capsule. A balanced salt solution is injected into the lens 
to separate the capsule from the fibres and to separate the nucleus from the cortex 
in a process known as hydrodissection and hydrolineation. Phacoemulsification is 
then performed on the fibre mass. An ultrasonic devise is inserted into the 
capsular bag to breakdown the fibres which are then aspirated. The majority of the 
lens is removed during surgery, leaving only the posterior capsule and a small 
amount of the anterior capsule. This is referred to as the capsular bag. A folded 
IOL is then inserted into the capsular bag, where it unfolds and assumes its 
position in the visual axis (Benjamin & Little, 2007). 
 
1.3.2 Posterior capsule opacification 
 A common complication of cataract surgery is the secondary loss of vision 
that occurs in a significant proportion of patients. During cataract surgery a 
portion of the anterior capsule of the lens is left as part of the capsular bag (see 
figure 1.6b). LECs attached to the lens capsule are difficult to remove during 
surgery and subsequently mount a wound healing response where they attempt to 
recover the denuded areas of the anterior capsule by multiplying and migrating. In 
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doing so, some migrate onto the surface of the IOL and also onto the previously 
cell free posterior capsule where they encroach onto the visual axis and cause 
fibrotic changes to the matrix (see figure 1.6c). Contraction of the capsule forms 
wrinkles which scatter light (Wormstone et al., 2009).  
 
 
Figure 1.6 – A diagrammatic representation of a capsular bag and the development of 
posterior capsule opacification (PCO) (a) An intraocular lens (IOL) with the supporting 
loops (haptics) which hold it in place following implantation. The dotted line indicates the 
area where the cross section seen in images b and c was taken (b) Modern cataract surgery 
forms a capsular bag which comprises of the posterior capsule and a portion of the anterior 
capsule. The capsular bag is used to house an IOL. (c) The residual LECs multiply following 
surgery and migrate onto the previously cell free posterior capsule, resulting in wrinkling 
and light scatter in a condition known as PCO (image adapted and modified from 
Wormstone (2002)). 
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The incidence of PCO is significantly higher in younger patient groups, 
most likely due to the increased growth capacity of their cells. The incidence of 
PCO in patients under 40 years of age is as high as 70%, compared to less than 
40% in patients over 60 years old (Wormstone, 2002). 
PCO is treated using a neodymium-yttrium-aluminum-garnet (Nd-YAG) 
laser which is used to remove a section of the posterior capsule to clear the visual 
axis. Nd-YAG treatment is not without risk (e.g. retinal detachment) and also 
costs the NHS a considerable amount each year. Prevention of PCO by more 
effective removal of LECs and better IOL design is the focus of current research. 
 
1.4 Myotonic Dystrophy 
 
 Myotonic dystrophy (DM, also known as dystrophia myotonica) is the 
most common form of adult muscular dystrophy, affecting around 1 in 8000 
people worldwide. It is an autosomal, dominantly inherited, neuromuscular 
disorder. DM is characterised by myotonia (a difficulty in relaxing the muscles 
following contraction), muscle weakness and atrophy (a wasting of the muscles), 
cardiac conduction defects and the development of pre-senile cataracts. Other 
symptoms include mental retardation, testicular atrophy, frontal balding and 
insulin resistance. DM is a multisystemic disease, affecting many tissues and 
organs within the body.  
 DM is a highly variable disease with the range of symptoms, age of onset 
and severity of symptoms varying from person to person (Harper, 2001). 
Symptoms can present at any time from birth to old age and vary from mild to 
severe. In its mildest form, the disease may present with only pre-senile cataract. 
In its most severe form the disease may be present at birth, causing mental 
retardation, muscle weakness and respiratory problems. DM can shorten life 
expectancy, but this is most significant in patients affected from a young age. DM 
patients have an increased risk of respiratory and cardiac diseases and of sudden 
death from heart failure (Meola, 2000).  
 
1.4.1 The history of DM 
 DM was first described as an independent disorder, distinct from other 
myotonic diseases in 1909. Hans Steinert reported nine cases of the disease, where 
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he observed a similar distribution of muscle weakness and atrophy and weak 
speech. He also described testicular atrophy in four of the cases (referred to in 
Harper, 2001). The disease was described independently in the same year by 
Frederick Batten and H.P. Gibb (Batten & Gibb, 1909).  
 In 1911 J.G. Greenfield recognised cataract as a symptom of DM after 
observing a high prevalence of cataract in a large family affected by the disease. 
The systemic nature of DM was first noted in 1912 by H. Curschmann, who 
considered cataract and testicular atrophy to be a sign of generalised endocrine 
disturbance. In 1918 B. Fleischer described cataracts in previous generations of 
patients who had otherwise appeared unaffected by the disease and was the first to 
describe the phenomenon called anticipation, where the severity of the disease 
increases from generation to generation (referred to in Harper, 2001). 
 Mental retardation and cardiac conduction defects had been linked to DM 
in numerous studies by 1950. In 1960 the congenital form of the disease and its 
maternal transmission were described by T.M. Vanier (referred to in Harper, 
2001). By this point the clinical features of DM had been well described, although 
the genetic mutation underlying the disease was still a mystery. The genetic 
mutation behind DM was discovered in 1992, however, some of the patients 
suffering from the disease were not shown to carry this mutation (Aslanidis et al., 
1992; Brook et al., 1992; Buxton et al., 1992; Mahadevan et al., 1992). In 2001, a 
rarer second mutation resulting in DM symptoms was discovered (Liquori et al., 
2001). The two forms of the disease were renamed as type 1 (DM1) (also known 
as Steinert’s disease) and type 2 (DM2) (also known as proximal myotonic 
myopathy). 
 
1.4.2 Clinical features of DM 
 The multisystemic nature of DM means that a patient can present with any 
of the symptoms associated with the disease, which can lead to difficulty in 
making a diagnosis as specialists in particular areas, such as ophthalmologists and 
cardiologists, may not be aware of the condition. A diverse range of clinical 
features are associated with DM. Many of the symptoms observed are common to 
both forms of the disease, however, some present in only one form of DM and 
many symptoms vary in severity or location. 
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Skeletal muscle weakness, wasting, myotonia and pain are common in DM, 
although the pattern of muscle involvement varies between the two forms. In 
DM1 the facial and distal limb muscles are most affected, with proximal skeletal 
muscle weakness occurring as the disease progresses. In contrast, weakness of 
proximal skeletal muscles is more prominent than distal muscles in DM2 
(Machuca-Tzili et al., 2005). In both forms, muscles of the neck and hands are 
affected and facial muscles show signs of weakness, including ptosis (drooping of 
the eyelid), albeit milder in DM2. Muscle biopsies from both DM1 and DM2 
patients show similar histological features such as fibre atrophy (some with 
pyknotic nuclear clumps), central nucleation (sometimes arranged in chains) and 
extreme variations in fibre size. Replacement of necrotic muscle tissue with 
fibrotic and adipose tissue can also be observed. In DM1 it is mainly type 1 
muscle fibres affected, compared to type 2 muscle fibres in DM2 (Wells & 
Ashizawa, 2006). Involvement of the smooth muscle is seen in DM1 but not in 
DM2 and includes dysmotility of the gastrointestinal tract resulting in, for 
example, diarrhoea, constipation and gallstones; and hypotension (Wells & 
Ashizawa, 2006). Muscle pain is also observed in both forms of the disease. 
Myotonia, which is a difficulty in relaxing the muscles due to an increase in the 
frequency of action potentials, is present in both forms of DM; however, it is more 
severe and symptomatic in DM1 patients. Myotonia is caused by spontaneous 
electrical discharges in the muscles that wax and wane (mostly waning in DM2) 
in frequency and amplitude, which is detected by electromyography (EMG) 
(Logigian et al., 2007). The abnormal electrical activity results in the inability to 
relax the muscles, causing for example the sustained grip following a handshake. 
Myotonia affects distal muscles more than proximal and can also affect facial 
muscles, tongue and bulbar muscles (which control talking, chewing and 
swallowing) (Machuca-Tzili et al., 2005; Logigian et al., 2007). Myotonia often 
improves during repetitive exercise of the affected muscles, known as the ‘warm 
up’ effect. The severity of myotonia is positively correlated with muscle weakness 
in DM1, but this is not the case in DM2 (Logigian et al., 2007). 
 The cardiac muscle is also affected by DM, resulting in cardiac 
arrhythmias, cardiomyopathy and conduction defects, which can all cause sudden 
death in DM patients. Cardiac conduction defects are diagnosed by 
electrocardiography (ECG) and are common to both forms of the disease, 
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however, around 75% of DM1 patients suffer conduction blocks, compared to 
only 20% of DM2 patients (Wells & Ashizawa, 2006).  
A key feature of DM is cataract formation, which is observed in both 
forms of the disease and in mildly affected patients it can be the only sign or 
symptom of DM. The cataract that forms is distinct in its early stages from other 
types of cataract and can be easily seen under slit-lamp examination.  
Central nervous system (CNS) abnormalities are more prominent in DM1, 
with degenerative CNS changes leading to mental retardation, depression, 
hypersomnia and anxiety disorders (Wells & Ashizawa, 2006).  
Endocrine abnormalities are common in DM. Abnormal glucose tolerance 
is present in both forms of the disease and can lead to diabetes mellitus, which is 
more common in DM2. Hypotestosteronism with elevated levels of follicle-
stimulating hormone (FSH), frontal balding and testicular atrophy are also 
common to both forms. Hyperhidrosis (excessive levels of perspiration) is found 
mainly in DM2 (Wells & Ashizawa, 2006). The occurrence of pilomatricomas, 
which are benign calcifying epitheliomas of the hair follicle, appear to be more 
common in DM1 patients than in the general public. It has also been suggested 
that DM1 is linked to certain types of cancer with cases of thymoma and 
neoplasms of the parotid gland, parathyroid and thyroid being the most commonly 
reported (Harper, 2001; Mueller et al., 2009). 
A congenital form of DM, where development of the foetus is affected and 
signs and symptoms are present from birth, is only seen in DM1. During 
pregnancy, mothers may notice reduced foetal movement and polyhydramnios 
(excess of amniotic fluid). Following birth, clinical characteristics of this form of 
the disease include hypotonia (low muscle tone resulting in being ‘floppy’ at 
birth); talipes; a tented upper lip; a high-arched palate; bilateral facial weakness; 
problems with swallowing, breathing and suckling; faecal incontinence and 
mental retardation (Machuca-Tzili et al., 2005; Schara & Schoser, 2006). 
Interestingly, neither myotonia nor cataracts are present at birth but both develop 
after the first decade of life. 
Diagnosis of DM is made after clinical examinations and tests have 
confirmed the presence of many of the clinical features described above (See table 
1.1 for a summary of the major clinical features associated with the two forms of 
the disease). Genetic tests which can identify the underlying genetic mutations are 
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also available and are commonly used to confirm the findings and differentiate 
between the two forms as variability in the presenting symptoms make a positive 
diagnosis almost impossible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Table 1.1 – A summary of the major clinical features associated with the two forms of DM.         
− = absent, ± = present to a mild degree, + = present. 
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1.4.3 The genetic mutations underlying DM 
 Two distinct mutations are known to cause DM, resulting in two forms of 
the disease. DM1 is the most prevalent form (responsible for around 98% of 
cases), although in some countries, such as Germany and Poland, the incidence of 
the two forms is approximately equal. The mutations that underlie DM are a type 
of mutation known as a repeat expansion, which are repeat sequences found 
within DNA that are unstable and of variable length. There are over 20 disorders 
caused by repeat expansions, including fragile X syndrome and the cerebellar 
ataxias. DM1 is caused by the expansion of a cytosine-thymine-guanine (CTG) 
triplet repeat located in the 3’ untranslated region (UTR) of the DMPK gene on 
chromosome 19 (Brook et al., 1992). DM2, however, results from a CCTG repeat 
located in the first intron of the ZNF9 gene on chromosome 3 (Liquori et al., 
2001). Therefore, the mutations underlying both forms of DM are located in non-
coding regions of genes, which are transcribed into RNA but are not translated 
into protein. Despite the differences in the sequence and location of the repeats 
that cause the two forms of DM, they share many of the same symptoms 
(summarised in table 1.1). Those of DM1, however, appear to be more severe than 
those of DM2. 
 The inheritance of both mutations is autosomal dominant, which means an 
affected individual will have one normal copy of the gene and one containing the 
repeat mutation. There is, therefore, a 50% chance of an affected individual 
passing the disease to their offspring, with males and females having an equal 
chance of inheriting the disease. 
 A small, stable CTG repeat in the DMPK gene is present in normal 
individuals, varying in length from 5-37 repeats. DM1 patients, however, have 
unstable repeats with lengths starting at 50 and ranging to over 1000. Repeats in 
the region of 38-50 do not result in DM1, but are considered a premutation which 
could lead to the development of the disease in future generations (Wells & 
Ashizawa, 2006). Repeat numbers in DM2 can be much larger and range from 75 
to 11 000. In normal individuals the repeat tract within the ZNF9 gene is shorter 
(≤ 26 repeats) and interrupted with GCTG and/or TCTG motifs (Liquori et al., 
2001).   
The repeat regions that cause DM are unstable and biased towards 
expansion. The repeats expand in the somatic cells of an individual during their 
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lifetime and also between generations, particularly when passed maternally. The 
number of repeats also varies depending on cell and tissue type. For example, 
cells in skeletal muscle, heart and brain have significantly larger repeat 
expansions than leukocytes (Thornton et al., 1994). This is known as somatic 
mosaicism. Expansions during the lifetime of an individual and somatic 
mosaicism are more pronounced in DM2 (Wells & Ashizawa, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 – A family affected by DM1 showing anticipation where the severity of the disease 
increases in subsequent generations. The grandmother (right) is only mildly affected, 
whereas the mother (left) shows signs of classic adult onset DM1, such as weakened facial 
muscles. The congenitally affected child has a characteristic tented upper lip and talipes 
(image from Jorde et al. (2000)). 
 
 
In DM1 the expansion of repeats between generations results in a 
phenomenon known as anticipation, where the severity of the disease increases 
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from generation to generation due to increasing repeat numbers. There is little 
evidence of this in DM2, despite the much larger repeat numbers associated with 
this form of the disease. Anticipation results in more severe symptoms and an 
earlier onset with successive generations leading to three different forms of DM1: 
mild; adult onset; and congenital (see figure 1.7). Individuals with the mild form 
are born with between 50 and 100 repeats, those with the adult onset form have 
200 to 500 and those with the severe congenital form have over 1000 repeats 
(Harper et al., 2004).  
In DM1, the transmission of repeats from generation to generation is 
different when passed maternally or paternally. Repeats in the range of 50 to 80 
are most likely to expand when passed paternally, whereas larger repeats of more 
than 100 are most likely to expand when passed maternally (Harper et al., 2004). 
The congenital form of DM1 is almost exclusively passed on by the mother, 
suggesting that oocytes with large triplet repeats remain viable, but sperm with the 
same sized repeats are unable to produce offspring (Meola, 2000). 
 
1.4.4 Molecular diagnosis of DM 
Variability between the two forms of DM results in the requirement of 
genetic testing for an accurate diagnosis. DNA tests involve amplification across 
the repeat expansion at the DM1 or DM2 locus by polymerase chain reaction 
(PCR), which reveals either two normal sized alleles in unaffected individuals, or 
a single allele in affected individuals as alleles containing large repeats do not 
amplify. To distinguish between affected individuals and unaffected homozygotes 
(15% of the population in DM2) which also present with a single band on PCR, 
Southern blot analysis is used. Somatic mosaicism in DM2 may cause a smear 
from the expanded allele using this method and therefore requires an additional 
repeat assay where the area containing the repeat is amplified by PCR with 
reverse primers at various sites within the CCTG repeat tract and the product is 
probed with specific internal oligonucleotide probes (Wells & Ashizawa, 2006). 
 
1.5 Myotonic dystrophy type 1 
 
 DM1 is the most prevalent form of DM and has been estimated to be the 
cause of 98% of cases. The following chapters of this thesis are aimed solely at 
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describing DM1 and at elucidating the mechanisms behind the effects of the CTG 
triplet repeat expansion.  
 
1.5.1 The DM1 gene locus 
 The DM1 locus (see figure 1.8) is located in a gene rich region of 
chromosome 19q13.3 within the DMPK (dystrophia myotonica protein kinase) 
gene, which is flanked upstream by the DMWD (dystrophia myotonica-containing 
WD repeat motif) gene (formally known as gene 59) and downstream by the SIX5 
(sine oculis homeobox homolog 5) gene (formally known as DMAHP). All three 
genes are located within a region spanning only 40 kb.  
 
 
 
Figure 1.8 – A diagrammatic representation of the DM1 locus. The CTG triplet repeat is 
located within exon 15 of the DMPK gene. 
 
 
The DMPK gene is around 13 kb in length and contains 15 exons. The 
mutation is found within the final exon which encodes the 3’ UTR of the DMPK 
mRNA. The DMPK gene encodes a serine/threonine protein kinase, which 
belongs to the AGC kinase family (the collective name for cAMP-dependent 
protein kinase A, cGMP-dependent protein kinase G, and phospholipid-dependent 
protein kinase C) and is closely related to other kinases that interact with members 
of the Rho family of small GTPases (van Herpen et al., 2005). There are 6 major 
isoforms and 1 minor isoform of DMPK resulting from a combination of three 
alternative splicing events (see figure 1.9). Of the major isoforms, four encode 
proteins of around 74 kDa and the final two, which are predominantly found in 
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smooth muscle, encode proteins of around 68 kDa (Elkins et al., 2009). The 
seventh minor isoform is only found in humans and does not contain the triplet 
repeat in its 3’ UTR. The predicted sequence of DMPK shows five distinct 
domains, three of which are conserved between isoforms: a leucine-rich N-
terminus; a serine/threonine protein kinase domain; and a coiled-coil region. 
Alternative splicing controls the inclusion of the final two domains which are 
isoform specific. These are the VSGGG motif and the C terminal tail, of which 
there are three forms (the seventh isoform contains a further unique C terminal tail) 
(Elkins et al., 2009). The C terminal domain controls the subcellular localisation 
of the DMPK protein (Wansink et al., 2003; van Herpen et al., 2005). The smooth 
muscle isoforms have a short C terminal tail of only 2 amino acids, which targets 
them to the cytoplasm. Of the other two tail forms, one is hydrophobic which 
targets to the ER, and one is hydrophilic which binds to the mitochondrial outer 
membrane (Kaliman & Llagostera, 2008).  
DMPK has been shown to be expressed in detectable amounts in the eye 
and in skeletal, smooth and cardiac muscle in humans (Dunne et al., 1996; 
Winchester et al., 1999; Lam et al., 2000). More sensitive methods used to 
analyse expression in mice, have shown DMPK to also be present in brain, testis, 
thymus, pituitary, skin, lung and liver (Sarkar et al., 2004a). The function of 
DMPK is not certain but overexpression of DMPK in undifferentiated mouse 
muscle cells resulted in expression of skeletal muscle-specific genes suggesting a 
role for DMPK in the myogenic pathway (Bush et al., 1996). A study conducted 
on skeletal muscle cells from dmpk knockout mice also revealed a possible role 
for DMPK in the modulation of Ca2+ homeostasis and events of excitation-
contraction coupling (Benders et al., 1997). Overexpression studies carried out in 
human lens cells resulted in blebbing of the plasma membrane, suggesting a 
further role in reorganisation of the actin cytoskeleton and plasma membrane (Jin 
et al., 2000). The reorganisation of the cytoskeleton is an important factor in 
synaptic plasticity and studies have shown that DMPK may also play a role in this, 
which could be relevant to the cognitive impairment observed in DM1 (Schulz et 
al., 2003). Further studies have identified possible substrates for DMPK which 
include phospholemman, phospholamban and the targeting subunit of myosin 
phosphatase (Mounsey et al., 2000; Muranyi et al., 2001; Kaliman et al., 2005). 
DMPK has also been shown to phosphorylate histone H1 in vitro (Dunne et al., 
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1994). A novel heat shock protein, designated myotonic dystrophy protein kinase 
binding protein (MKBP), was shown to bind and activate DMPK in vitro. MKBP 
was found to be highly expressed in human heart and skeletal muscle (Suzuki et 
al., 1998). Recently, DMPK has been shown to bind to other heat shock proteins 
including αB-crystallin, which is predominantly expressed in the lens, heart and 
skeletal muscle, which are all tissues affected by DM1 (Forner et al., 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9 – A diagrammatic representation of the protein domain organisation of DMPK 
isoforms produced by alternative splicing of the DMPK gene. DMPK A-F are the major 
isoforms, whereas DMPK G is a minor isoform only found in humans. All isoforms share a 
leucine-rich N-terminal domain, a serine/threonine protein kinase domain and a coiled-coil 
region.  Alternative splicing events lead to the presence or absence of a VSGGG motif within 
the kinase domain and the production of three different C-terminal tails, with a fourth 
unique tail exclusive to the minor G isoform (image from Wells & Ashizawa (2006)).  
 
 
Immediately downstream of the DMPK gene is the gene SIX5 which 
contains 3 exons and encodes a homeodomain containing transcription factor. 
SIX5 contains a Six domain (SD) which lies immediately N-terminal to a Six-type 
homeodomain (HD), which are both required for binding to specific DNA 
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sequences and also to transcriptional coactivators (Kawakami et al., 2000). SIX5 
can also act as a transcriptional repressor through interactions between the SD and 
Groucho family corepressors (Sato et al., 2002). SIX5 has been shown to bind to 
the Na+/K+ ATPase α1 subunit gene (ATP1A1) regulatory element (ARE) and the 
myogenic enhancing factor 3 (MEF3) consensus sequence, which regulate 
expression of genes such as ATP1A1, myogenin, aldolase A and cardiac troponin 
C (Harris et al., 2000). SIX5 is expressed in human skeletal and heart muscle, eye 
and brain (Thornton et al., 1997; Winchester et al., 1999). The mouse homologue 
has also been shown to be expressed in the testis where it is proposed to play a 
role in spermatogenic cell survival and spermiogenesis (Sarkar et al., 2004b).  
Upstream of DMPK is the gene DMWD which is around 11 kb in length 
and contains 5 exons (Jansen et al., 1995). The protein encoded by this gene has a 
proline rich N-terminal domain and contains four WD repeat units, but its 
function is unknown. DMWD is most prominently expressed in the brain and 
testis, but also in the heart, liver, kidney and spleen (Shaw et al., 1993; 
Westerlaken et al., 2003). High levels of the protein DMWD have been found in 
maturing and mature neurones, especially in the dendritic projections which 
contain many synapses, leading to speculation that it is involved in neuronal 
development (Westerlaken et al., 2003). 
 
1.5.2 How does the DNA triplet repeat cause DM1?  
Despite the discovery of the mutation that underlies DM1, the pathological 
mechanisms that lead to the wide array of symptoms seen in the disease is the 
subject of much debate. Many theories exist to explain how the expansion of a 
DNA triplet repeat could cause the multisystemic effects observed in DM1 but 
there are currently three main hypotheses to explain this: a reduction in DMPK 
expression; a reduction in expression of the neighbouring genes, SIX5 and DMWD; 
or a gain of function by the mutant DMPK mRNA. There is support for all three 
hypotheses but whether the effects seen in the patients can be attributed to only 
one or a combination of these is unknown. 
 
1.5.2.1 DMPK haploinsufficiency 
As the repeat is found within the DMPK gene, the most obvious theory for 
the cause of DM1 is an effect in cis on the DMPK gene resulting in a change in 
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the DMPK protein. As the repeat is located in a non-coding region of the DMPK 
gene, the disease is unlikely to be the result of a gain of function through the 
production of a mutant protein. However, it could be the result of a reduction in 
the expression of DMPK or a reduction in the translation of DMPK mRNA into 
protein.  
Studies have shown that mutant DMPK mRNA forms highly stable foci 
which are retained in the nucleus, however, a threshold of around 150 repeats has 
to be reached before this is observed (Taneja et al., 1995; Davis et al., 1997; 
Hamshere et al., 1997). The retention of transcripts only occurs from the affected 
allele, whereas those from the normal allele are able to pass into the cytoplasm, 
making them available for translation. Some mutant transcripts have been found 
within the cytoplasm but only as the result of the breakdown of the nuclear 
envelope during cell division, however, many of the tissues affected by DM1 are 
predominantly composed of postmitotic cells, therefore the retention of transcripts 
most likely results in haploinsufficiency of DMPK (Davis et al., 1997).  
Despite the evidence for this hypothesis it is unlikely to be sufficient to 
cause DM1 alone as no case of DM1 has ever been shown to be the result of a 
point mutation in the DMPK gene (Day & Ranum, 2005). Studies carried out in 
mice have shown that knockouts of one or both alleles of Dmpk result in only 
mild effects and development seemed unaffected (Jansen et al., 1996; Reddy et al., 
1996; Berul et al., 1999; Llagostera et al., 2007). The study by Jansen et al. (1996) 
showed only minor muscle fibre size changes in adult nullizygous (Dmpk-/-) mice, 
whereas Reddy et al. (1996) showed a progressive, late onset, skeletal myopathy, 
which was compared to the adult onset form of DM1. Berul et al. (1999) showed 
that Dmpk-/- mice develop cardiac conduction defects which are also characteristic 
of the human form of the disease. Subsequently, cardiac myocytes isolated from 
Dmpk+/- and Dmpk-/- mice were shown to display abnormalities in Na+ channel 
gating and Ca2+ cycling, both of which were implicated in the cardiac dysfunction 
observed in DM1 (Lee et al., 2003; Pall et al., 2003). A more recent study by 
Llagostera et al. (2007) showed that Dmpk-/- mice exhibit impaired insulin 
signalling and have an abnormal glucose tolerance which could be linked to the 
insulin resistance which leads to diabetes in DM1. Despite the features seen in the 
mouse models, none of the studies have shown the additional signs and symptoms 
characteristic of DM1, such as myotonia and cataract. It is therefore unlikely that 
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all of the effects seen in DM1 are the result of haploinsufficiency of DMPK, but it 
is possible that this contributes to the effects.  
 
1.5.2.2 Reduced expression of SIX5 and DMWD 
 The second hypothesis aimed at describing the cause of DM1 is a cis-
acting effect on the surrounding genes at the DM1 locus. The genes at the locus 
are so close that the 3’ terminus of the DMWD gene overlaps with the promoter of 
the DMPK gene and the 3’ terminus of the DMPK gene overlaps with the 
promoter of the SIX5 gene (Shaw et al., 1993; Boucher et al., 1995; Frisch et al., 
2001). The expansion of the CTG repeat has been suggested to result in changes 
to the higher-order structure of the DNA, resulting in changes in expression levels 
of the surrounding genes, known as the ‘field-effect’. The extended CTG repeats 
seen in DM1 have been shown to create the strongest known natural nucleosome 
positioning signal which attracts nucleosome assembly in vitro (Wang et al., 
1994). The wrapping of the CTG repeat around nucleosomes results in alterations 
to the local chromatin structure which limits the accessibility and formation of 
transcriptional complexes and could therefore limit the expression of all three 
genes at the DM1 locus.  
The promoter region of SIX5 contains an exceptionally large (around 3.5 
kb) CpG island (cytosine and guanine nucleotides joined by phosphodiester 
bonds), which is interrupted by the CTG repeat (Boucher et al., 1995). The triplet 
repeat expansion has been shown to alter the chromatin structure around the site, 
making the DNA in the region less accessible to nuclear proteins, such as DNase I 
(Otten & Tapscott, 1995). Many studies have looked at the expression levels of 
SIX5 in DM1 and the majority have shown a reduction in expression (Hamshere et 
al., 1997; Klesert et al., 1997; Thornton et al., 1997; Eriksson et al., 1999; Inukai 
et al., 2000; Frisch et al., 2001; Rhodes et al., 2006). Thornton et al. (1997) 
showed that expression of the DM1-linked allele in myoblasts of DM1 patients 
was reduced and in some cases approached complete inactivation, however, 
expression was not reduced in a DM1 patient with a small CTG expansion (< 80 
repeats) and no muscle weakness. Surprisingly, Klesert et al. (1997) and Inukai et 
al. (2000) showed that expression of SIX5 was actually reduced by more than half, 
suggesting that expression from the normal allele was also somehow affected. 
Conflicting studies by Hamshere et al. (1997) and Eriksson et al. (1999) showed 
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no difference in levels of SIX5 expression in DM1 cell lines and skeletal muscle 
samples compared to controls.  
Knock-out studies performed in mice have shown that partial (Six5+/-) or 
complete (Six5-/-) loss of Six5 results in the development of some of the signs and 
symptoms characteristic of DM1. Both Six5+/- and Six5-/- mice develop cataracts 
and the incidence and severity of lens opacities were shown to increase with 
decreasing Six5 dosage (Klesert et al., 2000; Sarkar et al., 2000). A further study 
has shown that male Six5-/- mice are sterile and suffer from testicular atrophy and 
both Six5+/- and Six5-/- mice were shown to have increased FSH levels (Sarkar et 
al., 2004b). These are all characteristic symptoms of DM1; however, it is unlikely 
that a loss of SIX5 alone could cause DM1 due to the lack of any abnormalities in 
skeletal muscle function. 
In the field-effect model, levels of DMWD expression are also predicted to 
be affected by the change in local chromatin structure. Again, a number of studies 
have looked at expression levels of DMWD and have had conflicting results 
(Hamshere et al., 1997; Alwazzan et al., 1999; Eriksson et al., 1999; Frisch et al., 
2001). Hamshere et al. (1997) and Frisch et al. (2001) showed that there was no 
difference in levels of DMWD expression between DM1 and control cell lines and 
Eriksson et al. (1999) showed considerable overlap in expression levels in skeletal 
muscle biopsies from DM1 patients and control individuals. However, Eriksson et 
al. (1999) did show that there was a strong inverse correlation between repeat size 
and DMWD expression in the patient samples. Alwazzan et al. (1999) performed 
allele-specific analysis in both nuclear and cytoplasmic compartments of DM1 
and control fibroblast cell lines. No difference was seen in levels of transcripts in 
the nuclear fraction, but a reduction in expression of 20-50% from the DM1-
linked allele was seen in the cytoplasmic fraction. No correlation was seen in this 
study between repeat size and expression levels in the cell lines. 
CNS abnormalities are common in DM1 with features such as variable 
cognitive dysfunction (including memory loss, lower IQ and mental retardation), 
somnolence, anxiety disorders and cerebral white matter lesions being associated 
with the disease (Harper, 2001). DMWD is found mainly in the brain and changes 
in DMWD expression levels could result in the CNS abnormalities observed. The 
inverse correlation between repeat size and DMWD expression in DM1 patients 
samples observed by Eriksson et al. (1999) could be used to describe why mental 
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retardation is such a prominent feature in congenital DM1 where repeat sizes are 
very large, compared to lower IQs which are seen in patients with adult onset 
DM1. There are at present no mouse models to elucidate any possible effects 
caused by a loss of DMWD. 
The field-effect hypothesis aims to describe the multisystemic effects seen 
in DM1 by the loss of multiple genes at the DM1 locus; however, there are still 
symptoms of DM1 that have not been observed in mouse models. One of the 
characteristic features of DM1 is myotonia, which has not been described by this 
theory. The theory also fails to explain how a second form of DM, DM2, can 
present with almost identical symptoms such as myotonia, cataract and cardiac 
abnormalities, without having any link to the DM1 locus or the genes within it. It 
is clear that although the field-effect model could explain some of the 
multisystemic effects observed in DM1, a further pathogenic mechanism must be 
present to explain the remaining effects.  
 
1.5.2.3 Toxic gain of function by DMPK mRNA 
The final theory to describe the cause of DM1 is the trans-acting effect of 
the repeat at the mRNA level. The DNA triplet repeat is transcribed into RNA, 
resulting in a CUG(n) repeat which is proposed to form stable secondary structures 
that sequester specific RNA binding proteins in a gain-of-function manner. The 
proteins sequestered by the CUG repeats have roles in splicing and could explain 
the altered splice patterns which are observed in DM1. The toxic gain of function 
hypothesis has the greatest support as the cause of DM and current research 
efforts are mostly focused in this area. 
 Evidence for this theory came from a study where expanded (around 250 
repeats) and non-expanded (5 repeats) repeats were inserted into a genomic 
fragment containing the human skeletal actin (HSA) gene and were expressed in 
the muscle of transgenic mice (Mankodi et al., 2000). The expanded repeats were 
inserted into the final exon of the HSA gene between the termination codon and 
polyadenylation site to mimic the situation seen in the DMPK gene, but without 
involving any of the genes that are normally associated with DM1. Mankodi et al. 
(2000) showed that the presence of long triplet repeats caused myotonia in mice 
as early as 4 weeks of age, which did not occur in short-repeat or wild-type mice. 
Myotonia was not observed in any of the previous mouse models for the disease 
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involving knock-outs of the genes at the DM1 locus. The transcripts were also 
observed to form foci and be retained in the nucleus, as is seen with the mutated 
DMPK transcripts in DM1.  
 The expanded CUG repeats have been shown to form stable hairpin 
structures where the repeat tract folds back on itself and results in double-stranded 
RNA (dsRNA) with G·C and C·G base pairs separated by U·U mismatches (Tian 
et al., 2000). The dsRNA structures have been shown to bind to and activate PKR, 
which is the dsRNA-activated protein kinase. PKR is involved in the viral 
response pathway which aims to prevent or slow viral replication through 
initiating mechanisms such as increased mRNA degradation and apoptosis (Tian 
et al., 2000). The CUG repeats have also been shown to bind to RNA-binding 
proteins from two families known as CUG-BP1 and ETR-3-like factors (CELF) 
and muscleblind-like (MBNL) proteins (Timchenko et al., 1996; Miller et al., 
2000). Both families are involved in the regulation of alternative splicing events 
during mRNA processing. The misregulation of splicing events is a characteristic 
of DM1, where the splicing patterns for a subset of transcripts revert to those 
observed during embryonic development. The MBNL proteins, MBNL1, MBNL2 
and MBNL3, bind to the dsRNA formed by the CUG repeats and have been 
shown to co-localise with the foci produced by mutant DMPK transcripts in DM1 
cells (Fardaei et al., 2001; Fardaei et al., 2002). The MBNL proteins are 
sequestered by the mutant DMPK transcripts and are unable to perform their usual 
functions. MBNL proteins regulate alternative splicing of muscle-specific 
chloride channel (ClC-1), cardiac troponin T (TNNT2), skeletal muscle troponin 
T (TNNT3), insulin receptor (IR) and Tau (τ) (Kanadia et al., 2003; Ho et al., 
2004; Jiang et al., 2004; Dansithong et al., 2005; Dhaenens et al., 2008). 
Interestingly, the Drosophila MBNL homologue, muscleblind, is essential for 
terminal differentiation of muscle and the photoreceptors of the eye, which are 
two tissues affected by DM1 in humans (Begemann et al., 1997; Artero et al., 
1998). In contrast to the MBNL proteins, CUG-binding proteins 1 and 2 (CUG-
BP1/2) are not sequestered by the CUG repeats, although a small fraction may 
localise to foci as they have been shown to bind to single-stranded RNA (ssRNA) 
at the base of the CUG repeat hairpin (Timchenko et al., 1996; Lu et al., 1999; 
Michalowski et al., 1999; Fardaei et al., 2001). In DM1, CUG-BP1/2 are 
translocated to the nucleus of DM1 cells where they have been shown to be 
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hyperphosphorylated by PKC (Timchenko et al., 1996; Roberts et al., 1997; 
Philips et al., 1998; Kuyumcu-Martinez et al., 2007). Phosphorylation of CUG-
BP1/2 increases their half life, resulting in their accumulation and therefore 
increased levels of activity. Despite the increase in activity, levels of CUG-BP1/2 
mRNA were not affected in DM1 (Timchenko et al., 2001a). CUG-BP1/2 act 
antagonistically to MBNL proteins in the splicing of TNNT2, IR and ClC-1 
(Philips et al., 1998; Savkur et al., 2001; Charlet-B et al., 2002; Ho et al., 2004; 
Dansithong et al., 2005; Paul et al., 2006). Foetal splicing patterns of these 
transcripts are observed in DM1 and may contribute to the cardiac abnormalities, 
insulin resistance and myotonia which are common features of the disease.  
Evidence for the toxic RNA theory comes from a knockout mouse model 
for Mbnl1 which was shown to develop cataracts with dust-like opacities, 
myotonia and altered regulation of mRNA splicing of transcripts for ClC-1, 
TNNT3 and TNNT2 (Kanadia et al., 2003). A knockout mouse model for Mbnl2 
has also been shown to develop myotonia, display histological features of muscle 
such as increased numbers of central nuclei and decreased fibre size and show 
altered regulation of mRNA splicing of transcripts for ClC-1 (Hao et al., 2008). 
Down-regulation of MBNL1/2 expression in normal human myoblasts using small 
interfering RNA (siRNA) resulted in abnormal IR splicing, as did overexpression 
of CUG-BP1 (Dansithong et al., 2005). In the same study it was also shown that 
MBNL1 down-regulation caused disaggregation of 70% of the foci formed in 
DM1 cells, compared to 25% following MBNL2 downregulation, suggesting that 
MBNL1 plays a key role in foci formation and maintenance (Dansithong et al., 
2005). Morpholino antisense oligonucleotides have also been used to block the 
interaction of Mbnl1 with CUG repeats in the transgenic mouse model of DM1 
where CUG repeats were inserted into the HSA gene. Nuclear foci were reduced 
and Mbnl1 was redistributed, allowing the regulation of splicing events to be 
corrected (Wheeler et al., 2009). MBNL proteins have also been shown to co-
localise with mutant transcripts in nuclear foci and have been implicated in the 
abnormal splicing of ClC-1 and IR in DM2 (Mankodi et al., 2001; Fardaei et al., 
2002; Mankodi et al., 2002; Savkur et al., 2004). The toxic gain of function model 
could therefore explain the similarities between the two forms of DM, as the 
production of foci and sequestration of MBNL proteins occur irrespective of the 
genes that are affected by the repeat mutations. 
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Interestingly, DM-like symptoms were induced in transgenic mice 
overexpressing DMPK containing a normal number of CTG repeats (11 repeats). 
DMPK transcripts were found to accumulate over time and symptoms became 
apparent in ageing mice between 11-15 months old. Symptoms included muscle 
myopathy and myotonia, hypertrophic cardiomyopathy and a reduction in the 
tolerated workload of the mice. The authors suggested that this was due to the 
accumulation of DMPK transcripts containing smaller repeats which mimicked 
the effects of those containing larger CUG repeats in DM1 (O'Cochlain et al., 
2004). A separate group have also shown that the overexpression of a normal 
DMPK 3’ UTR containing 5 CTG repeats leads to DM-like symptoms in 
transgenic mice, however, these effects were not age-dependent. This study 
showed that the transgenic mice developed myotonia as early as 2 days after the 
induction of transgene expression and sudden death due to cardiac conduction 
defects occurred after 4-6 weeks (Mahadevan et al., 2006). A subsequent study by 
the same group showed that overexpression of the normal DMPK 3’ UTR induced 
expression of the cardiac-specific transcription factor NKX2-5 which resulted in 
reduced levels of connexin 43 and connexin 40 (Yadava et al., 2008). Connexins 
are important components of gap junctions which are required for the propogation 
of electrical impulses in the heart. In the same study the level of NKX2-5 was also 
found to be greater in the hearts of human DM1 patients and it was also present in 
DM1 skeletal muscle, but not in controls (Yadava et al., 2008). Although the data 
described here appears to show that the CTG repeats are not responsible for the 
symptoms of DM1, it indicates that a gain of function by the DMPK transcripts is. 
 
1.6 The eye and myotonic dystrophy 
 
 The eye is one of the many systems affected by DM1 and a wide range of 
ocular problems can occur. Symptoms in the eye include cataract, retinal 
degeneration, low intraocular pressure, enophthalmos, ptosis, epiphora, corneal 
lesions, extraocular myotonia and muscle weakness and abnormal central control 
of eye movement (Harper, 2001). Not all of the ocular abnormalities may be 
present and many of them go unnoticed by the sufferer, but a reliable symptom 
present in the majority of patients, and even in those unaffected by the more 
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general muscle symptoms, is cataract. Cataracts result in a loss of visual acuity 
and contrast sensitivity which can make everyday tasks very difficult. 
 
1.6.1 Cataract and myotonic dystrophy 
 Cataracts were first linked to DM1 over one hundred years ago and since 
then have formed the basis of the phenomenon of anticipation in the disease. 
Cataract is a characteristic symptom of DM1 and even occurs in the adult onset 
form with minimally expanded CTG repeats, linking seemingly unaffected 
individuals to the disease (Harper et al., 2004). Cataracts are therefore often found 
in older generations of affected individuals and can be used to identify the line by 
which the disease was inherited, enabling other family members who may be 
affected by the disease to be identified. DM1 cataracts normally present at an 
earlier age than is usually associated with senile cataracts and have been seen in 
DM1 patients from their second decade of life onwards. 
 The cataract that forms in DM1 is very distinctive in its early stages and 
cataract detection using slit-lamp examination was widely used as a diagnostic 
tool before genetic tests became available. The DM1 cataract is still used to 
identify new families with DM1 through minimally affected patients (Kidd et al., 
1995). In its early stages the DM1 cataract presents with white or multicoloured 
iridescent scattered dust-like opacities (see figure 1.10a), which are mainly found 
in the posterior subcapsular region of the lens (see figure 1.5). As the cataract 
develops the opacities increase in size and number and cortical spokes (see figure 
1.10b) and star-shaped opacities form, which cloud the lens and eventually form a 
mature cataract. At this stage the cataract is indistinguishable from those of other 
causes as the iridescent opacities can no longer be seen (Harper, 2001).  
 Ultrastructural analysis of cataractous lenses from DM1 patients using 
electron microscopy revealed that the characteristic dust-like iridescent opacities 
are actually whorls of plasma membrane. The whorls of plasma membrane were 
found in fibre cells from about 10 fibres deep within the lens and contained 
cytoplasm. LECs had poorly delineated plasma membranes and were shown to 
contain nuclei with clumped chromatin, degenerating mitochondria and enlarged 
intracellular clefts or cristernae (Eshaghian et al., 1978).  
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Figure 1.10 – Slit-lamp photographs of DM1 cataracts. (a) A DM1 cataract in its early stages, 
showing the white and iridescent scattered dust-like opacities which distinguish it from most 
other types of cataract (diffuse illumination). (b) A DM1 cataract at a slightly later stage 
where cortical spokes have begun to form and the scattered opacities become less 
conspicuous (retro-illumination) (images from http://www.onjoph.com). 
  
 
The underlying cause of cataract formation in DM1 is unknown. At the 
molecular level, both DMPK and SIX5 have been shown to be expressed in the 
eye and in particular in the lens. Conflicting results exist as to whether DMPK is 
actually expressed in the lens, but studies have shown it to be expressed in human, 
bovine and mouse lenses (Dunne et al., 1996; Abe et al., 1999; Winchester et al., 
1999; Sarkar et al., 2004a; Rhodes et al., 2006). SIX5 has been implicated in the 
development of DM1 cataracts due to its role as a transcription factor in 
regulating ATP1A1 expression. If ATP1A1 expression is altered it could affect the 
ion balance in the lens and lead to cataract (Winchester et al., 1999). Two 
different studies conducted at the same time showed that Six5 knockout mouse 
models developed cataracts, however, the cataracts which formed were nuclear 
and not posterior subcapsular as is seen in DM1 in humans (Klesert et al., 2000; 
Sarkar et al., 2000). RNA extracted from the mouse models was used to analyse 
steady-state Atp1a1 mRNA levels and had conflicting results. Klesert et al. (2000) 
showed that there was no difference in steady-state levels, whereas Sarkar et al. 
(2000) showed that steady-state levels increased as a function of decreasing Six5 
a b 
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dosage. The role of SIX5 and ATP1A1 in DM cataract is therefore still the subject 
of debate. Overexpression of DMPK in lens cells has been shown to result in 
apoptotic-like blebbing and actin cytoskeleton reorganisation, resulting in 
speculation that DMPK may play a role in the breakdown of organelles during 
lens fibre differentiation (Jin et al., 2000). If this was the case then it has been 
proposed that reduced levels of DMPK could result in cataract formation due to 
the decreased removal of intracellular membranes, leading to the retention of 
organelles which can obscure vision (Jin et al., 2000). Loss of DMPK, if its 
predicted role is true, could therefore account for the observations from the 
ultrastructural studies which showed that the iridescent particles were light 
reflecting membranous structures derived from the plasma membrane (Eshaghian 
et al., 1978). If DMPK is indeed expressed in the lens then mutant RNA could 
also accumulate and sequester MBNL proteins as shown in other tissues. 
Interestingly, a Mbnl1 knockout mouse model developed cataracts which showed 
the distinctive iridescent opacities normally observed in DM (Kanadia et al., 
2003). The MBNL homologue in Drosophila, known as muscleblind, is essential 
for muscle and eye differentiation, which would indicate a role for MBNL in the 
vertebrate eye. 
At the cellular level, studies on cataracts in general have pointed at a loss 
of cells from the lens epithelium in the development of cataract due to the 
resulting loss of homeostasis in levels of ions and water (Konofsky et al., 1987; Li 
et al., 1995). Capsulorhexis samples from cataract patients were shown to have a 
significantly greater percentage of apoptotic cells compared to normal controls 
and LEC death was shown to precede cataract development in cultured rat lenses 
(Li et al., 1995). Loss of cells from the LEC layer was shown to be particularly 
relevant in the development of subcapsular cataracts as the cell densities were 
much lower when compared to those of nuclear cataract (Konofsky et al., 1987). 
A study in DM1 lenses by Abe et al. (1999) has indeed shown that DM1 cataract 
patients have reduced LEC densities and this was more noticeable in a patient 
with an earlier onset of the disease. The LECs in DM1 patients were also shown 
to be larger and were therefore able to maintain coverage of the anterior surface of 
the lens, however, it is likely that a reduced number of LECs are unable to 
maintain the balance of ions and water which is vital to lens transparency (Abe et 
al., 1999). 
 53
Although cataracts are such a common feature in DM1, congenitally 
affected children do not present with cataract at birth and do not develop them 
within the first decade of life (Harper, 2001). This would indicate that the repeat 
expansion does not affect the development of the lens and must therefore exert its 
effects postnatally. A study by Abe et al. (1999) showed that DMPK mRNA 
extracted from DM1 LECs had larger repeats than that extracted from peripheral 
blood of the same patients (Abe et al., 1999). A study on cultured DM1 LECs has 
also shown that they contain large triplet repeats in the DMPK gene even in the 
earliest passage sampled, which are highly unstable and expand during culture 
(Rhodes et al., 2006). This data would indicate that the lens is subject to tissue-
specific somatic mosaicism which results in large repeat numbers. This could 
explain the sensitivity of the lens to even small repeat numbers as they could 
expand greatly compared to those found in other tissues, increasing their effects 
during the lifetime of the patient. 
  Cataract development results in a loss in visual acuity, but cataracts are 
one of the most easily treated symptoms of DM1. Despite this, the sensitivity of 
the lens to even the smallest of expansions in the triplet repeat makes it an ideal 
tissue in which to study the mechanisms behind the disease. 
 
1.7 Aims  
 
 Despite cataract being a key feature of DM1, very little is known about the 
mechanisms which underlie their development in the disease. This project aims to 
verify the suitability of lens cell lines derived from DM1 patients as a model for 
the disease and to use these cell lines to investigate the mechanisms which lead to 
cataract development.  
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1 Cell lines and culture 
 
 A number of cell lines were obtained and employed in a variety of 
experimental procedures to elucidate the effects of the DM1 triplet repeat 
mutation on cellular signalling.   
 
2.1.1 Cell lines 
 Four DM1 and four control cell lines were derived by simian virus 40 
(SV40) transformation of human LECs. Capsulorhexis specimens were obtained 
from DM1 patients immediately following cataract surgery and from non-
cataractous post mortem donor lenses. The transformations were performed by Dr 
A. R. Prescott (University of Dundee, UK) as follows: the cells on capsulorhexis 
specimens were immortalised using adenovirus 12-SV40 hybrid virus, which was 
added directly to each specimen in a 24-well microtitre plate. SV40 immortalises 
cells via the production of large T antigen which binds to and inactivates the 
tumour suppressor proteins retinoblastoma protein (pRb) and p53. Once the cells 
had migrated and covered over 50% of the well (2-3 weeks) they were trypsinised 
and transferred into a 6-well plate. Once the cells reached confluency they were 
passaged into larger flasks until a sufficient number of cells could be frozen. The 
four DM1 cell lines named DMCat1-DMCat4 were obtained from patients aged 
67, 33, 31 and 69 respectively. The four control cell lines named CCat1-CCat4 
were obtained from donors aged 28, 43, 32 and 82 years respectively.  
A further human lens cell line, FHL124 (obtained from Dr J. R. Reddan, 
Oakland University, Michigan, USA), was also used in this study. The FHL124 
cell line is a spontaneously transformed human lens cell line derived from foetal 
capsule-epithelial explants (Reddan et al., 1999).   
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2.1.2 Cell culture 
 Cells stored under liquid nitrogen were brought up from frozen and 
cultured in 75 cm2 flasks (Nunc, Roskilde, Denmark) in Eagle’s Minimum 
Essential Medium (EMEM) (Sigma-Aldrich, Poole, Dorset, UK) supplemented 
with 10% Foetal Calf Serum (FCS) (Gibco, Paisley, Renfrewshire, UK) (5% FCS 
for FHL124 cells) and 50 µg/ml gentamicin antibiotic (Sigma-Aldrich). Medium 
was changed twice per week and cultures were maintained in an incubator at 35°C 
in an atmosphere of 5% CO2. Cells were passaged weekly by rinsing with 
Dulbecco’s phosphate buffered saline (DPBS, Sigma-Aldrich), followed by 
treatment with trypsin-ethylenediaminetetraacetic acid (EDTA) (0.05% trypsin 
and 0.02% EDTA in Hank’s balanced salt solution, Sigma-Aldrich) for 2-3 
minutes to detach the cells from the flask. The trypsin was neutralised with 
EMEM supplemented with 10% FCS and the cell suspension was transferred to a 
universal tube. Cell number was estimated using a haemocytometer. The cell 
suspension was centrifuged at 1000 rpm for 5 minutes and the pellet was 
resuspended in EMEM supplemented with 10% FCS. New flasks were seeded 
with known densities of cells and growth curves showing population doublings 
were created from the cell counts. The cell suspension was also used to seed cells 
onto coverslips (VWR International, Lutterworth, Leicestershire, UK) or culture 
dishes (Corning Incorporated, Corning, NY, USA). Unless stated otherwise, all 
cells were cultured in EMEM supplemented with 10% FCS and 1 µl/ml 
gentamicin. 
 
2.1.3 Conditioned medium (CM) collection 
To obtain CM, cells in 75 cm2 flasks were rinsed three times with 20 ml of 
serum-free (SF) EMEM before incubating in 10 ml of SF EMEM for 24 hours. 
CM was collected in universal tubes and centrifuged at 1000 rpm for 5 minutes to 
remove particulates. The supernatant was either used immediately or stored at          
-20°C until required. CM was also collected from 35 mm diameter culture dishes 
by the same method.  
 
 
 
 56
2.2 Cell treatment 
 
 A range of chemical activators and inhibitors of a variety of cell signalling 
molecules were employed to study the effects of particular signalling pathways on 
cell growth and death.   
 
 
 
 
Table 2.1 – Chemical and biological activators and inhibitors of cell signalling used in cell 
growth experiments.  
 
 
2.2.1 Cell growth experiments 
 To test the effects of various compounds on the levels of cell growth and 
death, cells were seeded into 35 mm diameter culture dishes. Cells were cultured 
for up to one week until they reached 60-70% confluency. The medium was 
replaced with SF medium without phenol red (Sigma-Aldrich) for 24 hours before 
the cells were exposed to experimental conditions for 48 hours. Following this, 
the experimental culture medium was collected and stored at 4ºC and the cells 
were rinsed in Phosphate Buffered Saline (PBS, Oxoid, Basingstoke, Hampshire, 
UK) before being lysed in 1 ml of 0.1 M NaOH. The lysates were stored at 4ºC. 
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Total protein was measured using a bicinchoninic acid (BCA) assay (Pierce, 
Cramlington, Northumberland, UK) and the level of lactate dehydrogenase (LDH) 
was measured using a Cytotoxicity Detection kit (Roche, Burgess Hill, West 
Sussex, UK). Additionally, some of the dishes were lysed in Mammalian Protein 
Extraction Reagent (MPER, Pierce) for Western blot analysis as described in 
section 2.8. Compounds tested in this way are summarised in table 2.1.  
 
2.2.2 Bicinchoninic acid (BCA) protein assay 
 The protein concentration in cell lysates was determined using a BCA 
protein assay (Pierce), which is a colorimetric assay based on the reduction of 
Cu2+ to Cu1+ by protein. The assay was performed according to the manufacturer’s 
instructions described as follows: a series of standards ranging from 1-1000 µg/ml 
were prepared by diluting a 2 mg/ml Bovine Serum Albumin (BSA, Sigma-
Aldrich) stock made up in either MPER (Pierce) or 0.1 M NaOH, depending on 
the method of cell lysis. Either 10 µl of cell lysate extracted in MPER or 20 µl of 
cell lysate extracted in 0.1 M NaOH were pipetted into a 96-well microtitre plate. 
The samples were made up to 50 µl with the appropriate volume of H2O. The 
standards were tested in triplicate and the samples in duplicate. The working 
reagent was prepared by mixing Reagent A and Reagent B in a ratio of 50:1 and 
200 µl was added to each well. The plate was gently shaken for 1 minute to mix 
the samples and working reagent together and was then incubated at 37ºC for 1 
hour. The plate was allowed to cool and the absorbance at 562 nm was read on a 
Wallac 1420 VICTOR2 multilabel plate counter using WorkOut 1.5 software 
(Perkin Elmer, Waltham, MA, USA). A standard curve was constructed and the 
concentration of protein in the samples was calculated. 
 
2.2.3 Lactate dehydrogenase (LDH) assay 
 Cell death was quantified using a Cytotoxicity Detection kit (Roche) 
which is a colorimetric assay of LDH activity released from the cytosol of 
damaged cells. The assay was performed according to the manufacturer’s 
instructions described as follows: cell medium was collected in 1.5 ml 
microcentrifuge tubes and briefly vortexed before being centrifuged for 5 minutes 
at 13 000 rpm. The supernatants were collected and stored at 4°C until required. 
100 µl of each sample was added to a 96-well microtitre plate. For background 
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correction 100 µl of fresh medium, along with any compounds used, was also 
added in triplicate. The reaction mixture was prepared by mixing the catalyst 
(diaphorase/NAD+) and dye solution (iodotetrazolium chloride and sodium lactate) 
at a ratio of 1:45 and 100 µl of this was added to each sample. The plate was 
incubated in the dark for up to 30 minutes at room temperature. The reaction was 
terminated by addition of 50 µl of 1 N hydrochloric acid (HCl) to each well. The 
absorbance of the reaction product was measured at 490 nm using a Wallac 1420 
VICTOR2 multilabel plate counter and WorkOut 1.5 software (Perkin Elmer). 
 
2.2.4 Cell growth with conditioned medium (CM)  
CM was applied to FHL124 cells which had been grown in SF medium for 
24 hours. After 48 hours the cells were lysed in 1 ml of 0.1 M NaOH and protein 
levels were measured using a BCA assay (described in section 2.2.2).  
To analyse the effects of CM addition on cell signalling in the FHL124 
cells using Western blotting (described in section 2.8), cells were lysed in 400 µl 
of MPER (Pierce).  
 
2.3 TaqMan® Quantitative real time polymerase chain reaction (QRT-PCR) 
 
The technique of QRT-PCR was used to analyse gene expression levels in 
the cell lines. The TaqMan® QRT-PCR system is based on the use of a 
fluorogenic-labelled oligonucleotide probe which has a fluorescent reporter dye 
on the 5’ end and a quencher dye on the 3’ end. When intact the reporter and 
quencher dyes are in close proximity and fluorescence of the reporter dye is 
quenched via fluorescence resonance energy transfer (FRET) by the quencher dye. 
Each reaction requires gene specific primers and probes. The primers anneal to the 
cDNA and amplify the region between the primers. The probe anneals to a 
sequence within the amplified region and is cleaved by the 5’ nuclease activity of 
Taq DNA polymerase during primer extension. Cleavage of the probe results in 
separation of the quencher and reporter dyes, allowing fluorescence of the reporter 
dye. During each PCR cycle a number of probes will be cleaved and the level of 
fluorescence will increase in proportion to the amount of message present for the 
gene of interest. The fluorescent signal is recorded for a total of 40 cycles. The 
point at which the fluorescent signal increases above the background is referred to 
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as the threshold cycle (CT) value and is used as a measure of the starting template 
present in each sample. The TaqMan process is summarised in figure 2.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 – A summary diagram of the principles behind the TaqMan RT-PCR system. The 
probe anneals to the cDNA but is displaced and cleaved during primer extension. The 
quencher and reporter dyes are separated, enabling the fluorescence of the reporter dye. 
 
 
2.3.1 RNA extraction 
 Cells were seeded into 60 mm diameter culture dishes and grown for one 
week before the medium was replaced with SF medium for 24 hours. Cells were 
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exposed to experimental conditions and RNA was extracted using an RNeasy 
Mini kit (Qiagen, Crawley, West Sussex, UK) according to the manufacturer’s 
protocol described as follows: the medium was aspirated and the cell membranes 
were disrupted by addition of 600 µl of buffer RLT with 10 µl/ml β-
mercaptoethanol. The dishes were scraped and the lysates were collected in 1.5 ml 
microcentrifuge tubes. The samples were homogenised by being vortexed and 
passed through a 20-gauge needle (0.9 mm diameter) at least 5 times. An equal 
volume of 70% ethanol was added to the homogenised sample to aid the binding 
of RNA to the membrane of the spin column. The lysate was passed through the 
columns by centrifuging for 15 seconds at 10 000 rpm. The flow through was 
discarded and 350 µl of buffer RW1 was applied to the column. The column was 
centrifuged for 15 seconds at 10 000 rpm and the flow through discarded. On 
column DNase digestion was performed using an RNase-free DNase I kit 
(Qiagen). The DNase stock solution and buffer RDD were mixed in a ratio of 1:7 
and a total of 80 µl was then applied to each column and incubated for 15 minutes 
at room temperature. Following this, a further 350 µl of buffer RW1 was added 
and the column was centrifuged for 15 seconds at 10 000 rpm. The flow through 
was discarded and 500 µl of buffer RPE was added to each column and 
centrifuged for 15 seconds at 10 000 rpm. A further 500 µl of buffer RPE was 
added and the column was centrifuged for 2 minutes at 10 000 rpm followed by a 
further 1 minute in a new collection tube to dry the membrane. The column was 
transferred to an RNase free 1.5 ml microcentrifuge tube and the RNA was eluted 
in 30-50 µl of RNase free water. The column was spun for 1 minute at 10 000 rpm 
and the RNA was then stored at -80ºC. The quantity of RNA was measured using 
a NanoDrop ND-1000 spectrophotometer (NanoDrop, Wilmington, DE, USA). 
 
2.3.2 Reverse transcriptase-polymerase chain reaction (RT-PCR) 
 RNA was reverse transcribed into cDNA using a PTC-200 DNA engine 
(MJ research, Reno, NV, USA). A total of 1 µg of RNA in 10 µl of RNase-free 
water was added to a thin-walled nuclease-free microcentrifuge tube. To this, 1 µl 
of Random primers (Invitrogen, Paisley, Renfrewshire, UK) and 1 µl of 10 mM 
dNTP Mix (Bioline, London, UK) were added and mixed by flicking the tube. 
The contents were collected at the bottom of the tube by briefly centrifuging 
before heating the mixture to 65°C for 5 minutes and then quickly chilling on ice. 
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Then 4 µl of 5X First-strand buffer, 2 µl of 0.1 M Dithiothreitol (DTT) and 1 µl 
RNasin® Ribonuclease Inhibitor (Promega, Southampton, Hampshire, UK) were 
added before incubating at 25°C for 10 minutes followed by 42°C for 2 minutes. 
Following this, 1 µl of SuperScript™ II reverse transcriptase (Invitrogen) was 
added and the mixture was incubated at 42°C for 50 minutes and then at 70°C for 
15 minutes. The cDNA product was stored at -20°C.  
 
 
 
 
Table 2.2 – The genes analysed by TaqMan QRT-PCR. The assay identification numbers for 
the probes purchased from Applied Biosystems are also shown.  
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2.3.3 TaqMan® Quantitative real time PCR (QRT-PCR) 
 Gene expression levels were measured using QRT-PCR (TaqMan®) 
performed using a standard run on a 7500 Fast Real-Time PCR System (Applied 
Biosystems, Warrington, Cheshire, UK). A total of 5 ng of sample cDNA was 
loaded per well of a MicroAmp® Optical 96-Well Reaction Plate (Applied 
Biosystems), except for those of the standard curve which had varying amounts of 
cDNA and those for analysis of 18S which had 1 ng per well. Gene-specific 
primers and probes (Applied Biosystems) were used to measure expression levels 
(see table 2.2 for a list of genes assayed). The primers and probes were mixed 
with Mastermix (Applied Biosystems) containing the components necessary for 
the PCR reaction to give a total reaction volume of 25 µl. The reactions were 
performed under the following conditions: 50ºC for 2 minutes, 95ºC for 10 
minutes followed by 40 cycles consisting of 95ºC for 15 seconds and 60ºC for 1 
minute. The threshold cycle (CT) values were obtained and the results were 
normalised to the 18S expression values. 
 
2.4 Northern blot 
  
The technique of Northern blotting was used to confirm the expression 
levels of the DMPK gene previously analysed by TaqMan QRT-PCR. Gel 
electrophoresis separates RNA by size and following transfer to a blotting 
membrane the RNA of interest is detected using a radiolabelled probe 
complimentary to the target sequence. 
 
2.4.1 RNA extraction 
 RNA was extracted as previously described in section 2.3.1. 
 
2.4.2 Agarose/formaldehyde gel electrophoresis 
 A 1.2% agarose gel was made in an RNase free tank containing 6.6% 
formaldehyde and 1x MOPS (0.02 M MOPS (3-[N-morpholino]propanesulfonic 
acid) (pH 7.0), 5 mM sodium acetate and 1 mM EDTA (pH 8.0) in DEPC treated 
H2O). Once the gel had set it was immersed in running buffer (1x MOPS and 
0.74% formaldehyde in H2O with ethidium bromide). The samples (8.5 µg of 
RNA) were concentrated to a volume of (around) 5 µl by vacuum drying in a 
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Concentrator 5301 (Eppendorf, Histon, Cambridge, UK). The samples were 
mixed with a mastermix (1x MOPS, 7.4% formaldehyde, 50% formamide) and a 
denaturation reaction was performed where they were heated to 65ºC for 10 
minutes. The samples were chilled on ice for 5 minutes before being combined 
with 10% gel loading buffer (50% glycerol, 10 mM EDTA (pH 8.0) and 0.4% 
(w/v) bromophenol blue) and loaded onto the agarose gel. The gel was run at 100 
V for approximately 2½ hours until the blue dye reached the end of the gel. The 
gel was removed from the tank and washed twice in sterile distilled H2O for 45 
minutes.  
 
 
 
 
Figure 2.2 – A diagram of the capillary transfer system used to transfer RNA from the gel to 
the blotting membrane. 
  
 
2.4.3 Capillary transfer of RNA to blotting membrane 
 A capillary transfer system was set up as follows (see figure 2.2): a 
reservoir was filled with 20x saline-sodium citrate (SSC, 175.3g of NaCl, 88.2g of 
sodium citrate in 800 ml distilled H2O) and a glass plate was rested on top. A long 
piece of Whatman filter paper was soaked in 20x SSC and placed over the glass 
plate with the ends in the 20x SSC reservoir to act as a wick. The gel was turned 
upside down onto the filter paper and the surrounding areas were covered with 
clingfilm. A piece of Hybond-N membrane (GE Healthcare, Chalfont St Giles, 
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Buckinghamshire, UK) was placed on top after dipping in H2O followed by 20x 
SSC. One layer of wet Whatman filter paper was placed on top followed by two 
dry layers. Air bubbles were removed and a 5 cm thick stack of tissue paper was 
placed on top. A glass plate was placed over this and weighed down with a 1 kg 
weight. The RNA was left to transfer over night. The following day the blotting 
system was dismantled and the membrane was removed after the position of the 
wells had been marked. The membrane was surrounded in filter paper and baked 
in an incubator at 80ºC for 2 hours to cross-link the RNA to the membrane. The 
blot was stored at room temperature. 
 
2.4.4 Probe synthesis 
 Custom made primers specific to DMPK and GAPDH transcripts were 
purchased from Invitrogen with the following sequences (obtained from Krol et 
al., 2007): DMPK (forward, 5’-AGGCTTAAGGAGGTCCGACTG-3’; reverse, 
5’-GCGAAGTGCAGCTGCGTGATC-3’), GAPDH (forward, 5’-
GAAGGTGAAGGTCGGAGT-3’; reverse, 5’-GAAGATGGTGATGGGATTTC-
3’). The primer sequences were aligned with the sequences of all known transcript 
variants of DMPK and GAPDH mRNA (using ClustalW software, URL - 
www.ebi.ac.uk/clustalw/ and the NCBI nucleotide website URL - 
www.ncbi.nlm.nih.gov/sites/entrez?db=Nucleotide). The primer sequences were 
located within homologous sites of the transcript variants found.  
The probes were amplified by a PCR reaction where 1 µl containing 20 ng 
of cDNA template was added to 28.5 µl H2O, 10 µl HF 5x PCR buffer, 5 µl 10x 
dNTP (2 mM), 2.5 µl 10 µM forward primer, 2.5 µl 10 µM reverse primer and 0.5 
µl Phusion™ Taq polymerase (Finnzymes Oy, Espoo, Finland). The PCR reactions 
were performed on a PTC-200 DNA engine (MJ research). For amplification of 
the DMPK transcript probe the PCR conditions were as follows: 98ºC for 30 
seconds, 34 cycles of 98ºC for 10 seconds, 68ºC for 30 seconds and 72ºC for 1 
minute, followed by 72ºC for 5 minutes and 7ºC until the tubes were removed. For 
amplification of the GAPDH transcript probe the PCR conditions were as follows: 
98ºC for 30 seconds, followed by 34 cycles of 98ºC for 10 seconds, 60ºC for 30 
seconds and 72ºC for 1 minute, followed by 72ºC for 5 minutes and 7ºC until the 
tubes were removed. The PCR products were run on a 1% agarose gel and bands 
at the appropriate sizes were excised.  
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 The DNA product was extracted from the gel using a QIAquick gel 
extraction kit (Qiagen) according to the manufacturer’s instructions described as 
follows: for every 100 mg of gel 300 µl of buffer QG was added. The gel was 
dissolved by heating to 50ºC for 10 minutes with occasional mixing before 100 µl 
of isopropanol was added per 100 mg of gel. The sample was applied to a 
QIAquick spin column in a 2 ml collection tube which was centrifuged for 1 min. 
The flow-through was discarded and 500 µl of Buffer QG was added to the 
column and centrifuged for 1 min to remove the agarose. To wash the sample, 750 
µl of Buffer PE was added to the column and centrifuged for 1 minute. The flow-
through was discarded and the column was centrifuged for an additional 1 minute. 
The QIAquick column was placed into a clean 1.5 ml microcentrifuge tube. To 
elute the DNA, 50 µl of water was added to the centre of the membrane and 
allowed to rest for 1 minute. The column was centrifuged for 1 minute and the 
eluant was stored at -20°C. 
 To sequence the DNA, a set of reactions were set up containing 3 µl of 
DNA, 2 µl of 5x buffer, 2 µl H2O, 1 µl primer, 1 µl Big Dye v3.1 and 1 µl ½ Big 
Dye (Applied Biosystems). Two reactions were set up for both the DMPK and 
GAPDH probe amplification products, one containing the forward primer and one 
containing the reverse primer. The mixtures were heated to 96ºC for 4 minutes 
followed by 24 cycles of 96ºC for 30 seconds, 50ºC for 15 seconds and 60ºC for 4 
minutes; the samples were then chilled at 4ºC. The products were sent to the John 
Innes Centre Genome Laboratory (Colney, Norwich, Norfolk) for sequencing on 
an ABI 3730 high throughput sequencer (Applied Biosystems). The results were 
viewed on Chromas Lite software (URL - 
www.technelysium.com.au/chromas_lite.html) and the sequences obtained were 
put into BLAST (URL - www.ncbi.nlm.nih.gov/blast/). The probe sequences 
showed specificity for the RNA they were designed to anneal to. The 
concentration of DNA in the samples was measured using a Qubit Fluorometer 
(Invitrogen). 
  
2.4.5 Pre-hybridisation and probe preparation 
 The membrane was placed in a glass tube with 6 ml of ULTRAhyb®-Oligo 
hybridisation buffer (Ambion, Huntingdon, Cambridgeshire, UK) pre-
hybridisation solution and incubated at 42ºC for 3 hours rotating. The probe was 
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prepared by denaturing 50 ng of DNA in a total volume of 45 µl by heating to 
100ºC for 10 minutes. The DNA was immediately placed on ice for 3 minutes and 
then centrifuged briefly to collect the sample at the bottom of the tube. A Ready-
To-Go DNA labelling bead (GE Healthcare) containing buffer, dATP, dGTP, 
dTTP, FPLCpure™ Klenow Fragment (7-12 units) and random 
oligodeoxyribonucleotides was placed in a tube and 45 µl of denatured DNA was 
added along with 5 µl of [α-32P]dCTP. The tube was mixed by gently pipetting up 
and down and was then incubated at 37ºC for 30 minutes. The reaction was 
stopped by adding 5 µl of 0.2 M EDTA (pH 8). Unincorporated oligonucleotides 
were removed by passing the mixture through a Sephadex G-50 DNA grade 
column by centrifuging at 2000 rpm for 2 minutes.  
 
2.4.6 Hybridisation and detection 
The DNA was denatured by heating to 97ºC for 5 minutes before cooling 
on ice for 3 minutes. The probe was added directly to the pre-hybridisation buffer, 
mixed thoroughly and left to hybridise with the membrane overnight at 42ºC 
rotating. 
The following day the probe solution was removed and the blot was 
washed twice with 2x SSC with 0.1% sodium dodecyl sulphate (SDS, Sigma-
Aldrich) for 10 minutes at 42ºC, followed by two washes with 0.1x SSC with 
0.1% SDS for 15 minutes at 42ºC. The membrane was wrapped in clingfilm and 
placed in a cassette with an intensifying screen for 3 hours. The bands were 
visualised using a Molecular Imager FX Pro Plus with Quantity One 4.5.1 
software (Bio-Rad, Hemel Hempstead, Hertfordshire, UK). The intensity of the 
bands was analysed using Kodak 1D 3.5 software (Kodak, Rochester, NY, USA). 
 
2.4.7 Membrane stripping 
  The membrane was stripped to be re-probed for different transcripts by 
washing repeatedly in boiling water until no radioactivity was measured.  
 
2.5 Fluorescent In Situ Hybridisation (FISH) 
 
To detect mutant DMPK transcripts with large CUG repeats the technique 
of FISH was used. The technique involves the use of a fluorescently labelled CAG 
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probe complimentary to the CUG repeat in the DMPK transcripts (protocol as 
described by Holt et al. (2007)). The probe is applied to the cells to detect the 
transcripts and their position within the cell.  
 Cells were seeded onto 12-16 mm round glass coverslips and grown for 
one week before the medium was replaced with SF medium for 24 hours. The 
cells were exposed to experimental conditions for 24 hours. The cells were 
washed in diethylpyrocarbonate (DEPC, Sigma-Aldrich) treated PBS (100 µl 
DEPC in 100 ml PBS) before being fixed in 4% formaldehyde in DEPC treated 
PBS for 25 minutes at room temperature. The fixative was aspirated and the cells 
were washed three times for 5 minutes with DEPC treated PBS with gentle 
agitation. The coverslips were stored at 4ºC overnight.  
 Cells were permeabilised in 1 ml of 0.2% Triton X-100 in DEPC treated 
PBS for 5 minutes at room temperature. The coverslips were then rinsed twice for 
5 minutes with 2x SSC with gentle agitation. The SSC was aspirated and 500 µl 
of denaturation solution (40% formamide in 2x SSC) was applied for 10 minutes. 
The denaturation solution was aspirated and 300 µl of hybridisation solution (10% 
dextran sulphate, 40% formamide, 0.2% BSA, 0.1 mg/ml herring sperm DNA 
(Sigma-Aldrich), 0.1 mg/ml baker’s yeast transfer RNA (Sigma-Aldrich), 4 mM 
ribonucleoside vanadyl complexes (Sigma-Aldrich), 200 nM (CAG)10 Alexa 555 
labelled probe in 2xSSC) was added. A plastic coverslip was placed over the 
solution to ensure even coverage and to prevent the solution drying out. The 
coverslips were placed in a humidified chamber and incubated overnight at 37ºC 
protected from light. The following day the coverslips were rinsed three times 
with DEPC treated PBS for 5 minutes each with gentle agitation. The nuclei were 
labelled by addition of 100 µl of 4′,6-diamidino-2-phenylindole dihydrochloride 
(DAPI, 1:200) in DEPC treated PBS for 30 minutes. The coverslips were washed 
three times for 5 minutes with DEPC treated PBS and mounted onto glass slides 
using Hydromount (National Diagnostics, Hessle, Yorkshire, UK). The slides 
were dried at room temperature for 30 minutes and imaged on a charge-coupled 
device (CCD) upright Zeiss fluorescence microscope with an attached digital 
camera and Axiovision 4.7 software (Zeiss, Oberkochen, Germany). 
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2.6 PCR of the insulin receptor (IR) mRNA 
  
In order to analyse alternative splicing of IR mRNA the technique of PCR 
was used. The technique involves amplification of IR transcript cDNA. PCR 
products are separated by gel electrophoresis and the ratio of the two isoforms 
calculated (protocol as described by Savkur et al., 2001). 
 
2.6.1 RNA extraction 
 RNA was extracted from cells as previously described in section 2.3.1. 
 
2.6.2 Reverse transcriptase-polymerase chain reaction (RT-PCR) 
 RNA was reverse transcribed into cDNA as described in section 2.3.2. 
 
2.6.3 PCR of IR mRNA 
PCR was carried out to amplify a region from exons 10 to 12 of the IR 
mRNA. A total of 200 ng of cDNA (in 4 µl) was mixed with 0.5 µl each of 50 µM 
forward primer (5’-CCAAAGACAGACTCTCAGAT-3’) and reverse primer (5’-
AACATCGCCAAGGGACCTGC-3’) (Invitrogen), 0.4 µl of 100 mM dNTP mix, 
5 µl of MgCl2 free PCR reaction buffer x10, 1.5 µl of 50 mM MgCl2 and 0.25 µl 
of Taq DNA Polymerase (5 U/µl) (Bioline). The volume was made up to 50 µl 
with H2O before mixing and briefly centrifuging to collect the solution at the 
bottom of the tube. The DNA was amplified using a PTC-200 DNA engine (MJ 
research) by heating to 94ºC for 4 minutes, followed by 30 cycles of 95ºC for 30 
seconds, 60ºC for 30 seconds and 72ºC for 30 seconds, then 72ºC for 10 minutes. 
The samples were stored at -20ºC. 
 
2.6.4 Agarose gel electrophoresis 
 The PCR products were separated by electrophoresis on a 4% agarose gel 
with TAE running buffer containing ethidium bromide. A total of 10 µl of PCR 
product was mixed with 5 µl of 5x loading buffer before loading onto the gel 
alongside a Hyperladder IV 1 kB ladder (Bioline). The gel was run at 80 V until 
the bands had separated. Images were taken on a UV transiluminator and the 
intensity was analysed using Kodak 1D 3.5 scientific imaging software (Kodak). 
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2.7 Terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) 
assay 
 
 Apoptotic cells were detected and quantified using a TUNEL assay. The 
technique detects DNA fragmentation which occurs during the ordered 
breakdown of cells during apoptotic cell death. When the DNA is fragmented 3’-
OH groups are exposed to which the terminal deoxynucleotidyl transferase (TdT) 
can add fluorescein-12-dUTP. The fluorescein-12-dUTP can then be detected 
using fluorescence microscopy. 
 Cells were seeded onto glass coverslips and grown for one week until the 
medium was replaced with SF medium for 24 hours. The cells were exposed to 
experimental conditions for 24 hours and then fixed in 4% formaldehyde in PBS 
for 25 minutes at room temperature. The fixative was aspirated and the cells were 
washed three times with PBS for 5 minutes each with gentle agitation. The 
coverslips were stored at 4ºC overnight. A DeadEnd™ Fluorometric TUNEL 
System (Promega) was used to detect and quantify apoptotic cells within cell 
populations according to the manufacturer’s instructions described as follows: the 
cells were permeabilised by addition of 1 ml of 0.2% Triton X-100 in PBS for 5 
minutes at room temperature. The coverslips were washed twice with PBS for 5 
minutes each with gentle agitation. The PBS was removed and 100 µl of 
Equilibration Buffer was added to each coverslip for 5-10 minutes. The edge of 
each coverslip was blotted on tissue paper to remove the majority of the 
Equilibration Buffer before 50 µl of rTdT reaction mix was added. The rTdT 
reaction mix contained 45 µl Equilibration Buffer, 5 µl Nucleotide Mix and 1 µl 
rTdT enzyme per reaction. A plastic coverslip was placed over the solution to 
ensure even distribution of the mix. The coverslips were placed in a humidified 
chamber and incubated for 1 hour and were protected from light from this step 
onwards. The reaction was terminated by immersing the coverslips in 2x SSC for 
15 minutes at room temperature. The coverslips were washed three times with 
PBS for 5 minutes each with gentle agitation. The cell nuclei and F-actin were 
labelled by the addition of 100 µl of DAPI (1:200) and Texas Red-X phalloidin 
(1:100) diluted in PBS for 15 minutes. The coverslips were washed three times 
with PBS for 5 minutes each with gentle agitation and mounted onto glass slides 
using Hydromount. The slides were dried at room temperature for 30 minutes and 
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then imaged on a CCD upright Zeiss fluorescence microscope with an attached 
digital camera and Axiovision 4.7 software (Zeiss). 
 
2.8 Western blot 
 
 In order to detect the presence, absence and activation of particular 
proteins of interest within the lysates of cell samples, the Western blot technique 
was used. The technique is based on the binding of a primary antibody specific to 
the protein of interest and its subsequent detection by a secondary antibody. The 
Western blot gives information about the size and the relative amount of the 
protein of interest in different samples. 
 
2.8.1 Cell lysis 
 Cells were grown in 35 mm culture dishes and subjected to experimental 
conditions as previously described (see section 2.2.1). The cells were rinsed in 
ice-cold PBS and lysed in MPER with 10 µl/ml of Halt protease inhibitor cocktail, 
10 µl/ml of Halt phosphatase inhibitor cocktail and 10 µl/ml EDTA (5 mM) 
(Pierce). Dishes were scraped and lysates were collected in 1.5 ml microcentrifuge 
tubes (Eppendorf) and centrifuged at 13 000 rpm for 10 minutes at 4°C. The 
supernatant was stored at -80°C. Protein concentration was measured using a 
bicinchoninic acid (BCA) protein assay (Pierce) according to the manufacturer’s 
protocol described in section 2.2.2.  
 
2.8.2 SDS PAGE 
 Protein samples were heated to 100ºC for 5 minutes with 20% sample 
buffer (4% SDS, 0.01% bromophenol blue, 30% glycerol, 12.5% β-
mercaptoethanol and 160 mM tris pH 6.8) and loaded alongside DualVue Western 
Blotting Markers (GE Healthcare) on a 10% precast polyacrylamide protein gel 
(Pierce). Gels were subjected to electrophoresis in a Mini-PROTEAN 3 cell (Bio-
Rad) run at a constant 100 V and a current of 100 mA per gel at room temperature 
until the loading dye reached the bottom of the gel. 
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2.8.3 Protein transfer 
 The gel was removed from the tank and placed in transfer buffer solution 
(48 mM Tris, 39 mM glycine, 4% methanol and 0.0375% SDS, pH 8.3) for 15 
minutes. Proteins were transferred onto a polyvinylidene difluoride (PVDF) 
membrane (Perkin Elmer) by sandwiching the gel and the PVDF membrane 
(activated in 100% methanol), between thick filter papers. The sandwich was 
placed on a trans-blot semi-dry transfer cell (Bio-Rad) and run at a constant 15 V 
and a current of 0.3 A per gel for 30 minutes.  
 
2.8.4 Blocking and antibody incubation 
Following protein transfer the gels were discarded and the PVDF was 
rinsed three times for 5 minutes in PBS and blocked for 1 hour in PBS-T (100 ml 
PBS, 0.5 g Marvel milk powder and 50 µl Tween® 20) at room temperature with 
gentle agitation. The primary antibody made up in PBS-T was left on overnight at 
4°C with gentle agitation. The antibodies used in this study are summarised in 
table 2.3. 
The following day the membrane was allowed to return to room 
temperature before washing three times for 15 minutes in PBS-T with gentle 
agitation. The secondary antibody conjugated to horseradish peroxidase was made 
up in PBS-T at a concentration of 1:1250. The membrane was incubated in the 
secondary antibody for one hour at room temperature with gentle agitation. A 
further two 15 minute washes with PBS-T were carried out before a final wash in 
PBS with 10 µl/ml Tween® 20 (Sigma-Aldrich) for 10 minutes. 
 
2.8.5 Detection 
ECL plus western blotting detection reagents (GE Healthcare) were mixed 
at a ratio of 40:1 of solutions A and B respectively and a volume of 0.1 ml/cm2 
was pipetted onto the membrane and allowed to rest for 5 minutes at room 
temperature in the dark. The membrane was blotted onto tissue paper before being 
placed in a film cartridge. In a darkroom the membrane was exposed to 
Amersham Hyperfilm ECL photographic paper (GE Healthcare) which was then 
passed through Kodak GBX developer and replenisher solution (Kodak), SB 80 
indicator stop bath (Photosol, Basildon, Essex, UK) and Hypam fixer (Ilford, 
Mobberley, Cheshire, UK). The revealed bands were scanned and the intensity 
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was analysed densitometrically using Kodak 1D 3.5 scientific imaging software 
(Kodak). 
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2.8.6 Membrane stripping 
Membranes were stripped to be re-probed with other antibodies using Re-
blot Strong solution (Millipore, Watford, Hertfordshire, UK) which was left on 
the membrane for 20-25 minutes. The membrane was blocked by two 5 minute 
washes with PBS-T before being placed in the next primary antibody. 
 
2.9 bFGF estimation by the enzyme-linked immunosorbent assay (ELISA) 
 
 The level of bFGF in conditioned medium was measured using an ELISA. 
The technique involves the use of a primary antibody specific to the protein of 
interest which is bound to the surface of the wells of a 96-well plate. The samples 
are added to the wells and if the protein of interest is present it will bind to the 
antibody. An enzyme-linked antibody is then pipetted into the wells which also 
binds to the protein of interest. Addition of an enzyme substrate produces a colour 
change proportional to the amount of protein of interest present. 
A Quantikine® human FGF basic (bFGF) ELISA kit (R&D Systems, 
Abingdon, UK) was used to quantify the levels of bFGF released into the medium 
by the cells. Conditioned medium (CM) was collected from cells after 24 hours 
and was centrifuged at 13000 rpm for 5 minutes. The supernatant was removed 
and frozen at -20°C until required. The bFGF ELISA kit was used according to the 
manufacturer’s protocol described as follows: a 96-well microplate pre-coated 
with a monoclonal antibody specific to bFGF was supplied and 100 µl of Assay 
Diluent RD1-43 was added to each well. A series of standards with known 
concentrations of bFGF were prepared from a bFGF stock solution. Each test was 
performed in duplicate and 100 µl of the standards or samples were added to each 
well. The wells were covered with an adhesive strip and incubated for 2 hours at 
room temperature. Each well was aspirated and washed with 400 µl of wash 
buffer which was repeated three times for a total of four washes. The plate was 
blotted to remove as much wash buffer as possible before adding 200 µl of bFGF 
Conjugate to each well. The wells were covered with an adhesive strip and 
incubated for 2 hours at room temperature. The wash step was repeated before 
200 µl of Substrate Solution was added to each well. The plate was incubated for 
30 minutes at room temperature protected from light before 50 µl of Stop Solution 
was added. The absorbance was determined using a Wallac 1420 VICTOR2 
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multilabel plate counter and WorkOut 1.5 software at a wavelength of 450 nm. A 
standard curve was constructed and used to determine the levels of bFGF in the 
CM samples. 
 
2.10 Statistical analysis 
 
 Student’s T-test analysis was performed using Excel® software (Microsoft, 
Redmond, WA, USA) to determine any statistical difference between two 
experimental groups. Statistical analysis of multiple experimental groups was 
performed by one-way analysis of variance (ANOVA) with Tukey’s post-hoc 
analysis using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). Significance was 
assessed using a p value of ≤ 0.05. 
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CHAPTER 3 
CHARACTERISATION OF DM1 LENS 
EPITHELIAL CELLS 
 
3.1 Introduction 
 
 Diseases can be modelled in a variety of different ways in order to study 
the mechanisms which underlie them. This includes techniques such as the 
culturing of tissues and primary cells from patients, the immortalisation of cells to 
produce cell lines and the production of animal models to mimic disease. 
Although all of these techniques are valuable to research, the availability and 
lifespan of primary cells from patients is often limited and the use of animal 
models poses an ethical dilemma as well as posing problems with differences 
between species. Therefore, in this study, cell lines have been produced from 
primary human LECs (as described in section 2.1.1) to study the mechanisms 
behind cataract development in DM1.  
The use of in vitro studies using cell lines in research has become 
commonplace due to the availability of cells, the ease with which they can be 
maintained, the speed with which results can be obtained and the relatively low 
cost of experiments. However, cell lines must be characterised in order to verify 
their origin and to show that they possess characteristics that are relevant to the 
disease they represent. 
 
3.1.1 Molecular characterisation of DM1 lens epithelial cells 
The cell lines used in this study were produced from DM1 patient samples 
and normal donor lenses. To confirm their origins a study by Rhodes et al. (2006) 
confirmed the presence and length of the expanded triplet repeat in the DM1 lens 
cell lines and showed its absence in the controls through Small Pool-PCR analysis 
of repeat length variation (see figure 3.1a). The controls were confirmed to have 
small stable normal alleles, whereas the DM1 cell lines contained large unstable 
expanded alleles even in the earliest passage sampled, suggesting that the primary 
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cells from which they were derived also contained large triplet repeats (Rhodes et 
al., 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 – Characterisation of DM1 lens epithelial cells. (a) Small Pool-PCR analysis of 
CTG repeat length at passage 10, showing 8 reactions for each cell line. No detectable 
expanded alleles were found in the control cell lines (data not shown), whereas the DM1 cell 
lines were shown to contain large triplet repeats. DMCat1 had two major alleles of 1480 and 
450 repeats, DMCat2 had three major alleles of 1440, 730 and 450 repeats, DMCat3 had a 
single major allele of 2950 repeats and DMCat4 had two major alleles of 1590 and 880 
repeats (image from Rhodes et al. (2006)). (b) QRT-PCR analysis of mRNA expression from 
CRYAA normalised to 18S expression, showing expression in all cell lines tested (Dr. J.D. 
Rhodes and Dr. L.M. Hodgkinson, unpublished data).  
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Further characterisation performed by Rhodes et al. (2006) showed that 
the DM1 lens cells expressed mRNA from DMPK, DMWD and SIX5, but only 
SIX5 was found to have reduced levels of both mRNA and protein. To confirm 
their lens cell origins, the expression of the gene CRYAA, which encodes the 
protein αA-crystallin was analysed. αA-crystallin is found in native LECs and 
expression of CRYAA was found in all of the DM1 and control cell lines tested 
(see figure 3.1b, Dr. J.D. Rhodes and Dr. L.M. Hodgkinson, unpublished data).  
 
3.1.1.1 Triplet repeat-containing DMPK transcripts form 
nuclear foci in DM1 lens epithelial cells 
Many reports have shown that DMPK transcripts accumulate in discrete 
foci in the nuclei of DM1 cells. Foci of DMPK transcripts have been found in 
cultured fibroblasts and myoblasts; in cells from heart, spinal cord, brain, gall 
bladder smooth muscle and skeletal muscle from DM1 patients; and in muscle 
cells and trophoblasts cultured from DM1 foetuses (Taneja et al., 1995; Davis et 
al., 1997; Hamshere et al., 1997; Furling et al., 2001b; Liquori et al., 2001; Jiang 
et al., 2004; Mankodi et al., 2005; Bonifazi et al., 2006; Wheeler et al., 2007a; 
Cardani et al., 2008). These studies indicate that all tissues which show symptoms 
of the disease could have foci of DMPK transcripts retained in the nuclei. As the 
lens is affected by DM1, and cataracts are a characteristic symptom of the disease, 
it would be interesting to confirm whether lens cells express DMPK and whether 
or not triplet repeat-containing DMPK transcripts accumulate in foci.  
The formation of nuclear foci in DM1 is associated with sequestration of 
the MBNL proteins (MBNL1, MBNL2 and MBNL3) and increased levels of 
CUG-BP proteins (CUG-BP1 and CUG-BP2). MBNL proteins accumulate in 
nuclear foci as they bind to the stem of the dsRNA formed by the CUG repeats in 
DMPK transcripts (Miller et al., 2000; Fardaei et al., 2001; Fardaei et al., 2002; 
Yuan et al., 2007). In humans, MBNL1 and MBNL2 show widespread expression 
in all tissues tested, including pancreas, kidney, skeletal muscle, liver, lung, 
placenta, brain and heart, but MBNL3 is almost exclusively expressed in the 
placenta (Fardaei et al., 2002). MBNL1 was shown to be expressed in the mouse 
eye but there is no data available for expression of any MBNL genes in the human 
lens (Miller et al., 2000). Unlike MBNL proteins, CUG-BP1/2 are not recruited 
into nuclear foci, despite being shown to bind to (CUG)8 repeats (Timchenko et 
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al., 1996; Lu et al., 1999; Michalowski et al., 1999; Fardaei et al., 2001). 
Interestingly, CUG-BP1 levels were actually shown to be increased in both 
cultured cells expressing CUG repeats and in DM1 heart tissue, with greater 
levels being observed with increasing repeat numbers (Timchenko et al., 2001a). 
Greater levels of CUG-BP1 have also been found in skeletal muscle tissue from 
DM1 patients and in cultured DM1 myoblasts (Savkur et al., 2001; Dansithong et 
al., 2005). Analysis of CUG-BP1 expression showed that levels of mRNA were 
not affected and instead an increase in the half-life of CUG-BP1 was shown to be 
responsible for increased protein levels (Timchenko et al., 2001a). The increased 
protein half-life was shown to result from an increase in the steady state levels of 
the protein due to hyperphosphorylation (Kuyumcu-Martinez et al., 2007). In 
humans, CUG-BP1 expression was found in all tissues tested, including liver, 
skeletal muscle and spleen, with high levels of expression in the brain and heart 
(Roberts et al., 1997). Widespread expression of CUG-BP1 was also found in 
mice (Ladd et al., 2001). In humans, CUG-BP2 is expressed predominantly in the 
heart, with low levels of expression found in the brain and skeletal muscle (Lu et 
al., 1999). In contrast, in mouse, CUG-BP2 was expressed in all tissues tested 
including heart, brain, spleen, lung, liver, skeletal muscle and testis (Lu et al., 
1999; Ladd et al., 2001). No data is available for the expression of CUG-BP1/2 in 
the eye or lens. 
If DMPK is expressed in lens cells and foci of the transcripts are shown to 
form, then it is possible that the active levels of MBNL and CUG-BP proteins will 
be disturbed if they too are expressed in the lens.  
 
3.1.1.2 Altered splicing events in DM1 
Both MBNL and CUG-BP proteins are involved in the regulation of 
splicing events, many of which are disrupted in DM1. The sequestration of 
MBNL and increased levels of CUG-BP result in the misregulation of splicing, 
where the splicing patterns of certain transcripts revert back to that observed 
during embryonic development. Alternative splicing generates protein isoforms 
with different biological properties, and embryonic isoforms are likely to have 
different levels of sensitivity and action compared to their adult counterparts. It 
has been suggested that the altered splicing patterns of certain proteins in DM1 
contributes to the observed phenotype of the disease. For example, the altered 
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splicing of ClC-1 could cause the myotonia which is a characteristic feature of 
DM1; altered splicing of IR could lead to insulin resistance and diabetes which is 
observed in the disease; and altered splicing of ryanodine receptor 1 (RYR1) 
could be involved in the myopathy associated with DM1 (Savkur et al., 2001; 
Mankodi et al., 2002; Kimura et al., 2005). If MBNL and CUG-BP proteins are 
found in the lens then it is possible that splicing patterns could be altered, leading 
to changes in the lens which could result in the development of cataract.  
 Myotonia is caused by hyperexcitability in muscle fibres leading to 
repetitive action potentials which result in involuntary after-contractions. These 
effects have been linked to impaired transmembrane conductance of either 
chloride or sodium ions (Franke et al., 1991; Charlet-B et al., 2002; Mankodi, 
2008). A number of non-dystrophic myotonias are caused by mutations in the 
CLCN1 gene, which encodes the chloride ion channel ClC-1, and the SCN4A gene 
which encodes a skeletal muscle sodium ion channel (Mankodi, 2008). A study 
using human skeletal muscle tissue from DM1 patients showed that SCN4A was 
present in membrane fractions extracted from the cells, whereas ClC-1 was absent 
or present at greatly reduced levels compared to normal skeletal muscles (Charlet-
B et al., 2002). Studies in mice and humans have shown that ClC-1 is 
alternatively spliced in DM1. In mice expressing large CUG repeats a broad 
spectrum of altered splicing events were observed, with the inclusion of a novel 
exon, designated “7a”, being the most common (Mankodi et al., 2002). In the 
same study Mankodi et al. (2002) showed that patients with both DM1 and DM2 
had a high frequency of alternative isoforms of ClC-1 and that severely affected 
DM1 patients had aberrant splicing in 100% of the cDNAs examined. The most 
common alternative splicing event was the inclusion of the 7a exon, which was 
accompanied by the inclusion of another novel exon, designated “6b” (Mankodi et 
al., 2002). Intron 2 (located between exons 2 and 3) was also shown to be retained 
in skeletal muscle tissue from DM1 patients (Charlet-B et al., 2002). In the same 
study it was shown that coexpression of CUG-BP with a ClC-1 intron 2 minigene 
in a normal fibroblast cell line resulted in retention of intron 2 (Charlet-B et al., 
2002). A Mbnl1 knockout in mice showed increased inclusion of exon 7a in ClC-1 
and myotonia (Kanadia et al., 2003). The insertion of novel exons and retention of 
intron 2 result in the insertion of premature stop codons and degradation of ClC-1 
mRNAs by nonsense-mediated decay, leading to the reduced levels of ClC-1 seen 
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in DM1 skeletal muscle (Charlet-B et al., 2002). The correction of ClC-1 splicing 
by morpholino antisense oligonucleotides in mice restored the full-length reading 
frame and increased ClC-1 expression, therefore eliminating myotonia (Wheeler 
et al., 2007b). These results strongly support a role for MBNL1 and CUG-BP1 in 
the alternative splicing of ClC-1 transcripts leading to myotonia in DM1. As the 
misregulated splicing of ClC-1 transcripts in DM1 is proposed to be the cause of 
myotonia, which is a major symptom of the disease, it would be interesting to see 
whether the mis-splicing event could be the cause of other symptoms, such as the 
development of cataract in the lens. In the lens, the level of Cl- is important for the 
maintenance of a constant cell volume and alterations in Cl- are thought to result 
in cataract development through a loss of osmotic equilibrium (Zhang & Jacob, 
1997). If ClC-1 channels are expressed in the lens and the splicing pattern is 
disturbed then this could result in disturbances in Cl- levels and cataract 
development.  
 Transcripts of the α-subunit of IR are also subject to alternative splicing 
where exon 11 can either be excluded to produce isoform A (IR-A), or included to 
produce isoform B (IR-B). The A isoform has a higher affinity for insulin, 
however, it has a lower signalling capacity and therefore it is the B isoform which 
results in an increased level of insulin sensitivity and is expressed predominantly 
in insulin responsive tissues (Savkur et al., 2001). A switch from the predominant 
IR-B in normal skeletal muscle, to IR-A in DM1 skeletal muscle was shown to 
occur and was linked to the increased steady-state levels of CUG-BP1 in the 
disease, although the same switch in isoforms was not observed in DM1 
fibroblasts (Savkur et al., 2001). A further study showed that MBNL1 and 
MBNL2 act antagonistically with CUG-BP1 in the regulation of IR exon 11 
inclusion (Dansithong et al., 2005). Down-regulation of MBNL1/2 and 
overexpression of CUG-BP1 were both shown to result in decreased inclusion of 
exon 11 in normal human myoblasts. Rescue experiments showed that loss of 
MBNL1 was the primary cause of the aberrant IR splicing with overexpression of 
CUG-BP1 playing a secondary role (Ho et al., 2004; Dansithong et al., 2005; Paul 
et al., 2006). In the rat lens, insulin plays a role in the maintenance of 
differentiation in fibre cells and activates the transcription of crystallin genes 
which maintain transparency during ageing by binding damaged proteins to 
prevent their precipitation (Leenders et al., 1997; Civil et al., 2000). In bovine 
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lens epithelial cells, insulin has been shown to activate the phosphatidylinositol 3-
kinase signalling pathway, which is involved in survival, growth and 
differentiation. Insulin receptors are also found in the human lens (Naeser, 1997). 
Insulin-like growth factor-1 (IGF-1) can also bind to IR and is present in the lens 
(Pavelic et al., 2007). Changes in signalling levels from the insulin receptor could 
therefore be linked to cataract through possible alterations in levels of the 
crystallin proteins or through disturbed cellular signalling resulting in a reduction 
in survival, growth or differentiation in LECs. For this reason, it would be 
interesting to see whether the ratio of IR isoforms is altered in DM1 lens cells. 
 A suggested cause of skeletal muscle wasting in DM1 is the altered 
splicing of RYR1, which is a Ca2+ release channel situated in the sarcoplasmic 
reticulum (SR). RYR1 is stimulated to release Ca2+ from the SR in myocytes 
following the generation of an action potential. This stimulates muscle contraction 
in a process known as excitation-contraction (EC) coupling. Two regions of 
RYR1, known as ASI and ASII, are variably spliced and developmentally 
regulated (Futatsugi et al., 1995). The ASI region is absent in the juvenile form 
and present in the adult form. In DM1 muscle the juvenile form of RYR1 is 
overexpressed and was shown to have a lower level of activity which was 
analysed by assessing the open probability of the channel (Kimura et al., 2005). 
Interestingly, voltage-activated Ca2+ release during EC coupling was shown to be 
significantly increased in myocytes expressing the juvenile form of RYR1 and it 
was suggested that the ASI region forms a regulatory module which contributes to 
EC coupling, and therefore, its absence facilitates stronger EC coupling (Kimura 
et al., 2009). Levels of Ca2+ in cultured myocytes from DM1 patients were found 
to be elevated when compared to normal controls (Jacobs et al., 1990). Alterations 
in EC coupling could result in the increased levels of Ca2+ observed in DM1 
muscle cells and could lead to muscle degeneration through increased activation 
of Ca2+ dependent proteases (Kimura et al., 2009). An increase in activation of 
Ca2+ dependent proteases could cause myopathy through the breakdown of 
proteins in the muscle cells. RYR1 is primarily expressed in skeletal muscle, but 
is also expressed in the brain and at low levels in the heart (Futatsugi et al., 1995). 
There are two further forms of ryanodine receptor, known as RYR2, which is 
mainly expressed in the heart, and RYR3, which is more widely expressed in 
tissues including the heart, brain and skeletal muscle (Dulhunty et al., 2006). A 
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study found expression of RYR1 in a human lens cell line but found greater levels 
of expression of RYR3 and showed that the receptors were involved in the 
regulation of intracellular Ca2+ levels (Qu & Zhang, 2003). Excessive levels of 
Ca2+ in the lens can lead to cataract formation also through activation of Ca2+ 
dependent proteases, such as calpains, which break down fibre cell proteins 
(Biswas et al., 2005). For this reason it would be interesting to see whether 
ryanodine receptors are present in our human lens cells and, if so, whether the 
splicing patterns are the same in DM1 and control cells. 
 
3.1.2 Cellular characterisation of DM1 lens epithelial cells 
At the cellular level, studies on cataracts in general have pointed at a loss 
of cells from the lens epithelium in the development of cataract due to the 
resulting loss of homeostasis in levels of ions and water (Konofsky et al., 1987; Li 
et al., 1995). Loss of cells from the LEC layer was shown to be particularly 
relevant in the development of subcapsular cataracts, as the cell densities were 
much lower when compared to those of nuclear cataract (Konofsky et al., 1987). 
A study by Abe et al. (1999) investigated the density of the LEC layer in native 
human lenses from DM1 patients with cataract. They showed that DM1 lenses 
contained fewer cells in the LEC layer than those from age matched control lenses 
with senile cataract (Abe et al., 1999). A significant decrease in cell density was 
observed with DM1 lenses having an average density of 2274 cells/mm2 
compared to 4627 cells/mm2 in the control lenses. The decrease in cell density 
was also shown to be more prominent in a patient with an earlier onset of the 
disease and more severe symptoms. Despite the decrease in cell density, coverage 
of the lens was maintained by an increase in cell size (Abe et al., 1999). This data 
would suggest that a reduced number of LECs may not be sufficient to maintain 
the balance of ions and water which is vital to lens transparency, therefore 
resulting in cataract formation in DM1. Rhodes et al. (2006) characterised the 
growth of most of the lens epithelial cell lines used in this study and showed that 
the DM1 cell lines had longer doubling times compared to the controls (Rhodes et 
al., 2006). The rate of growth of the DM1 cell lines also began to decline at a 
much earlier stage and continued to decline until a point was reached where there 
were not enough cells remaining to start the next passage (Rhodes et al., 2006). 
This data indicates that behaviour of the cell lines is similar to the situation seen 
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in vivo and it would be interesting to see whether the two further control cell lines 
employed in this study confirm these findings. 
The decrease in density of DM1 LECs could be due to a decrease in cell 
proliferation or an increase in cell death. Cell death can occur either via apoptosis, 
which is the orderly breakdown of the cell into apoptotic bodies which can be 
phagocytosed (also known as programmed cell death), or via necrosis, which is 
characterised by the early breakdown of the plasma membrane resulting in the 
release of the cell contents. Interestingly, capsulorhexis samples from non-DM1 
cataract patients were shown to have a significantly greater percentage of 
apoptotic cells compared to normal controls (Li et al., 1995). To elucidate 
whether apoptosis of LECs preceded cataract development or vice versa, Li et al. 
(1995) performed experiments using cultured rat lenses. Hydrogen peroxide was 
used to induce cataract formation and was shown to trigger apoptosis in the LECs 
prior to cataract development (Li et al., 1995). Rhodes et al. (2006) investigated 
whether reduced levels of cell proliferation or increased levels of cell death were 
responsible for the reduced population doublings times observed in the DM1 lens 
cell lines and found that fold stimulation of growth by 10% FCS was similar 
across the cell lines, but release of LDH was increased, indicating increased levels 
of cell death were the cause (Rhodes et al., 2006). As cell death was implicated in 
the reduced population doubling times, it would be interesting to establish the 
mode by which it occurs, i.e. apoptosis or necrosis.   
 
3.2 Aims 
 
 The aim of this chapter is to establish whether the DM1 and control cell 
lines are a valid model in which to study the disease. Expression levels of the 
genes at the DM1 locus will be analysed and a primary aim is to show whether 
DMPK is expressed in the lens cell lines and whether transcripts form foci as seen 
in other affected cell types. If foci form then splicing patterns may be altered 
within the lens and therefore these secondary effects of the triplet repeat will also 
be investigated in order to establish whether they may be the underlying cause of 
cataract formation. Cell growth, proliferation and death of the lens cell lines will 
also be investigated as these are thought to impact on cataract formation in the 
native human lens. 
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3.3 Results 
 
3.3.1 SIX5 and DMPK expression in DM1 lens epithelial cells 
QRT-PCR showed that SIX5 is expressed in human LECs, however, in 
contrast to previous reports, no difference in expression levels was observed 
between the control and DM1 cell lines (see figure 3.2, expression analysed at 
days 8, 50 and 78 of the culture period shown in figure 3.9) (Rhodes et al., 2006). 
The previous study by Rhodes et al. (2006) used only two of the control cell lines 
(CCat1 and CCat2), but recently, two further control cell lines were obtained 
(CCat3 and CCat4) and revealed that the level of SIX5 expression in the DM1 cell 
lines falls within the range of normal expression values. The mean expression 
value across the control cell lines was 5.10 ± 1.39 (arbitrary units) compared to 
3.91 ± 0.43 (arbitrary units) across the DM1 cell lines. This data would indicate 
that reduced expression of SIX5 is unlikely to be responsible for cataract 
formation in the lens as previously proposed (Winchester et al., 1999; Klesert et 
al., 2000).  
 
 
 
 
Figure 3.2 – SIX5 is expressed in DM1 lens epithelial cells. QRT-PCR analysis of mRNA 
expression from SIX5 normalised to 18S expression. SIX5 was expressed in both control and 
DM1 lens cells and no difference was observed in expression levels between the two groups 
(n = 3,  data expressed as mean ± SEM of three independent experiments). 
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Figure 3.3 – DMPK is expressed in DM1 lens epithelial cells. (a) QRT-PCR analysis of 
mRNA expression from DMPK normalised to 18S expression (n = 3, data expressed as mean 
± SEM of three independent experiments). (b) Northern blot analysis of mRNA expression 
from DMPK. Graph shows the bands analysed densitometrically and normalised to GAPDH 
mRNA levels. 
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Using both QRT-PCR and Northern blot analysis to detect DMPK mRNA, 
DMPK was shown to be expressed in human LECs (see figure 3.3). In both cases 
there was no significant difference in expression levels between DM1 and control 
LECs. Two separate probes crossing different exon boundaries were used to 
detect DMPK transcripts by QRT-PCR. Probes were selected to cross the 
boundaries of exons 2-3 and 8-9 (see table 2.2 for the assay identification 
numbers). Both probes detected similar levels of DMPK expression so the results 
are shown for only one of the probes (see figure 3.3a). The mean expression value 
across the control cell lines was 21.98 ± 1.96 (arbitrary units) compared to 26.46 ± 
1.05 (arbitrary units) across the DM1 cell lines. Using Northern blot analysis (see 
figure 3.3b), one band of the same size was observed in all of the cell lines, but 
surprisingly no larger bands were observed in the DM1 cells. A larger band, or 
smear, representing transcripts of differing length depending on the size of the 
triplet repeat, would have been expected due to the large repeats found in the 
DMPK mutant allele. The lack of this band could indicate a problem in the RNA 
extraction procedure as the mutant transcripts are possibly subjected to 
mechanical damage or it could indicate inefficient transfer of the larger RNAs to 
the membrane. From the band detected, the mean values of transcript levels across 
the control cell lines was 4.74 ± 0.14 (arbitrary units) compared to 5.74 ± 0.40 
(arbitrary units) across the DM1 cell lines. Despite not showing expression of 
mutant DMPK transcripts, both Northern blotting and QRT-PCR showed that 
DMPK was expressed in human LECs. Both techniques actually showed that 
expression of DMPK was higher in DM1 LECs, although this was not statistically 
significant. The presence of DMPK mRNA in human lens cells indicates that foci 
of transcripts may form in DM1 nuclei.  
 
 
Figure 3.4 – DMPK transcripts form nuclear foci in DM1 lens epithelial cells. Triplet repeat 
RNA was detected using fluorescence in situ hybridisation with a (CAG)10 alexa 555 labelled 
oligonucleotide probe (red) in nuclei counterstained with DAPI (blue). No foci were observed 
in control lens cells (a) CCat1 and (b) CCat2, however, foci (indicated by white arrows) were 
detected in DM1 lens cells (c) DMCat1, (d) DMCat2, (e) DMCat3 and (f) DMCat4 (bar = 20 
µm). (g) Summary of mean number of foci (n = 2, data expressed as mean of two 
independent experiments, statistical analysis was performed by Student’s T test, ** p < 0.01 
relative to controls). 
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Figure 3.4 – see previous page for figure legend 
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3.3.2 Formation of nuclear foci of mutant DMPK transcripts in DM1 
lens epithelial cells 
 Fluorescence in situ hybridisation (FISH) of lens cells with (CAG)10 alexa 
555 labelled oligonucleotide probes revealed nuclear foci of DMPK transcripts in 
all DM1 cell lines, but these were absent in the controls (see figure 3.4). This 
confirms that the mutant DMPK allele is expressed in the DM1 cells, despite not 
being detected during Northern blot analysis of DMPK expression. In all cell lines 
a very diffuse cytoplasmic staining could be seen, however, bright and distinct 
spots of staining were found only in the nuclei of DM1 cells. Many of the foci 
were found at the very edge of the nucleus, however, attempts to produce a 3D 
image of the nuclei to visualise the position of the foci in more detail using laser 
scanning confocal microscopy failed as the signal was of insufficient intensity. 
The nuclear foci ranged in size from 0.5 to 2 µm and the number of foci ranged 
from 0 to as many as 24 per cell, with an average of 2.7 per cell (a minimum of 
153 cells were counted per cell line). 
 
3.3.3 MBNL and CUG-BP expression in DM1 lens epithelial cells 
 Both MBNL1 and MBNL2 are expressed in control and DM1 LECs and no 
difference in expression levels was observed between the two groups (see figure 
3.5). The expression level of MBNL3 was not analysed in the cell lines as its 
expression is almost exclusively limited to the placenta in humans (Fardaei et al., 
2002). The mean expression value for MBNL1 across the control cell lines was 
1.03 ± 0.08 (arbitrary units) compared to 1.17 ± 0.09 (arbitrary units) across the 
DM1 cell lines. For MBNL2, the mean expression value across the control cell 
lines was 12.01 ± 1.86 (arbitrary units) compared to 13.12 ± 0.90 (arbitrary units) 
across the DM1 cell lines.  
Both CUG-BP1 and CUG-BP2 are also expressed in control and DM1 
LECs, with no difference in expression levels between the two groups (see figure 
3.6). The mean expression value for CUG-BP1 across the control cell lines was 
24.46 ± 4.37 (arbitrary units) compared to 21.15 ± 3.28 (arbitrary units) across the 
DM1 cell lines. For CUG-BP2, the mean expression value across the control cell 
lines was 15.59 ± 6.17 (arbitrary units) compared to 10.01 ± 4.03 (arbitrary units) 
across the DM1 cell lines. Both MBNL and CUG-BP proteins are thought to be 
responsible for the altered splicing patterns of many transcripts in DM1 and their 
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expression in the lens makes it possible that alternative splicing may also play a 
role in DM1 cataract formation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 – MBNLs are expressed in DM1 lens epithelial cells. QRT-PCR showed that both 
(a) MBNL1 and (b) MBNL2 are expressed in control and DM1 lens epithelial cells. 
Expression is shown normalised to 18S expression. There is no observed difference in 
expression levels between the two groups (n = 2, data expressed as mean, representative of 
two independent experiments). 
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Figure 3.6 – CUG-BPs are expressed in DM1 lens epithelial cells. QRT-PCR showed that 
both (a) CUG-BP1 and (b) CUG-BP2 are expressed in control and DM1 lens epithelial cells. 
Expression is shown normalised to 18S expression. There is no observed difference in 
expression levels between the two groups (n = 2, data expressed as mean). 
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3.3.4 Alternative splicing in DM1 lens epithelial cells 
 A number of alternative splicing events have been characterised in DM1 
and have been shown to cause a variety of the symptoms associated with the 
disease. In order to establish whether any of these could play a role in cataract 
development, the expression of a number of affected genes were analysed using 
QRT-PCR. 
 Expression of CLCN1 was not found in any of the human lens cell lines 
employed in this study. Expression of RYR1 was found in only three of the cell 
lines (CCat2, DMCat3 and DMCat4) at very low levels (data not shown). 
Expression of two further ryanodine receptors, RYR2 and RYR3, was analysed and 
only RYR3 was found to be expressed at low levels (data not shown). No 
alternatively spliced isoforms of RYR3 have been described in DM1, however. 
 Expression of IR was found in all of the lens cell lines. QRT-PCR was 
used to analyse the expression levels of the two isoforms of IR, utilising probes 
which crossed different exon boundaries (see table 2.2 for assay identification 
numbers). As only IR-B contains exon 11, the first probe used crossed the exon 
11-12 boundary and would therefore only show expression of IR-B. The second 
probe used crossed the exon 16-17 boundary, which is not affected by the 
alternative splicing event observed in DM1 and would therefore show the total 
expression of both IR isoforms. The expression of IR (both isoforms) appears to 
be slightly lower in the DM1 LECs (see figure 3.7a), with the exception of CCat1, 
however, this is not statistically significant. The mean expression value for IR 
across the control cell lines was 18.52 ± 5.01 (arbitrary units) compared to 11.34 ± 
0.94 (arbitrary units) across the DM1 cell lines. The mean expression value for the 
IR-B isoform across the control cell lines was 3.20 ± 0.82 (arbitrary units) 
compared to 2.48 ± 0.18 (arbitrary units) across the DM1 cell lines. The 
expression of IR-B is more even across the cell lines (see figure 3.7b), and 
although it is not possible to accurately compare expression levels using different 
probes in QRT-PCR, the lower total IR expression values in DM1 cells would 
suggest that they actually express less of the IR-A isoform than the control cells. 
This is in contrast to the reports in DM1 that show that DM1 cells express more 
IR-A, leading to insulin resistance and diabetes (Savkur et al., 2001).  
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Figure 3.7 – IR is expressed in DM1 lens epithelial cells. QRT-PCR showed that (a) IR and (b) 
specifically the IR-B isoform are expressed in control and DM1 lens cells. There is no 
observed difference in expression levels between the two groups (n = 2, data expressed as 
mean, representative of four independent experiments). 
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Figure 3.8 – Insulin receptor splicing is not altered in DM1 lens epithelial cells. (a) Schematic 
of exon splicing in IR. Primers amplify IR-B (167 bp, includes exon 11) and IR-A (131 bp, 
excludes exon 11). (b) RT-PCR products of IR were electrophoretically resolved on 4% 
agarose gels. The bands were measured densitometrically and the percentage of IR-B was 
calculated and is shown in the graph as an average of the two samples. The percentage of IR-
B in the DM1 cells fell within the range of those of the control cells, indicating that IR 
splicing is not affected in the lens (n = 2, data expressed as mean). 
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To investigate the ratio of the expression of the IR-A and IR-B isoforms 
more accurately, the technique of RT-PCR was used to amplify a region of the IR 
transcripts from exon 10 to 12. Exon 11 is 36 nucleotides long and therefore the 
fragment produced from the IR-A isoform is only 131 bp long compared to that of 
IR-B which is 167 bp (see figure 3.8a). The RT-PCR products were 
electrophoretically resolved and the percentage of IR-B was calculated (see figure 
3.8b). Two of the control cell lines, CCat1 and CCat2, showed almost equal 
expression of IR-A and IR-B (a total of 42.8% and 49.1% IR-B respectively), 
whereas CCat3 and CCat4 showed much lower levels of IR-B (11.3% and 16.0% 
respectively), as did all of the DM1 cell lines. The average level of IR-B in the 
control cell lines was 29.8% ± 9.4% compared to 19.7% ± 3.3% in the DM1 cell 
lines. Due to the large spread of the levels of IR-B in the control cell lines it 
appears that IR splicing is not affected in DM1 LECs, as is the case in DM1 
fibroblasts (Savkur et al., 2001). 
 
3.3.5 Population doubling times of DM1 lens epithelial cells 
 To analyse the growth of populations of the cell lines during culture, flasks 
were seeded with a set number of cells and were passaged weekly and counted 
using a haemocytometer. Population doublings times were calculated for all of the 
human lens cell lines and confirmed the findings of Rhodes et al. (2006) (see 
figure 3.9). Passage numbers (P) of the cell lines at day 0 were as follows: CCat1 
P = 17, CCat2 P = 14, CCat3 P = 8, CCat4 P = 6 and all DM1 cell lines P = 12. At 
early passages all of the cell lines were seen to be doubling at a similar rate, 
however, after 40 days in culture a clear separation was observed between the 
control and DM1 cell lines. At this point the population doubling times of the 
DM1 cell lines began to slow and were shown to decline at later passages as fewer 
cells were harvested than seeded. After 80 days in culture three out of four DM1 
cell lines no longer had enough cells to start the next passage. The control cell line, 
CCat4, had also ceased by this point, however, this was not due to a natural 
decline in cell numbers as was seen in the DM1 cell lines, but rather because they 
had grown too fast and reached a confluent state before passaging which caused 
the cells to lift off the bottom of the culture flask. The remaining control cell lines 
continued to grow well throughout the culture period and cell counts were only 
stopped once the DM1 cell lines had all ceased to grow. The lifespan of the DM1 
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cell lines was significantly shorter than the control cell lines (CCat4 was omitted 
from this as cell growth was halted abruptly and did not reach a natural decline) (p 
< 0.01). The DM1 cell lines survived for an average of 79.5 ± 7.4 days in culture, 
whereas the controls cell lines continued to grow and were stopped after 101 days 
in culture. All four DM1 cell lines were shown to have significantly reduced 
doubling times compared to the four control cell lines (p < 0.01). The DM1 cell 
lines had an average of 1.51 ± 0.10 population doublings per week compared to 
3.52 ± 0.18 in the controls.   
 
3.3.6 Morphology of DM1 lens epithelial cells 
 Cells were seeded in 35 mm culture dishes on day 28 of the culture period 
shown in figure 3.9a. Cells were grown in medium supplemented with 10% FCS 
for 10 days before light microscope phase images of the DM1 and control cell 
lines were taken (see figure 3.10). Despite the fact that the populations of all cell 
lines at this point were shown to be growing at similar rates by analysing the 
population doubling times, there are clear differences in the density of the cells 
seen in the images. Many more cells can be seen in the images of the control cell 
lines compared to the DM1 cell lines. The control cells are closely packed 
together, forming confluent sheets or patches of cells. In contrast, the DM1 cells 
are not confluent and are less densely packed. 
 
3.3.7 Cell death in DM1 lens epithelial cells 
 Cell death in medium supplemented with 10% FCS and in SF medium was 
analysed in the DM1 and control LECs using a lactate dehydrogenase (LDH) 
assay. Greater levels of cell death were observed in DM1 cells in medium 
supplemented with 10% FCS and SF medium compared to control cells, however, 
neither was statistically significant (see figure 3.11). In both cell types, levels of 
cell death were significantly greater in SF medium compared to medium 
supplemented with 10% FCS (p < 0.05). 
 Further experiments were repeated using only CCat1 and DMCat1 cells 
and reveal that DMCat1 has significantly greater levels of cell death in both 
medium supplemented with 10% FCS and SF medium compared to the control 
CCat1 (p < 0.01). There was no significant difference in levels of cell death 
between conditions in the same cell type (see figure 3.12). 
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Figure 3.9 – Population doubling times of DM1 lens epithelial cells.  Cells were grown in 75 
cm2 flasks and counted weekly using a haemocytometer. (a) Passage numbers (P) of the cell 
lines at day 0 were as follows: CCat1 P = 17, CCat2 P = 14, CCat3 P = 8, CCat4 P = 6 and all 
DM1 cell lines P = 12. At early passages all cell lines were doubling at a similar rate, however, 
after 40 days in culture a clear separation was seen between DM1 and control cell lines. The 
population doubling times of the DM1 cell lines slowed and declined at later passages as 
fewer cells were harvested than seeded. The lifespan of DM1 cell lines was significantly 
shorter than that of the controls (statistical analysis performed by Student’s T test, p < 0.05) 
(b) The average number of population doublings per week, showing that DM1 lens cells have 
significantly reduced doubling rates compared to control lens cells (data expressed as mean ± 
SEM, statistical analysis was performed by Student’s T test, ** p < 0.01 relative to controls). 
** 
0
10
20
30
40
50
60
0 20 40 60 80 100 120
Days in culture
Po
pu
la
tio
n
 
do
u
bl
in
gs
CCat1
CCat2
CCat3
CCat4
DMCat1
DMCat2
DMCat3
DMCat4
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
CC
at1
CC
at2
CC
at3
CC
at4
DM
Ca
t1
DM
Ca
t2
DM
Ca
t3
DM
Ca
t4
Av
er
ag
e 
n
u
m
be
r 
o
f p
o
pu
la
tio
n
 
do
u
bl
in
gs
 
pe
r 
w
ee
k
a 
 
 
 
 
 
 
 
 
 
 
 
b 
 
 
 97
 
 
Figure 3.10 – Light microscope phase images of DM1 lens epithelial cells. Cells were grown 
in medium supplemented with 10% FCS and images were taken to show the density and 
morphology of the DM1 and control lens cells.  The DM1 cell lines (e) DMCat1, (f) DMCat2, 
(g) DMCat3 and (h) DMCat4 never reached a confluent state, in contrast to the control cell 
lines (a) CCat1, (b) CCat2, (c) CCat3 and (d) CCat4. 
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Figure 3.11 – Cell death in DM1 lens epithelial cells.  All control and DM1 cells were 
cultured in SF medium or medium supplemented with 10% FCS for 48 hours and levels of 
LDH were measured and normalised to total protein at T = 0. Averages across the control 
and DM1 cell lines were calculated and reveal significantly increased levels of cell death in 
SF medium in both control and DM1 cells (n = 4, data expressed as mean ± SEM of three 
independent experiments, statistical analysis was performed by Student’s T test, * p < 0.05 
relative to medium supplemented with 10% FCS).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 – Cell death in DM1 lens epithelial cells.  CCat1 and DMCat1 cells were cultured 
in SF medium or medium supplemented with 10% FCS for 48 hours and levels of LDH were 
measured and normalised to total protein at T = 0. Cell death was shown to be significantly 
increased in DMCat1 cells in both SF medium and medium supplemented with 10% FCS (n 
= 11, data expressed as mean ± SEM of eleven independent experiments, statistical analysis 
was performed by Student’s T test, ** p < 0.01 relative to CCat1).  
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Figure 3.13 – See next page for figure legend 
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Figure 3.13 – Apoptotic cell death in DM1 lens epithelial cells cultured in medium 
supplemented with 10% FCS. (a) Fluorescent micrographs of cells showing nuclei labelled 
with DAPI (blue), apoptotic cells labelled using a TUNEL assay (green) and F-actin labelled 
with Texas red-X phalloidin (red) (bar = 100 µm). (b) Analysis of TUNEL positive apoptotic 
cells (n = 2, data expressed as mean of two independent experiments). 
 
 
3.3.8 Apoptosis in DM1 lens epithelial cells 
 Cell death via apoptosis was analysed in the DM1 and control LECs using 
a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. 
Cells were cultured in medium supplemented with 10% FCS and in SF medium 
before being fixed and the assay performed. In medium supplemented with 10% 
FCS, similar levels of apoptosis were observed in all cell lines tested (see figure 
3.13). The control cell lines had an average of 9.0% ± 0.2% apoptotic cells, 
compared to 11.4% ± 2.7% apoptotic cells in the DM1 cell lines. There was no 
significant difference between the two groups. In SF medium all four DM1 cell 
lines had greater levels of apoptotic cells than the controls (see figure 3.14). The 
control cell lines had an average of 8.3% ± 0.6% apoptotic cells, compared to 
17.4% ± 2.8% apoptotic cells in the DM1 cell lines, however, this was not 
statistically significant. The level of apoptosis in the controls did not appear to be 
affected by the medium they were cultured in, with similar levels being observed 
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under both conditions. In contrast, the DM1 cell lines had greater levels of 
apoptosis in SF medium compared to medium supplemented with 10% FCS, 
although this was also not statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14 – See next page for figure legend 
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Figure 3.14 – Apoptotic cell death in DM1 lens epithelial cells cultured in SF medium. (a) 
Fluorescent micrographs of cells showing nuclei labelled with DAPI (blue), apoptotic cells 
labelled using a TUNEL assay (green) and F-actin labelled with Texas red-X phalloidin (red) 
(bar = 100 µm). (b) Analysis of TUNEL positive apoptotic cells (n = 2, data expressed as 
mean of two independent experiments). 
 
 
Although there is an increase in DM1 cell death via apoptosis in SF 
medium, the variability in the cell lines prevented this from being statistically 
significant. Therefore, further repeats were conducted using only the CCat1 and 
DMCat1 cell lines (see figure 3.15). CCat1 was chosen as it was typical of the 
control cell lines, showing even and consistent growth throughout the culture 
period. The DMCat1 cell line was chosen because although it had a significantly 
reduced growth rate compared to the control cell lines, it could be sustained over a 
greater number of passages than the other DM1 cell lines, enabling more 
experiments to be performed (see figure 3.9). In SF medium, DMCat1 had 
significantly greater levels of apoptotic cell death with an average of 21.1% ± 
2.1% apoptotic cells compared to only 8.8% ± 0.9% in CCat1 (p < 0.01). In 
medium supplemented with 10% FCS, DMCat1 cells had greater levels of 
apoptotic cell death, as CCat1 had an average of 7.1% ± 2.1% apoptotic cells, 
compared to 11.4% ± 1.4% apoptotic cells in DMCat1, however, the difference 
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was not statistically significant. In CCat1 cells, no difference was observed in 
levels of apoptosis in either SF medium or medium supplemented with 10% FCS. 
However, in DMCat1 cells a significant increase in levels of apoptotic cell death 
was observed in cells cultured in SF medium compared to medium supplemented 
with 10% FCS (p < 0.01). Interestingly, this data suggests that the DM1 cells do 
not respond to stress, such as that observed during serum starvation, as well as the 
controls cells do, resulting in greater levels of apoptosis. A lack of serum, and 
therefore added growth factors, in the medium would require autocrine signalling 
in the cells in order to sustain growth. This data could therefore indicate an 
impairment in autocrine signalling in the DM1 cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 – Apoptotic cell death in DM1 lens epithelial cells. Semiquantitative analysis of 
TUNEL positive apoptotic CCat1 and DMCat1 cells cultured in SF medium and medium 
supplemented with 10% FCS. Although apoptotic cell death was greater in DMCat1 cells 
cultured in medium supplemented with 10% FCS than CCat1 cells, this was not significant, 
however in cells cultured in SF medium apoptotic cell death was significantly higher in 
DMCat1 cells compared to CCat1 cells. Apoptotic cell death was also significantly higher in 
DMCat1 cells cultured in SF medium compared to those cultured in medium supplemented 
with 10% FCS (n = 6, data expressed as mean ± SEM of six independent experiments, 
statistical analysis was performed by Student’s T test, ** p < 0.01 relative to CCat1 in SF 
medium, # # p < 0.01 relative to DMCat1 in medium supplemented with 10% FCS). 
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3.4 Discussion 
 
Many studies have investigated the role of SIX5 in the lens and have 
linked a downregulation in expression to cataract formation in DM1, adding 
weight to the theory that the triplet repeat causes changes to the local chromatin 
structure which results in downregulation of the downstream gene (Winchester et 
al., 1999; Rhodes et al., 2006). Two separate studies using SIX5 knockout mouse 
models have reported cataract formation in the lens, which appeared to confirm 
the theory, however, the cataracts seen in the mouse models did not show the 
distinctive characteristics observed in human DM1 patients (Klesert et al., 2000; 
Sarkar et al., 2000). The iridescent particles were not present and the opacity was 
located within the nucleus of the lens as opposed to the posterior subcapsular area 
where it forms in humans. Cataracts with iridescent opacities have been shown to 
form in a mouse model for DM1, however, it was the result of a Mbnl1 gene 
knockout and not Six5. In this study we have presented evidence that the level of 
SIX5 expression in DM1 lens cells is not affected by the triplet repeat (see figure 
3.2) and based on this data, we propose that although a reduction in SIX5 
expression can lead to cataract formation, it is probably not responsible for the 
formation of DM1 cataracts.  
Previous reports investigating the expression of DMPK in the human lens 
have been contradictory (Dunne et al., 1996; Winchester et al., 1999; Rhodes et 
al., 2006). Here, in support of the studies by Dunne et al. (1996) and Rhodes et al. 
(2006), we have shown by QRT-PCR, Northern blotting and FISH that DMPK 
mRNA is present in human LECs (see figures 3.3 and 3.4). The levels of DMPK 
mRNA analysed by QRT-PCR and Northern blotting showed that the triplet 
repeat had no effect on DMPK expression. Surprisingly, the technique of Northern 
blotting failed to detect the DMPK transcripts from the mutant allele, as no larger 
band or smear representing transcripts containing expanded triplet repeats was 
seen. The lack of this band is likely due to problems in extracting larger RNAs as 
the mutant transcripts are possibly subjected to increased levels of mechanical 
damage, resulting in shearing of the mutant RNAs, or it could indicate inefficient 
transfer of the larger RNAs to the membrane. However, the mutant allele was 
shown to be expressed in the DM1 LECs using the technique of FISH to detect 
the CUG repeats in the DMPK mRNA (see figure 3.4). We have shown that 
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DMPK transcripts form foci in DM1 LECs which are trapped within the nucleus. 
This is a significant finding because the formation of nuclear foci of DMPK 
transcripts is a common feature in cells affected by DM1 and is linked to the 
sequestration of MBNL proteins and the increased activation of CUG-BPs which 
are involved in the regulation of splicing events (Timchenko et al., 2001a; Fardaei 
et al., 2002). Changes in the levels of MBNLs and CUG-BPs results in the 
production of proteins with different biological properties due to disruption in the 
regulation of splicing events. The production of alternatively spliced proteins has 
been shown to be the cause of many of the symptoms associated with DM1 and 
could therefore also be the cause of cataract formation in the lens.  
The expression of two members of the muscleblind family, MNBL1 and 
MBNL2, were analysed in this study. We found expression of both genes in all of 
the cell lines and the expression levels were not found to be affected by DM1 (see 
figure 3.5). The expression of two members of the CELF family, CUG-BP1 and 
CUG-BP2, were also analysed. Again, we found expression of both genes in all 
cell lines (albeit very low for CUG-BP2 in CCat2) and the levels of expression 
were not affected by DM1 (see figure 3.6). The expression levels of the genes 
above are not expected to be altered by DM1, but the levels of active proteins 
could be; MBNL proteins are sequestered by the CUG repeats and activation of 
CUG-BPs is increased. However, the expression of these splicing regulators in 
human lens cells could indicate a role for alternative splicing events leading to 
cataract formation in DM1 lenses.  
To investigate the role of alternative splicing in cataract development, we 
looked at some of the proteins known to be affected by alternative splicing events 
in DM1 and analysed their expression in human lens epithelial cells. We found 
that expression of CLCN1 was absent in the lens cell lines and RYR1 was only 
expressed in a few of the cells lines at very low levels and therefore altered 
splicing of the protein products ClC-1 and RYR1 is unlikely to cause cataract 
formation. However, the human lens cells were shown to express IR and both of 
the alternatively spliced isoforms were shown to be present (see figures 3.7 and 
3.8). The ratio of IR isoforms in DM1 skeletal muscle was shown to shift towards 
the production of IR-A, which results in decreased insulin sensitivity (Savkur et 
al., 2001). IR has been found in the epithelial layer of human lenses and is 
interestingly absent in lenses of diabetic cataract patients, although this was 
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suggested to be due to lens degeneration caused by cataract formation (Naeser, 
1997). Insulin has been shown to increase the rate of crystallin production in the 
rat lens and therefore a reduced response to insulin signalling by production of IR-
A instead of IR-B could result in cataract formation (Leenders et al., 1997; Civil 
et al., 2000). The ratio of IR isoforms in the human lens cell lines was analysed by 
separating PCR products of the two forms of IR on agarose gels (see figure 3.8). 
Although production of IR-A was shown to be favoured in the DM1 cell lines 
with an average of only 19.7% IR-B, it was not significantly different from the 
control cell line average of 29.8%. This was due to the large spread of the data 
from the control cell lines, with two showing an almost equal expression of IR-A 
compared to IR-B (CCat1 and CCat2) and the other two showing a greater bias 
towards IR-A expression than most of the DM1 cell lines (CCat3 and CCat4). 
Therefore, the splicing pattern of IR was not shown to be affected in the DM1 
LECs. From our data it appears that splicing patterns of proteins in DM1 LECs 
are not altered, however, we did not examine the expression of these proteins in 
lens fibre cells where cataract forms and there are many proteins affected by mis-
splicing in DM1 that we have not investigated. Therefore we cannot completely 
rule out a role for alternative splicing in cataract formation in DM1.  
As no molecular cause underlying cataract formation has so far been 
elucidated, we looked at the cellular effects which could result in their 
development. Previous studies on cataracts in general have indicated that a loss of 
cells from the lens epithelium results in the development of cataract, and in 
particular subcapsular cataracts, due to the resulting loss of homeostasis in levels 
of ions and water (Konofsky et al., 1987; Li et al., 1995). A study by Abe et al. 
(1999) investigated the density of the LEC layer in native human lenses from 
DM1 patients and showed that DM1 lenses contained significantly fewer cells in 
the LEC layer than those from age matched control lenses with senile cataract. 
Despite the decrease in cell density, coverage of the lens was maintained by an 
increase in cell size (Abe et al., 1999). This data would suggest that a reduced 
number of LECs may not be sufficient to maintain the balance of ions and water 
which is vital to lens transparency, therefore resulting in cataract formation in 
DM1. Here, we have shown that DM1 LECs had longer population doubling 
times compared to controls, which confirms the data presented by Rhodes et al. 
(2006) (see figure 3.9). We showed that the growth rate of DM1 LECs was 
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significantly reduced compared to control LECs and a point was reached where 
DM1 cell populations began to slow and decline, which was not observed in 
controls. DM1 LECs were therefore shown to have a significantly shorter lifespan 
than control LECs. Li et al. (1995) showed that capsulorhexis samples from non-
DM cataract patients had a significantly greater percentage of apoptotic cells 
compared to normal controls and that apoptotic cell death occurred prior to 
cataract development. We therefore investigated the role of apoptotic cell death in 
the reduced population doubling times in DM1 LECs. We showed that under 
normal culture conditions there was no difference in levels of apoptotic cell death 
(see figures 3.13 and 3.15), however, if the cells were cultured in SF medium an 
increase in apoptosis was observed in the DM1 cells but not the controls (see 
figures 3.14 and 3.15). This is very interesting as it indicates that DM1 LECs are 
less able to withstand stress, such as serum deprivation, than normal LECs.  
Interestingly, increased susceptibility to stress has been shown in cell lines 
transfected with CTG repeats. Studies on mouse myoblasts transfected with 
DMPK containing varying numbers of CTG repeats, showed CTG repeat number-
dependent susceptibility to oxidative stress, resulting in apoptosis (Usuki et al., 
2000). Subsequently, it was shown that greater levels of reactive oxygen species 
(ROS) form in cells with larger repeats (160 repeats) and that these cells activate 
the stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) pathways 
as opposed to the extracellular signal-related protein kinase (ERK) pathway which 
was activated in cells transfected with very short repeats (5 repeats) (Usuki et al., 
2008). This data is particularly relevant to lens cells as the lens is subject to 
oxidative stress from radiation (e.g. UV) and other sources and the production of 
ROS is a major contributor to age-related cataract formation (Berthoud & Beyer, 
2009).  
As DM1 LECs show a greatly reduced ability to maintain their own 
survival in the absence of added growth factors, this could indicate an impairment 
in autocrine signalling. As the lens is not innervated, vascularised or penetrated by 
lymphatic vessels, LECs in their native environment are not likely to receive 
many external signals in order to encourage growth or survival (Ishizaki et al., 
1993). Rat LECs have been shown to survive in culture, and even to divide, in the 
absence of signals from other cell types, but only when cultured at high densities. 
At low densities the cells undergo apoptosis, which suggests that they rely on 
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other LECs for their survival (Ishizaki et al., 1993). Human LECs have also been 
shown to survive in protein-free medium when cultured on the lens capsule 
(although the lens capsule has subsequently been shown to contain growth factors 
which are available to the LECs (Tholozan et al., 2007)) and proliferate and 
migrate as occurs in vivo (Wormstone et al., 1997). Lens cells are one of the few 
cell types which are capable of surviving and maintaining their phenotype in the 
absence of external signals. Chondrocytes are also capable of this, however, they 
do not actively proliferate as is observed in LECs (Ishizaki et al., 1994). Therefore, 
lens cells should be able to actively maintain their own growth and survival in SF 
medium, but the DM1 LECs have been shown to undergo significantly increased 
levels of programmed cell death. An impairment in autocrine signalling may 
result in increased levels of apoptosis, either due to the cells not releasing enough 
of their own signalling factors or an impairment in the way that they respond to 
the signalling factors which they produce. It is possible that, as is seen in mouse 
myoblasts transfected with DMPK containing large triplet repeats, the DM1 lens 
cells are activating different pathways in response to stress than the controls cells, 
resulting in increased levels of cell death (Usuki et al., 2008).  
From the data described in this chapter, it appears that the DM1 lens 
epithelial cell lines are a good model in which to study the disease. Expression of 
SIX5 was not shown to be affected by the triplet repeat, which means the focus 
can be placed on DMPK expression and the downstream affects of mutant mRNA 
production. The lens cells have been shown to express DMPK, which is also seen 
in normal human lenses (Dunne et al., 1996; Rhodes et al., 2006). The mutant 
DMPK transcripts were also shown to form distinct nuclear foci which is a 
common feature in other DM1 cell lines and patient samples (Taneja et al., 1995; 
Davis et al., 1997; Hamshere et al., 1997; Furling et al., 2001b; Liquori et al., 
2001; Jiang et al., 2004; Mankodi et al., 2005; Bonifazi et al., 2006; Wheeler et 
al., 2007a; Cardani et al., 2008). Although the characteristic splicing defects 
observed in other DM1 cell types have not been found in our cell lines, it is not 
known to what extent mis-splicing plays a role in the native human lens in DM1. 
In DM1 fibroblasts, DMPK transcripts have been shown to produce foci which 
sequester MBNL proteins in the nuclei. However, a further study showed that 
aberrant IR splicing did not occur in DM1 fibroblasts until they were transformed 
to a muscle phenotype, when they then showed a switch towards the IR-A 
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isoforms (Fardaei et al., 2001; Savkur et al., 2001; Fardaei et al., 2002). Therefore, 
it is possible that foci may normally be present in some cell types without 
observing any impact on splicing patterns. Despite the lack of an observed 
splicing defect to describe the mechanism behind cataract development in the lens, 
the presence of mutant DMPK mRNA in LECs indicates that it is likely to play a 
role in DM1 cataract formation. DM1 LECs were shown to have significantly 
reduced population doubling times and serum deprivation was shown to result in 
significantly increased levels of apoptotic cell death. This could indicate an 
impairment in autocrine signalling which requires further investigation. 
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CHAPTER 4 
AUTOCRINE SIGNALLING IN DM1 LENS 
EPITHELIAL CELLS 
 
4.1 Introduction 
 
 Cells communicate and bring about changes to their behaviour through 
cell signalling. Decisions made by a cell are the result of signalling pathways 
which are often complex and consist of signalling molecules, receptors, kinases, 
phosphatases, target proteins and more (Alberts et al., 2002). Cells communicate 
with each other through the release of signalling molecules, such as growth 
factors and hormones, which can activate receptors on the surface of other cells. 
Cells can communicate to other cell types over long distances; known as 
endocrine signalling, or short distances; known as paracrine signalling. Cells can 
also signal to other cells of the same type, or themselves, over short distances; 
known as autocrine signalling. The activation of receptors triggers a cascade of 
signalling within a cell which can bring about changes in a variety of processes 
such as cell motility, proliferation, growth, survival and death. A lack of cellular 
signalling can also have serious effects on a cell as a certain level of signalling is 
required for survival. Cells that do not receive the level of signalling required 
undergo apoptotic cell death. Cell signalling is therefore tightly controlled, 
however, disturbances in cell signalling pathways can occur and could lead to 
many different diseases ranging from cancer to neurological disorders.  
 
4.1.1 Cell signalling 
 In order for cells to respond to the signals they receive, they require 
receptors on their cell surface which can be activated by the signal molecule, 
which is also known as a ligand. The three major types of cell surface receptor are 
ion-channel-linked receptors, which are activated by neurotransmitters to alter ion 
permeability in electrically excitable cells; G protein-linked receptors, which 
regulate the activity of target enzymes or ion channels via a guanosine 
trisphosphate (GTP) binding protein (G protein); and enzyme-linked receptors, 
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which when activated function as enzymes, or are linked to enzymes, commonly 
protein kinases (Alberts et al., 2002). The enzyme-linked receptors respond to 
ligands known as growth factors, which are linked to signalling involved in the 
growth, proliferation, differentiation and survival of cells. The largest class of 
enzyme-linked receptors are the receptor tyrosine kinases (RTKs) (Alberts et al., 
2002). Binding of growth factors to their respective RTK usually results in a 
conformational change which leads to phosphorylation of tyrosine residues within 
the kinase domain of the receptor, resulting in its activation. This triggers the 
activation of a cascade of molecules involved in the transduction of the signal 
within the cell, resulting in a specific biological response. 
 
4.1.2 Cell signalling in the lens 
 A number of different growth factors and their RTKs are important for cell 
signalling within the lens. These include epidermal growth factor (EGF), acidic 
fibroblast growth factor (aFGF, or FGF-1), basic fibroblast growth factor (bFGF, 
or FGF-2), hepatocyte growth factor (HGF), insulin-like growth factor (IGF-1) 
and platelet-derived growth factor (PDGF) (Bhuyan et al., 2000; Wormstone et al., 
2000). The growth factors which act upon the lens are involved in signalling 
which results in the maintenance of growth, proliferation and survival of the lens 
cells, as well as regulating the processes of differentiation and migration. 
 
4.1.2.1 Paracrine signalling in the lens 
 Many ocular tissues secrete growth factors into the aqueous and vitreous 
humours of the eye. Paracrine signalling from these ocular tissues has been shown 
to be important in processes such as proliferation, migration and differentiation of 
LECs. PDGF was found to be expressed by the ciliary body and iris and its 
receptor PDGFR was expressed in LECs (Kok et al., 2002). Studies have 
suggested that PDGF plays a role in proliferation, migration and differentiation in 
LECs (Reneker & Overbeek, 1996; Kok et al., 2002; Xiong et al., 2010). Growth 
factors found to be present within the aqueous and vitreous humours, include IGF-
1 which was found in both the aqueous and vitreous humours from bovine eyes, 
with levels in the aqueous being twice that found in the vitreous (Arnold et al., 
1993). The growth factor EGF was also found to be present in the aqueous 
humour, but was not found in the vitreous humour (Majima, 1997). bFGF was 
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present in bovine aqueous and vitreous humours, with levels in the vitreous being 
greater than that found in the aqueous, however, aFGF was only present in the 
vitreous (Schulz et al., 1993).  
 The aqueous bathes the anterior of the lens which contains the LECs and 
the vitreous bathes the posterior of the lens which contains the fibre cells, 
therefore, the distribution of growth factors is likely to affect cellular responses 
and the polarity and architecture of the lens. For example, bovine vitreous humour, 
which contains high levels of bFGF, was shown to induce fibre differentiation in 
rat lens epithelial explants but aqueous humour did not (Schulz et al., 1993). 
Different levels of bFGF have been shown to have different effects on rat lens 
epithelial explants. Proliferation, migration and differentiation have been shown 
to be induced as concentrations of bFGF are increased, with half maximal 
responses for each at 0.15, 3 and 40 ng/ml respectively (McAvoy & Chamberlain, 
1989). The distribution of bFGF in the aqueous and vitreous humours results in 
increasing concentrations of bFGF from the anterior to the posterior of the lens 
and is therefore likely to play a major role in determining the spatial patterns of 
proliferation, migration and differentiation (Lovicu & McAvoy, 1993).  
 Interestingly, lens cells have been shown to survive in culture in the 
absence of paracrine signalling factors, indicating that autocrine signalling plays 
an important role in their survival (Ishizaki et al., 1993).  
 
4.1.2.2 Autocrine signalling in the lens 
 Although many growth factors are present within the aqueous and vitreous 
humours, the lens has also been shown to synthesise many of its own growth 
factors which act in an autocrine manner. The lens contains just two cell types 
(epithelial cells and fibre cells) and is not penetrated by blood vessels, lymphatic 
vessels or nerves. It is therefore not surprising that lens cells are some of the only 
cell types that do not require signals from other cells to survive. LECs from young 
rats have been shown to survive in culture for weeks in the absence of added 
serum and proteins when cultured both with and without the lens capsule. Not 
only did the cells survive, but some were also shown to divide during the culture 
period (Ishizaki et al., 1993). A subsequent study also showed that human LECs 
could grow in the absence of added serum and proteins, reaching confluency in  
95% of cultures (Wormstone et al., 1997). Human LECs cultured on the capsule 
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could be maintained in the absence of added protein and serum for over a year 
(Wormstone et al., 2001). Although the lens is surrounded by the aqueous and 
vitreous humours which contain growth factors that are available to the lens, this 
data shows that these are not necessary for LEC survival or proliferation. 
Autocrine signalling must therefore play an important role in LEC survival during 
culture. Interestingly, rat LECs only survived under protein- and serum-free 
conditions when cultured at high densities. When cultured at low densities the 
LECs underwent apoptotic cell death (Ishizaki et al., 1993). This data shows that 
although the LECs do not require signals from other cell types to survive, they do 
require signals from other LECs and it was also shown that this was not contact 
dependent, indicating that factors are being released by the cells to promote 
survival. Survival of low density cultures could be promoted by the addition of 
conditioned medium (CM) from high density cultures, which raised survival rates 
to those of the high density cultures (Ishizaki et al., 1993). The factor, or factors, 
responsible for increasing survival of LECs in culture were not identified, 
however, addition of many of the growth factors known to act on LECs, for 
example, IGF-1 and bFGF, did not increase survival, indicating that these were 
either not responsible or were at too low a concentration to have an effect. 
 A number of autocrine signalling systems have been identified in the lens. 
Human LECs cultured on the lens capsule have been shown to synthesise bFGF 
and the receptor FGFR1 when cultured under protein- and serum-free conditions, 
establishing an autocrine signalling system. When this system was blocked, a 
marked attenuation of growth was observed (Wormstone et al., 2001). Autocrine 
signalling via aFGF has also been shown to be critical to survival in bovine LECs 
(Renaud et al., 1994). EGF and HGF autocrine signalling systems have also been 
revealed in both human and rabbit lenses and in cultured LECs (Majima, 1995; 
Weng et al., 1997; Wormstone et al., 2000). Signalling via EGF and its receptor, 
EGFR, was linked to proliferation, whilst signalling via HGF and its receptor, c-
met, was shown to stimulate proliferation, protein synthesis and migration in 
cultured human LECs (Majima, 1995; Wormstone et al., 2000). Expression of c-
met was found to be upregulated following mechanical trauma, indicating a role 
for HGF signalling in wound healing (Wormstone et al., 2000). During 
development, autocrine signalling via IGF-1 and its receptor, IGFR-1, in the chick 
lens has been shown to be important for the differentiation of fibre cells (Caldes et 
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al., 1991). A role for autocrine signalling via IGF-1 is uncertain in adult lenses as 
a study in the adult rat lens failed to show expression of IGF-1 (Danias & 
Stylianopoulou, 1990). IGFR-1 is expressed in the adult human lens, but the 
expression of IGF-1 was not examined (Bhuyan et al., 2000). However, cultured 
bovine LECs were shown to express both IGFR-1 and IGF-1 and signalling via 
this pathway was shown to regulate migration, proliferation and differentiation 
(Palmade et al., 1994).  
 
4.1.2.2.1 The EGF signalling pathway 
 The growth factor EGF binds with high affinity to its receptor EGFR. 
EGFR is an RTK which consists of an extracellular ligand binding domain, a 
hydrophobic transmembrane domain and an intracellular tyrosine kinase domain. 
Binding of EGF ligands results in receptor dimerisation and autophosphorylation 
of the tyrosine kinase domains. The phosphorylated tyrosine kinase domains 
recruit substrates and docking proteins which results in the activation of signal 
transduction pathways (see figure 4.1) (Carpenter & Cohen, 1990; Lurje & Lenz, 
2009). Proteins which are recruited include: phosphatidylinositol 3-kinase (PI3K), 
which activates the PI3K/Akt signalling pathway; growth factor receptor-bound 
protein 2 (GRB2) and son of sevenless (SOS) which bind directly or via the 
adaptor molecule Src homology 2 domain containing protein (Shc), which 
activate the mitogen-activated protein kinase (MAPK)/extracellular signal related 
kinase (ERK) cascade; phospholipase Cγ (PLCγ), which results in the production 
of diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3), which activate 
protein kinase C (PKC) and Ca2+ release respectively; and Janus kinase (JAK), 
which activates signal transducers and activators of transcription (STAT) 
pathways (Carpenter & Cohen, 1990; Lurje & Lenz, 2009). 
 In serum-free conditions EGF has been shown to promote mitosis in the 
LECs of cultured rabbit lenses, revealing a role in cell proliferation (Reddan & 
Wilsondziedzic, 1983). EGF has also been shown to promote cell growth in a 
further study using rabbit LECs (Hongo et al., 1993). In cultured human LECs, 
EGF has been shown to play a role in cell migration via the MAPK/ERK and 
PI3K/Akt signalling pathways (Jiang et al., 2006). Growth of human LECs 
cultured on the lens capsule in serum-free medium has been shown to be reduced 
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in the presence of an EGFR inhibitor (Maidment et al., 2004). This data indicates 
that autocrine signalling via EGF is important for growth in LECs. 
 
 
 
Figure 4.1 – The EGF signalling pathway. The binding of EGF ligands results in 
dimerisation of EGF receptors and phosphorylation of intracellular tyrosine kinase domains. 
Various proteins can be recruited, including PI3K which activates the PI3K/Akt pathway; 
Shc, GRB2 and SOS which activate the MAPK/ERK signalling pathway; PLCγ which results 
in the activation of PKC and the release of Ca2+; and JAK which activates STAT pathways. 
 
 
4.1.2.2.2 The FGF signalling pathway 
 The FGFs are a family of 22 small polypeptide growth factors, the 
majority of which are secreted by cells and bind to heparin or heparan sulphate 
proteoglycans (HSPG) in the extracellular matrix (ECM) or on the cell surface. 
Heparin and HSPG regulate FGF binding to their RTKs, known as FGFR1-
FGFR4. The receptors contain an extracellular ligand-binding domain composed 
of three immunoglobulin-like domains, a stretch of acidic residues, known as the 
 116
acid box, and a positively charged region which binds to heparin. The receptors 
also contain a transmembrane domain and an intracellular domain containing a 
protein tyrosine kinase. Following ligand binding, the receptors dimerise and 
become activated through phosphorylation of the tyrosine residues within the 
tyrosine kinase domain (Powers et al., 2000; Eswarakumar et al., 2005). The 
phosphorylated tyrosine kinase domains recruit various signalling molecules, 
activating different signalling cascades (see figure 4.2). These include: PI3K, 
which activates the PI3K/Akt signalling pathway; the docking protein fibroblast 
growth factor receptor substrate 2 (FRS2), which recruits and activates GRB2 and 
SOS which activate the MAPK/ERK cascade; and PLCγ, which results in the 
production of DAG and IP3, which activate PKC and Ca2+ release respectively. 
 
 
 
 
 
Figure 4.2 – The FGF signalling pathway. The binding of FGF ligands results in dimerisation 
of FGF receptors and phosphorylation of intracellular tyrosine kinase domains. Various 
proteins can be recruited, including PI3K which activates the PI3K/Akt pathway, FRS2 
which activates the MAPK/ERK signalling pathway and PLCγ which results in the 
activation of PKC and the release of Ca2+. 
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Neither aFGF or bFGF, which have been shown to be important in lens 
cell signalling, contain a signal peptide to enable them to be secreted by cells, 
however, receptors for these growth factors are found in the plasma membrane, 
indicating that they act extracellularly. Mignatti et al. (1991) showed that 
fibroblast cells produced bFGF and their motility was inhibited by the addition of 
bFGF antibodies to the culture medium, revealing that bFGF acted extracellularly 
and in an autocrine manner to promote motility. From this data it was suggested 
that rather than being secreted by the ER-Golgi system, the growth factors are 
instead released via an exocytotic pathway (Mignatti et al., 1991). FGF has also 
been shown to be released from damaged or dead cells (D'Amore, 1990).  
Both aFGF and bFGF were found to be expressed and active in the bovine 
lens and in the surrounding aqueous and vitreous humours (Schulz et al., 1993). In 
bovine LECs, aFGF is thought to act as a survival factor, being produced at 
greater levels by serum deprived cells compared to those cultured in medium 
supplemented with serum. When antisense primers specific to aFGF were added 
to the serum deprived bovine LECs, cell viability decreased, indicating that 
autocrine signalling involving aFGF is required for survival (Renaud et al., 1994). 
The lens capsule has been proposed as a reservoir of growth factors, including 
bFGF, and release of bFGF from the ECM of the capsule by matrix 
metalloproteinase 2 (MMP-2) has also been shown to be critical for survival 
during serum deprivation in a human lens cell line cultured on bovine lens 
capsules (Tholozan et al., 2007). During serum deprivation, human LECs cultured 
on their own capsule were shown to synthesise bFGF and the receptor, FGFR1, 
enabling autocrine signalling via the FGF signalling pathway. When FGFR1 was 
blocked using a synthetic inhibitor (SU5402) growth rates and the release of 
bFGF were reduced (Wormstone et al., 2001). In a cultured human lens cell line, 
bFGF was shown to suppress apoptosis induced by serum deprivation via 
upregulation of bcl-2 expression (Wang et al., 1999). In rat LECs, bFGF has been 
shown to induce proliferation, migration and differentiation in a concentration-
dependent manner. The half maximal concentrations of bFGF shown to induce 
proliferation, migration and differentiation were 0.15, 3 and 40 ng/ml respectively 
(McAvoy & Chamberlain, 1989). bFGF induced proliferation and differentiation 
were later shown to be dependent on the MAPK/ERK pathway, although a more 
recent study showed that both the MAPK/ERK and PI3K/Akt signalling pathways 
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were required for bFGF induced lens fibre differentiation in rat LECs (Lovicu & 
McAvoy, 2001; Wang et al., 2009b). During differentiation, bFGF has also been 
shown to induce expression of the lens fibre protein MIP26 in rat lens epithelial 
explants, which is dependent on the MAPK/ERK and MAPK/JNK pathways 
(Golestaneh et al., 2004). In porcine lenses, bFGF was also shown to strongly 
activate the MAPK/ERK pathway and was shown to weakly activate the 
PI3K/Akt pathway (Zatechka & Lou, 2002a). In human LECs, both aFGF and 
bFGF increase cell proliferation and differentiation, however, much higher 
concentrations of aFGF are required to observe effects similar to those seen with 
lower concentrations of bFGF (Ibaraki et al., 1995). Overall, signalling via the 
FGF pathway, and in particular via the ligand bFGF, has been shown to be 
important for differentiation, proliferation, migration and survival of LECs, 
making it a critical signalling pathway for the function of the lens. 
 
4.1.2.2.3 The HGF signalling pathway 
 HGF is a disulphide-linked heterodimeric protein which binds with high 
affinity to its receptor, c-Met. c-Met is an RTK which consists of an extracellular 
α-subunit and a β-subunit which has an extracellular region, a membrane spanning 
segment and an intracellular tyrosine kinase domain (Ma et al., 2003). Binding of 
HGF to c-Met results in phosphorylation of the extracellular domain enabling 
homodimerisation of receptors and phosphorylation of the intracellular tyrosine 
kinase domains (Conway et al., 2006). The activated receptor recruits signalling 
proteins such as: PLCγ, which results in the production of DAG and IP3, which 
activate PKC and Ca2+ release respectively; PI3K, which activates the PI3K/Akt 
pathway; GRB2 and SOS which activate the MAPK/ERK pathway; and STAT3 
(see figure 4.3). 
 Cultured human and rabbit LECs were shown to express both HGF and c-
Met using RT-PCR. Addition of HGF to rabbit LECs resulted in increased levels 
of proliferation and the expression of crystallin proteins (Weng et al., 1997). 
LECs from porcine capsular bag models were shown to release HGF and addition 
of neutralising antibodies to the receptor, c-Met, resulted in a reduction in cell 
proliferation (Choi et al., 2004). Addition of HGF to cultured human LECs 
increased cell proliferation which was also confirmed in rat lens epithelial 
explants (Choi et al., 2004). HGF was detected in human capsular bag models 
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cultured in serum-free medium and the receptor, c-Met, was also detected in the 
epithelial cells. Following mechanical trauma the expression of the receptor 
increased in the cells which grew across the cell free areas, indicating a role in 
proliferation and/or migration. In the same study, the addition of HGF to cultured 
human LECs under serum-free conditions was shown to increase proliferation, 
protein synthesis and migration (Wormstone et al., 2000). HGF was shown to 
activate pathways that resulted in ERK, JNK and Akt activation which were 
linked to cyclin D1 expression (Choi et al., 2004). This data indicates that 
autocrine signalling via HGF plays a role in cell proliferation and also protein 
synthesis and migration. 
 
 
 
 
Figure 4.3 – The HGF signalling pathway. The binding of HGF ligands results in 
dimerisation of c-Met receptors and phosphorylation of intracellular tyrosine kinase 
domains. Various proteins can be recruited, including PI3K which activates the PI3K/Akt 
pathway; GRB2 and SOS which activate the MAPK/ERK signalling pathway; PLCγ which 
results in the activation of PKC and the release of Ca2+; and STAT3. 
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4.1.2.2.4 The IGF-1 signalling pathway 
The growth factor IGF-1 is similar to the hormone insulin in structure and 
function and can bind to both the IGF receptor 1 (IGFR-1) and the insulin receptor 
(IR), although it has lower affinity for IR. IGFR-1 is an RTK which consists of 
two extracellular ligand-binding α-subunits and two transmembrane tyrosine 
kinase domain containing β-subunits which are linked to each other by disulphide 
bonds. Binding of IGF-1 to IGFR-1 can be regulated by IGF binding proteins 
(IGFBPs), which either bind to IGF-1 or enhance its ability to bind to the receptor. 
Ligand binding results in autophosphorylation of the tyrosine kinase domains of 
the receptor, activating them and enabling the phosphorylation of downstream 
proteins, such as insulin receptor substrate-1 (IRS-1) and Shc (Pavelic et al., 
2007). IRS-1 activates the PI3K/Akt pathway, whereas Shc signals via GRB2 and 
SOS to activate Ras and the MAPK/ERK pathway (see figure 4.4) (Riedemann & 
Macaulay, 2006). 
 
   
 
 
Figure 4.4 – The IGF-1 signalling pathway. The binding of IGF-1 ligands to IGFR-1 causes a 
conformational change resulting in autophosphorylation of intracellular tyrosine kinase 
domains. Proteins recruited to the activated receptor include IRS-1 which activates the 
PI3K/Akt pathway and Shc which recruits GRB2 and SOS which activate the MAPK/ERK 
signalling pathway. 
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 Expression of IGF-1 was not detected in the rat lens, however mRNA for 
IGFR-1 was found (Burren et al., 1996). IGF-1 was shown to be synthesised and 
released by bovine LECs and both IGF-1 and IGFBP-2 were found in the aqueous 
and vitreous humours which surround the lens (Arnold et al., 1993; Palmade et al., 
1994). In human LECs, IGFR-1 was found in the cell membrane by Western 
blotting (Bhuyan et al., 2000). 
 In bovine, chicken and rabbit lens cells, IGF-1 has been shown to 
stimulate the PI3K/Akt pathway which was linked to proliferation and 
differentiation of LECs (Chandrasekher & Bazan, 2000; Chandrasekher & Sailaja, 
2003). In rabbit LECs, IGF-1 stimulation of the PI3K/Akt pathway was linked to 
survival and proliferation, with proliferation being linked to the activation of p70 
S6 kinase (p70S6K) found downstream of Akt, however, the p70S6K pathway 
had no effect on survival (Chandrasekher & Sailaja, 2004). In the porcine lens, 
IGF-1 has been shown to activate both the MAPK/ERK pathway and PI3K/Akt 
pathway which was linked to proliferation and survival (Zatechka & Lou, 2002a). 
In rat LECs, IGF-1 was shown to stimulate proliferation but not differentiation, 
which required addition of bFGF (Civil et al., 2000). By adding increasing levels 
of IGF-1 to the rat LECs, IGF-1 was also shown to increase the levels of β- and γ-
crystallin in relation to α-crystallin, which could predispose the lens to cataract 
(Civil et al., 2000). In human LECs, IGF-1 was shown to stimulate cell 
proliferation and differentiation (Ibaraki et al., 1995). In serum-free conditions 
IGF-1 has been shown to promote mitosis in the LECs of cultured rabbit lenses, 
further indicating the role of IGF-1 in cell proliferation (Reddan & 
Wilsondziedzic, 1983). Signalling via the IGF-1 pathway has therefore been 
shown to influence lens cell proliferation, differentiation and survival which are 
critical to the function of the lens. 
 
4.1.3 Autocrine signalling in DM1 lens epithelial cells 
 We have shown that DM1 lens epithelial cells have significantly increased 
levels of apoptotic cell death compared to controls when cultured in protein- and 
serum-free medium. We hypothesised that this was due to an impairment in 
autocrine signalling which promotes survival. This impairment could either be 
due to the cells not releasing enough autocrine signalling factors, or not 
responding correctly to those that they do release. As autocrine signalling systems 
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involving EGF, FGF, HGF and IGF-1 have been identified in the lens, it is 
possible that an impairment in one or more of these systems could result in the 
increased levels of apoptotic cell death observed in the DM1 LECs. 
 
 4.2 Aims 
 
Under stress conditions, such as serum deprivation, autocrine signalling 
appears to be important for maintaining survival in LECs. Autocrine signalling 
may be impaired in DM1 resulting in increased levels of cell death. The role of 
autocrine signalling will be investigated further with particular emphasis on the 
FGF pathway which is a known autocrine signalling pathway established in the 
human lens that has previously been shown to increase survival.  
 
4.3 Results 
 
4.3.1 Autocrine signalling in DM1 lens epithelial cells 
 To investigate the role of autocrine signalling during conditions of serum 
deprivation, conditioned medium (CM) was collected from the control and DM1 
cell lines after 48 hours and was applied to the foetal human lens cell line, 
FHL124. After 48 hours the cells were lysed and total protein was calculated as a 
measure of cell growth (see figure 4.5a). Culturing the FHL124 cells in SF 
medium resulted in a decrease in growth, whereas, a significant increase in growth 
was observed following addition of 5% FCS (p < 0.01). CM from all of the DM1 
cell lines also caused a significant increase in growth (p < 0.05). Of the control 
cell lines, however, only CM from CCat1 caused a significant increase in growth 
(p < 0.01). This is interesting because the control cell lines were growing much 
faster than the DM1 cell lines, resulting in much higher numbers of cells in the 
flasks from which CM was collected (see table 4.1), therefore, more cells were 
available to release factors into the medium. For comparison, the growth factor 
bFGF was also applied to FHL124 cells as it is a known autocrine signalling 
factor involved in growth and survival in the human lens. Addition of bFGF (5 
ng/ml) caused a slight, but non-significant increase in cell growth. The data shows 
that the cell lines are releasing a factor into the medium which can increase 
growth and/or survival in the FHL124 cells.  
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Figure 4.5 – The effect of CM from DM1 lens epithelial cells on FHL124 cell growth. (a) The 
growth of FHL124 cells was measured by calculating total protein (µg/ml) after 48 hours in 
CM. CM from all of the DM1 cell lines caused a significant increase in growth. Of the 
control cell lines, however, only CM from CCat1 caused a significant increase in growth (n = 
4, data expressed as mean ± SEM, statistical analysis was performed by one-way ANOVA 
with Tukey’s test, * p < 0.05 and ** p < 0.01 relative to T = 0). (b) Growth was normalised to 
the number of cells from which the CM was collected and reveals that the DM1 cell lines 
increased growth in FHL124 by a significantly greater amount per cell than the controls (n = 
4, data expressed as mean ± SEM, statistical analysis was performed by Student’s T test, ** 
p < 0.01 relative to controls).  
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FHL124 cell growth was also normalised to the number of cells from 
which the conditioned medium was collected (see table 4.1 and figure 4.5b) and 
shows that the DM1 cell lines increased growth by a significantly greater amount 
per cell than the controls. This data suggests that the DM1 cells are releasing 
greater levels of factors that are responsible for increasing growth in FHL124 cells. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1 – The number of cells per flask from which CM was collected. 
 
 
4.3.2 Signalling pathways activated by CM in FHL124 cells 
To investigate the signalling pathways activated by CM from control and 
DM1 lens cell lines, CM collected over 24 hours was applied to FHL124 cells and 
protein was collected after 10 minutes. Levels of activated downstream signalling 
molecules were examined using Western blotting. The CM from both control and 
DM1 cell lines activated downstream signalling pathways in FHL124 cells 
resulting in phosphorylation of Akt and ERK1/2 (see figure 4.6). No significant 
difference was observed between the levels of activation of either Akt or ERK1/2 
following addition of control or DM1 CM.  
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Figure 4.6 – Signalling pathways activated in FHL124 cells by CM. Protein levels of (a) pAkt 
and (b) pERK were examined by Western blotting and analysed densitometrically. Graphs 
show the activated protein levels normalised to their total protein control. A β actin loading 
control was included but is not shown. Both Akt and ERK1/2 were activated in FHL124 cells 
by addition of CM for 10 minutes. No significant difference was observed between control 
and DM1 CM.  
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 The CM from DM1 cell lines significantly increased growth in FHL124 
cells, and it was therefore expected that greater levels of activation of the major 
pathways involved in growth and survival would have been observed. As this was 
not found, the CM was diluted to see whether maximal levels of activation had 
been reached, which were masking any differences that may have been seen. CM 
was diluted with SF medium to give 100%, 75%, 50%, 25% and 0% CM and was 
applied to FHL124 cells for 10 minutes. The levels of pAkt, pERK, pJNK and 
pPKC were examined by Western blotting (data from CCat1 and DMCat1 is 
shown in figure 4.7).  
  Levels of pAkt were shown to increase with increasing concentrations of 
CM, with higher levels seen following addition of CM from DM1 cell lines 
compared to control cell lines. Akt is activated to a similar level following 
addition of 100% CM from both CCat1 and DMCat1, however, it is possible that 
this represents the maximal level of Akt activation in the FHL124 cells. The 
dilutions of CM reveal that the factor responsible for causing Akt activation is 
more potent in the DMCat1 CM as the level of activation does not decrease as 
quickly as is seen with the control CM.  
Levels of pERK were also found to increase with increasing 
concentrations of CM in both control and DM1 cell lines, however, levels of 
pERK were also very high following addition of 0% CM (SF medium), which 
could either be due to the stress caused by a change of medium, or a reaction to 
the lack of growth factors present in the medium. Although levels of pERK were 
higher following addition of 100% CCat1 CM compared to DMCat1 CM, neither 
was very different from the level observed following 0% CM addition. 
 Levels of both pJNK and pPKC appeared to be unaffected by the addition 
of different concentrations of CM, indicating that no factors capable of 
stimulating the pathways responsible for their activation are present in CM.  
 A Western blot performed using the 75% CM samples from each cell line 
revealed that DM1 CM results in a significant increase in levels of pAkt in 
FHL124 cells compared to control CM (p < 0.05) (see figure 4.8). No significant 
difference in pERK levels between DM1 and control CM were observed at this 
dilution (data not shown). 
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Figure 4.7 – see page 129 for figure legend 
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Figure 4.7 - see page 129 for figure legend 
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Figure 4.7 – Signalling pathways activated in FHL124 cells by CM. CM from CCat1 and 
DMCat1 cell lines was diluted with SF medium to give 100%, 75%, 50%, 25% and 0% CM 
which was applied to FHL124 cells for 10 minutes. (a) Western blotting was used to examine 
the activation of Akt, ERK1/2, JNK and PKC. Bands were analysed densitometrically and 
activated protein levels were normalised to their total protein control. Levels of both (b) 
pAkt and (c) pERK increased with increasing concentrations of CM, however, pERK levels 
also increased following addition of 0% CM. Levels of pAkt were higher with addition of 
DMCat1 CM compared to CCat1 CM until a maximal response was reached. Levels of (d) 
pJNK and (e) pPKC were unaffected by CM. (f) Levels of pAkt were significantly increased 
following addition of 75% dilutions of DM1 CM compared to control CM (statistical analysis 
was performed by Student’s T test, * p < 0.05 relative to control CM). 
 
 
4.3.3 Autocrine signalling via the FGF pathway in human lens 
epithelial cells 
 CM collected from all of the DM1 cell lines significantly increased growth 
in FHL124 cells, indicating that factors were released by the cells into the medium. 
These factors are capable of activating the PI3K/Akt pathway which likely leads 
to the increased levels of cell growth and/or survival. Of the autocrine signalling 
systems known to be active in the human lens, all can signal via the PI3K/Akt 
pathway. As the FGF signalling pathway is well characterised in the lens and has 
been shown to encourage growth and survival in LECs, we investigated its role in 
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CM stimulated events (Wang et al., 1999; Wormstone et al., 2001; Tholozan et al., 
2007). 
 
4.3.3.1 Release of bFGF by DM1 lens epithelial cells 
 CM was collected from cells seeded in culture dishes (after weekly 
passaging) every 21 days during the culture period shown in figure 3.9, beginning 
at day 7 and ending on day 70. CM was collected from the culture dishes after 24 
hours. Levels of bFGF in the CM were measured using an ELISA. bFGF was 
detected in CM from each cell line, but was absent from SF medium (see figure 
4.8a). The control cell lines released an average of 0.34 pg/ml ± 0.21 pg/ml bFGF 
compared to an average of 1.31 pg/ml ± 0.73 pg/ml bFGF released by the DM1 
cell lines. This data confirms that the LECs release bFGF which could increase 
growth in FHL124 cells, however, the difference in the levels of bFGF released 
between the control and DM1 lens cells was not statistically significant. 
Interestingly, the levels of bFGF released by the cells increased over increasing 
passage numbers, which was especially evident in the DM1 cell lines (see figure 
4.8b). Levels of bFGF increased over the culture period in all four DM1 cell lines, 
whereas levels only increased in two of the four control cell lines, CCat3 and 
CCat4. The average values for control and DM1 cell lines at each point in culture 
reveals a 55.3 fold increase in release of bFGF in DM1 cells from day 10 to day 
73, compared to only a 10.5 fold increase in the control cells. 
As CM from LECs seeded at high densities has been shown to increase 
survival in cultures seeded at low densities, the effect of cell number on bFGF 
release was analysed in the cell lines (Ishizaki et al., 1993). Culture flasks were 
seeded with either 5 000, 10 000 or 20 000 cells per cm2 of CCat1 or DMCat1 
cells. CM was collected from the flasks after 24 hours and levels bFGF were 
measured using an ELISA (see figure 4.9a). The cells were lysed and total protein 
from each flask was calculated as a measure of cell density (see figure 4.9b). The 
level of bFGF in the CM was normalised to the total protein value extracted from 
each flask and the data shows that there is no effect of cell density on bFGF 
release in the densities tested (see figure 4.9c). Cells seeded at a density of 5 000 
cells per cm2 released the same level of bFGF per µg of protein as those seeded at 
20 000 cells per cm2, however, the level of bFGF released by both cell types 
seeded at a density of 10 000 cells per cm2 was slightly lower. The average level 
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of bFGF released per microgram of protein from CCat1 cells was 0.02 pg/ml ± 
0.003 pg/ml compared to 0.08 pg/ml ± 0.007 pg/ml from DMCat1 cells which was 
significantly higher (p < 0.01, statistical analysis was performed by Student’s T-
test).   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 – The release of bFGF from DM1 lens epithelial cells. Levels of bFGF in the CM 
after 24 hours were analysed using an ELISA and normalised to the total protein values 
extracted from each dish. (a) Both control and DM1 lens cells released bFGF into the culture 
medium, however, no significant difference was found between DM1 and control lens cells (n 
= 4, data expressed as mean ± SEM). (b) Levels of bFGF released from the cells increased 
during the culture period, which was especially evident in the DM1 cell lines. After 73 days 
in culture, control cells released an average of 10.5 times more bFGF than after 10 days in 
culture, compared to 55.3 times more in DM1 cells (n = 4, data expressed as mean ± SEM).  
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Figure 4.9 – bFGF release is directly proportional to cell density. CM was collected from 
CCat1 and DMCat1 cells seeded at different densities (5 000, 10 000 and 20 000 cells per cm2). 
(a) bFGF in CM was measured using an ELISA. (b) Total protein from each flask was 
calculated as a measure of cell density (n = 3, data expressed as mean ± SEM). (c) bFGF 
release was normalised to total protein levels revealing that bFGF release is directly 
proportional to cell density. DMCat1 cells release significantly greater levels of bFGF than 
CCat1 cells (n = 3, statistical analysis was performed by Student’s T-test, p < 0.01). 
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4.3.3.2 Expression of FGFR1 in DM1 lens epithelial cells 
As all of the cell lines were shown to release bFGF, the presence of the receptor 
FGFR1 was tested by QRT-PCR analysis of FGFR1 expression. FGFR1 was 
found to be expressed in all of the cell lines, including FHL124 cells (see figure 
4.10). This data reveals that autocrine signalling via bFGF is possible in the cell 
lines and could cause the growth effects observed by the addition of CM to 
FHL124 cells. 
 
 
 
 
Figure 4.10 – FGFR1 is expressed in DM1 lens epithelial cells. QRT-PCR showed that 
FGFR1 was expressed in both control and DM1 lens cells and was also expressed in FHL124 
cells.  There was no significant difference observed in expression levels between control and 
DM1 lens cells (n = 2, data expressed as mean, representative of two independent 
experiments). 
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was also applied to the FHL124 cells. After 48 hours, total protein was calculated 
as a measure of cell growth (see figure 4.11a). CM from both CCat1 and DMCat1 
cells stimulated an increase in FHL124 cell growth, however, in the presence of 
SU5402 (10 µM), the stimulation from CM was significantly decreased (p < 0.05) 
when compared to the relevant DMSO control. FHL124 cell growth was also 
reduced in SF medium and medium supplemented with bFGF (5 ng/ml) in the 
presence of SU5402 compared to the relevant DMSO control, however, this was 
not statistically significant. The effects of the CM on FHL124 cell growth was not 
completely blocked following FGFR1 inhibition as cell growth was still above 
that observed following addition of SF medium in the presence of SU5402. This 
data indicates that other growth factors are released by the cells which do not act 
via FGFR1. 
 The release of LDH into the medium was measured to see whether 
reduced FHL124 cell growth following FGFR1 inhibition was due to increased 
cell death or reduced proliferation. The LDH levels were similar in each condition, 
showing that levels of cell death were not affected by FGFR1 inhibition. This data 
indicates that the reduction in FHL124 cell growth following FGFR1 inhibition 
was due to the reduced proliferative capacity of the cells and not due to increased 
cell death.  However, the effects of CM on cell survival with and without FGFR1 
inhibition were not analysed due to the presence of LDH already in the CM. 
 As inhibition of FGF signalling caused a reduction in the proliferative 
capacity of the FHL124 cells following addition of CM, the signalling pathways 
activated following SU5402 addition were also examined by Western blotting (see 
figure 4.12). FHL124 cells were exposed to SF medium, medium supplemented 
with bFGF (5 ng/ml) and CM from DMCat1 cells in the presence and absence of 
SU5402 (10 µM) for 10 minutes before the cells were lysed and protein extracted.  
Levels of pAkt did not increase following addition of SF medium to 
FHL124 cells (see figure 4.12a). Addition of bFGF led to an increase in pAkt 
levels, however, levels were increased to a much greater extent by the addition of 
DMCat1 CM. In the presence of SU5402 the levels of pAkt following bFGF 
addition were reduced, but levels were still elevated following DMCat1 CM 
addition. This data indicates that stimulation of Akt following DMCat1 CM 
addition is partially due to signalling via FGF, however, other factors capable of 
activating the PI3K/Akt pathway must also be present in the CM. 
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Figure 4.11 – The effect of CM from DM1 lens epithelial cells on FHL124 cell growth 
following FGFR1 inhibition over 48 hours. (a) When SU5402 (10 µM) was added to CM from 
CCat1 and DMCat1 cell lines FHL124 cell growth was significantly decreased when 
compared to the relevant DMSO (1 µl/ml) control (n = 4, data expressed as mean ± SEM, 
statistical analysis was performed by one-way ANOVA with Tukey’s test, * p < 0.05 and ** p 
< 0.01 relative to the relevant DMSO control, # p < 0.05 relative to T = 0). (b) LDH levels 
were not affected by SU5402 (10 µM) (n = 4, data expressed as mean ± SEM). 
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Figure 4.12 – Signalling pathways activated in FHL124 cells by CM following FGFR1 
inhibition. Protein levels of (a) pAkt and (b) pERK were examined by Western blotting and 
analysed densitometrically. Graphs show the activated protein levels normalised to their 
total protein control. A β actin loading control was included but is not shown. Addition of 
DMCat1 CM for 10 minutes stimulated activation of Akt and ERK1/2 and in the presence of 
SU5402 (10 µM) neither pAkt or pERK levels were returned to baseline levels, however, 
greater levels of pAkt remained compared to pERK. 
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Addition of SF medium to FHL124 cells resulted in an increase in levels 
of pERK when compared to baseline levels (T = 0). The addition of bFGF 
resulted in a considerable increase in pERK levels when compared to SF medium, 
whereas levels of pERK following addition of DMCat1 CM fell between those of 
bFGF and SF medium. In the presence of SU5402 the levels of pERK were 
returned to baseline levels (T = 0) following both SF medium and bFGF addition. 
Interestingly, the levels of pERK were still slightly elevated after DMCat1 CM 
addition in the presence of SU5402. This data indicates that the stimulation of 
ERK1/2 following DMCat1 CM addition was only partially due to signalling via 
the FGF signalling pathway (see figure 4.12b).  
  
4.3.4 FGF signalling in DM1 lens epithelial cells 
 In order to investigate the role of FGF signalling in the control and DM1 
lens cells in both SF medium and medium supplemented with 10% FCS, the cells 
were grown in the presence and absence of SU5402 (10 µM) for 24 hours. Cells 
were lysed and total protein was extracted as a measure of cell growth. Protein 
values for each cell line were normalised to the T = 0 value and average values 
across the control and the DM1 cell lines were calculated. A reduction in cell 
growth was observed in both cell types with SU5402 in SF medium, however, this 
was not statistically significant when compared to the DMSO (1 µl/ml) controls 
(see figure 4.13a). In medium supplemented with 10% FCS, no effect was 
observed from the addition of SU5402. Levels of LDH in the medium were also 
calculated as a measure of cell death. LDH values were normalised to the T = 0 
protein value for each cell line in order to observe the LDH released per µg/ml of 
protein (see figure 4.13b). The T = 0 values were chosen to normalise to as a bias 
would be introduced by normalising to the protein values from the same dish due 
to the reduction in cell number (and therefore total protein) that occurs during cell 
death. A slight increase in cell death was observed in both control and DM1 cells 
in SF medium with SU5402, but not with SU5402 in medium supplemented with 
10% FCS, however, this was also not significant. Although neither is statistically 
significant, the slight decrease in cell growth and increase in cell death during 
FGFR1 inhibition may indicate that signalling via the FGF pathway is more 
important in both control and DM1 cells in the absence of added growth factors, 
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indicating that autocrine signalling via the FGF pathway occurs in the control and 
DM1 LECs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13 – The effect of FGFR1 inhibition on DM1 lens epithelial cells over 24 hours. (a) 
Cell growth was measured by calculating the total protein (µg/ml) in cell lysates after 24 
hours. Protein values were normalised to the T = 0 value for each cell line and averages were 
calculated. Addition of SU5402 (10 µM) had no significant effect on cell growth. (b) LDH 
release was measured to analyse cell death and levels were normalised to the total protein 
levels at T = 0. There was no significant difference in levels of cell death following addition of 
SU5402 (n = 4, data expressed as mean ± SEM, statistical analysis was performed by one-
way ANOVA with Tukey’s test). 
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Figure 4.14 - The effect of FGFR1 inhibition on DM1 lens epithelial cells over 48 hours. (a) 
Cell growth was measured by calculating the total protein (µg/ml) in cell lysates after 48 
hours. Protein values were normalised to the T = 0 value for each cell line and averages were 
calculated. Addition of SU5402 (10 µM) resulted in a significant decrease in cell growth of 
both CCat1 and DMCat1 cells, however, DMCat1 had significantly lower levels of cell 
growth following SU5402 addition compared to CCat1 (n = 4, data expressed as mean ± SEM 
of four independent experiments, statistical analysis was performed by one-way ANOVA 
with Tukey’s test, * p < 0.05 and ** p < 0.01 relative to the relevant DMSO control, # # p < 
0.01 relative to CCat1 treated with SU5402 (10 µM)). (b) LDH release was measured to 
analyse cell death and levels were normalised to the total protein levels at T = 0. Addition of 
SU5402 resulted in a slight increase in levels of cell death but this was not statistically 
significant (n = 4, data expressed as mean ± SEM of four independent experiments, statistical 
analysis was performed by one-way ANOVA with Tukey’s test). 
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 As the small effect seen after FGFR1 inhibition for 24 hours was not 
statistically significant, further experiments were performed on CCat1 and 
DMCat1 cells to analyse the effect of FGFR1 inhibition in SF medium for 48 
hours (see figure 4.14). The data shows that growth is significantly reduced in 
both CCat1 (p < 0.01) and DMCat1 (p < 0.05) cells in SF medium with SU5402 
(10 µM) compared to the relevant DMSO controls. Interestingly, cell growth 
following FGFR1 inhibition was also shown to be significantly lower in DMCat1 
cells than CCat1 cells (p < 0.05). A slight increase in LDH levels was also 
observed following addition of SU5402, however, this was not statistically 
significant. The data implies that an autocrine FGF signalling loop is engaged 
when the cells are cultured in SF medium which is involved in cell growth, but 
that it is not critical to their survival. 
 
4.3.5 IGF-1 signalling in DM1 lens epithelial cells 
 As signalling via FGF did not appear to be critical for survival in SF 
medium, the role of another growth factor, IGF-1, which is also important for 
survival in lens cells was analysed. As with the FGF pathway, the IGF-1 pathway 
can also signal via the PI3K/Akt pathway, which is activated by DM1 CM. CCat1 
and DMCat1 cells were grown in SF medium in the presence and absence of the 
IGFR-1 inhibitor AG1024 (1 µM) for 48 hours. Normalised protein values show 
that cell growth was decreased in the presence of AG1024, especially in CCat1 
cells, however, this was not found to be statistically significant (see figure 4.15a). 
There was no difference in LDH levels, indicating that cell death was not affected 
by IGFR-1 inhibition (see figure 4.15b).  
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Figure 4.15 - The effect of IGFR-1 inhibition on DM1 lens epithelial cells over 48 hours. (a) 
Cell growth was measured by calculating the total protein (µg/ml) in cell lysates after 48 
hours. Protein values were normalised to the T = 0 value for each cell line and averages were 
calculated. Although addition of AG1024 (1 µM) resulted in a decrease in cell growth of both 
CCat1 and DMCat1 cells, the difference was not statistically significant. (b) LDH release was 
measured to analyse cell death and levels were normalised to the total protein levels at T = 0. 
Addition of AG1024 had no significant effect on cell death (n = 3, data expressed as mean ± 
SEM of three independent experiments, statistical analysis was performed by one-way 
ANOVA with Tukey’s test). 
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4.4 Discussion 
 
 DM1 lens epithelial cells have significantly increased levels of apoptotic 
cell death when cultured in SF medium compared to controls (see figure 3.15). No 
significant difference in levels of apoptosis was seen between control and DM1 
cell lines when cultured in medium supplemented with 10% FCS. It can be 
hypothesised that this was due to an impairment in autocrine signalling which is 
required for survival in SF medium. This could either be due to the cells not 
releasing enough of their own signalling factors or an impairment in the way that 
they respond to the signalling factors which they produce. Here we have shown 
that DM1 lens epithelial cells are releasing factors into their environment which 
are capable of increasing levels of cell growth and/or survival in the non-virally 
transformed lens cell line FHL124 (see figure 4.5). This data indicates that it is 
not an impaired ability to release autocrine signalling factors that results in 
increased levels of cell death, but rather a reduced ability to respond to these 
factors.  
 As well as increasing cell growth and/or survival in FHL124 cells, the 
factors released by DM1 LECs were shown to activate signalling pathways in 
FHL124 cells resulting in significantly greater levels of Akt activation compared 
to controls (see figure 4.7f). Akt is downstream of PI3K and this data indicates 
that the PI3K/Akt pathway is involved in growth and/or survival in FHL124 cells. 
It has been shown previously that signalling via the PI3K/Akt pathway is 
important for both growth and survival in rabbit and rat LECs (Chandrasekher & 
Sailaja, 2003, 2004; Iyengar et al., 2006).   
 To elucidate the mechanisms behind the increase in apoptotic cell death in 
SF medium, we investigated the role of a known autocrine signalling system in 
the lens: the FGF pathway. Autocrine signalling via bFGF is likely to occur in the 
cell lines as all were shown to release bFGF and express the receptor FGFR1 (see 
figures 4.8a and 4.10). The DM1 cell line, DMCat1, was shown to release 
significantly more bFGF than the control, CCat1, and the DM1 cell lines were 
shown to release more bFGF at later passages, however, no significant difference 
was seen when all of the cell lines were analysed together (see figures 4.9 and 
4.8b). The cell lines released a relatively low level of bFGF (0.17-3.17 pg/ml), 
however, very few cell types have been shown to release bFGF and this is 
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therefore an interesting finding (Rogelj et al., 1988). The release of bFGF may be 
a feature of lens cells as human LECs cultured on their capsule have also been 
shown to release bFGF (Wormstone et al., 2001). As bFGF has also been shown 
to be released from dead or damaged cells, this cannot be ruled out from our 
experiments (D'Amore, 1990). The observed levels of bFGF in the CM could 
therefore be due to release from dead cells and not a true autocrine signalling 
system. However, evidence that an FGF autocrine signalling system does exist in 
the LECs comes from the inhibition of FGFR1 in the cell lines themselves. 
FGFR1 inhibition had no effect on cell growth in cells cultured in medium 
supplemented with 10% FCS, but a decrease in cell growth was observed in cells 
cultured in SF medium with the inhibitor and this was found to be significant 
when repeated in CCat1 and DMCat1 cells (see figures 4.13 and 4.14). This data 
shows that in the presence of serum which contains other growth factors, 
signalling via FGFR1 is not required for cell growth, most likely due to other 
activated signalling pathways which can compensate for its loss. However, in SF 
medium the only growth factors available are those that the cells can synthesise 
themselves, revealing that signalling must occur via FGFR1 under these 
conditions in order for a reduction in cell growth to be observed. This data 
indicates that autocrine signalling via FGFR1 is present in the cells and is 
important for cell growth but is not critical for their survival. 
 Extensive investigations indicate that although signalling via the FGF 
pathway plays a role in growth in human LECs, it is unlikely that the factors 
released by DM1 LECs signal via this pathway. Addition of medium 
supplemented with bFGF (5 ng/ml) at much greater levels than those released 
from the cells themselves had no significant effect on FHL124 cell growth or 
survival (see figures 4.5 and 4.11). This is in contrast to the addition of bFGF (10 
ng/ml) to rabbit LECs, which increased proliferation by 70-80% and was 
significantly blocked by the PI3K inhibitors, wortmannin (200 nM) and 
LY294002 (10 µM) (Chandrasekher & Sailaja, 2003). Addition of bFGF to rat 
LECs, has been shown to induce proliferation, migration and differentiation in a 
concentration-dependent manner. The half maximal concentrations of bFGF 
shown to induce proliferation, migration and differentiation were 0.15, 3 and 40 
ng/ml respectively (McAvoy & Chamberlain, 1989). If the same is true in human 
LECs, this may account for the absence in growth stimulation by addition of 5 
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ng/ml of bFGF as bFGF at this concentration would result in a response of 
migration and differentiation which were not examined in the FHL124 cells. The 
FHL124 cells may also be producing and releasing bFGF themselves and addition 
of further bFGF may therefore have no added effect. Although the addition of 
bFGF had no significant effect on the FHL124 cells, the addition of DM1 CM did, 
and as it contained much lower levels of bFGF, this data would indicate that it is 
not the factor responsible for increasing growth and/or survival in the FHL124 
cells. Further to this data, inhibition of FGFR1 in FHL124 cells treated with CM 
resulted in a decrease in cell growth and/or survival and also resulted in a 
reduction in active levels of the downstream signalling molecules Akt and ERK 
(see figures 4.11 and 4.12). However, levels of growth were still greater than 
those observed with the FGFR1 inhibitor in SF medium alone and levels of pAkt 
and pERK were also not completely returned to baseline levels. This data 
indicates that other factors must be present in DM1 CM which activate Akt and 
ERK independently of FGFR1 to increase growth.  
  As FGF does not appear to be the factor released by the DM1 LECs 
which increases growth and/or survival, we investigated the role of the IGF-1 
pathway in the DM1 cells as it has also been shown to signal via the PI3K/Akt 
pathway to mediate growth and survival in LECs (Chandrasekher & Bazan, 2000; 
Chandrasekher & Sailaja, 2004). Inhibition of IGFR-1 resulted in reduced cell 
growth in the cell lines, which was more notable in the control cell line CCat1 
compared to DMCat1, however, this was not significant (see figure 4.15). No 
difference was observed in levels of cell death, indicating that signalling via IGF-
1 may play a role in growth but not in survival in LECs cultured in SF medium. 
This is in contrast to a study conducted on rabbit LECs which showed that 
signalling via IGF-1 stimulated the PI3K/Akt pathway and suppressed apoptosis 
to increase survival (Chandrasekher & Sailaja, 2004). Despite the fact that the 
presence of IGF-1 in the CM or the effect of inhibiting signalling via IGFR-1 in 
FHL124 cells treated with CM was not investigated, the fact that no significant 
effect was seen in levels of cell growth or death in the DM1 cells lines indicates 
that IGF-1 is unlikely to be the factor responsible for increased growth and/or 
survival in FHL124 cells following addition of DM1 CM.  
 The factor, or factors, released by DM1 lens epithelial cells which are 
responsible for increasing growth and/or survival and activating Akt in the 
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FHL124 cells were not identified. Of the four autocrine signalling systems which 
have previously been identified in the lens, FGF and IGF-1 do not appear to be the 
factors released by DM1 LECs which are responsible for promoting growth 
and/or survival. This leaves the autocrine signalling systems involving EGF and 
HGF to still be investigated (Palmade et al., 1994; Majima, 1995; Weng et al., 
1997; Wormstone et al., 2000; Wormstone et al., 2001). Both EGF and HGF have 
previously been shown to signal via PI3K and both have been shown to play roles 
in proliferation in LECs, however, neither has been shown to influence levels of 
survival in LECs (Reddan & Wilsondziedzic, 1983; Wormstone et al., 2000; Choi 
et al., 2004; Jiang et al., 2006). As the presence of EGF and HGF autocrine 
signalling systems in our cell lines have not been tested, we cannot confirm or 
rule out a role for either growth factor in the effects observed following CM 
addition to FHL124 cells. Further, although the autocrine systems involving EGF, 
FGF, HGF and IGF-1 are known to promote growth and/or survival in LECs, 
other currently unidentified or less common autocrine signalling systems could 
also be responsible for the increase in growth and/or survival in the FHL124 cells 
in response to CM. Other growth factors are present within the lens, such as 
vascular endothelial growth factor (VEGF), transforming growth factor β 2 (TGF-
β2) and lens derived growth factor (LEDGF), however, whether autocrine 
signalling systems exist and whether they signal via the PI3K/Akt pathway to 
promote growth and/or proliferation is questionable. VEGF and its receptor 
VEGFR are expressed in the lens and signal via the PI3K/Akt pathway, however, 
the autocrine signalling system is initiated in response to hypoxic conditions and 
results in activation of genes involved in, for example, glucose transportation in 
the lens (Shui et al., 2003; Radreau et al., 2009). Interestingly, hypoxia has been 
shown to play a role in the suppression of lens growth, however, this was shown 
to likely be due to the increasing thickness of the lens with age and is therefore 
unlikely to play a role in the growth of cultured LECs (Shui et al., 2008; Shui & 
Beebe, 2008). LEDGF has been shown to promote LEC survival and is activated 
under stress conditions, however, LEDGF is not known to signal via the PI3K/Akt 
pathway (Ayaki et al., 1999; Singh et al., 2000). TGF-β2 and its receptors are 
expressed in the lens and addition of TGF-β2 has been shown to increase 
proliferation in LECs (Kampmeier et al., 2006). TGF-β2 also plays a role in 
wound healing and its expression is upregulated by LECs in response to addition 
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of TGF-β2 which occurs in response to injury (Wormstone et al., 2006; Dawes et 
al., 2007). However, as with LEDGF, TGF-β2 is not known to signal via the 
PI3K/Akt pathway and these growth factors are therefore unlikely to be 
responsible for the effects of CM addition to FHL124 cells. Further investigation 
is required to establish the role of EGF, HGF and other possible growth factors in 
the effects of DM1 CM.  
 It is possible that no one single factor is responsible for the increase in 
FHL124 growth and/or survival following addition of DM1 CM. The effects 
observed may instead be due to a combination of factors which may be released, 
all activating receptors and downstream signalling pathways which increase 
growth and/or survival. Inhibition of FGFR1 in FHL124 cells treated with CM 
resulted in a reduction in growth and/or proliferation (see figure 4.11) and a 
reduction in the activation of Akt and ERK (see figure 4.12), however, other 
signalling factors must have been present as neither was returned to baseline 
levels. Other signalling factors may have been activating pathways which 
compensated for the loss of signalling via the FGF pathway. Blocking pathways 
in combination, such as FGF and IGF-1 together, may result in a greater reduction 
in the effects of CM.  
 Although the growth factor(s) and receptor(s) responsible for initiating the 
signalling which increased growth and/or survival in FHL124 cells were not 
identified, the downstream signalling pathway which was activated by them was 
revealed. Activation of the PI3K/Akt pathway was significantly increased by 
DM1 CM, indicating that this pathway was responsible for the subsequent 
increase in growth and/or survival of FHL124 cells (see figure 4.7f). This data 
would indicate that the PI3K/Akt pathway should also be upregulated in the DM1 
cell lines themselves, unless an impairment in autocrine signalling results in 
aberrant activation of different pathways in response to the factors released. The 
aberrant activation of pathways in response to stress has been observed in mouse 
myoblasts transfected with DMPK containing small repeats (5 repeats) and large 
repeats (160 repeats). In response to oxidative stress the cells containing small 
repeats activated the MAPK/ERK pathway which led to cell survival, whereas 
those containing large repeats activated the MAPK/JNK pathway which led to 
apoptosis (Usuki et al., 2000; Usuki et al., 2008). This data reveals that in other 
cell types the expanded CTG repeats which are found in DM1 can disturb the 
 147
activation of signalling pathways. If serum deprivation in the DM1 LECs also 
causes stress to the cells which triggers aberrant activation of cell signalling 
pathways then this could cause the increased levels of cell death in SF medium. 
Therefore, the activation of downstream signalling pathways, and in particular the 
PI3K/Akt pathway, in DM1 LECs requires further investigation to elucidate the 
cause of increased levels of cell death when cultured in SF medium.  
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CHAPTER 5 
CELL SIGNALLING PATHWAYS IN DM1 
LENS EPITHELIAL CELLS 
 
5.1 Introduction 
 
 Growth factor activation of receptor tyrosine kinases (RTKs) results in the 
downstream activation of a number of different signalling cascades in the lens, 
such as the MAPK/ERK and PI3K/Akt cascades. Signalling cascades transduce 
signals from receptors to many possible biological responses in the cell, including 
growth, differentiation, survival and apoptosis. Some signalling cascades which 
are active in the lens, such as the MAPK/JNK and MAPK/p38 cascades, are only 
rarely activated by growth factor activation of RTKs and are instead mostly 
associated with activation under stress conditions, such as exposure to UV 
radiation. These pathways may be of particular importance to the processes of 
survival and apoptosis within the lens.  
  
5.1.1 The PI3K signalling pathway 
 The PI3K pathway plays roles in growth, proliferation and survival in 
many different cell types (see figure 5.1). PI3K is a heterodimeric protein 
composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. Src 
homology 2 (SH2) domains in the regulatory subunit interact with phosphorylated 
tyrosine residues of activated RTKs and result in stabilisation of the catalytic 
subunit. Through these interactions, PI3K is brought into close proximity to 
phosphoinositides in the plasma membrane where it catalyses the addition of 
phosphate groups to the 3’-OH of the inositol ring, preferentially producing 
phosphatidylinositol-3,4,5-trisphosphate (PIP3) from phosphatidylinositol-4,5-
bisphosphate (PIP2) (Franke, 2008). The conversion of PIP2 into PIP3 is 
negatively regulated by phosphatase and tensin homolog (PTEN). Pleckstrin 
homology domains in both Akt and phosphoinositide-dependent kinase 1 (PDK1) 
bind to PIP3 and are brought into close proximity where PDK1 can phosphorylate 
Akt at the threonine residue T308. Akt must first be phosphorylated at the serine 
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residue S473 by mammalian target of rapamycin (mTOR) complex 2 (mTORC2) 
before it can be fully activated by PDK1 and capable of greater levels of 
signalling. The mechanism by which mTORC2 is activated is unknown, although 
it is thought to also be downstream of PI3K as Akt S473 phosphorylation is 
stimulated by growth factors and inhibited by LY294002 and wortmannin, which 
are specific PI3K inhibitors (Sarbassov et al., 2005; Yang & Guan, 2007). There 
are three isoforms of Akt, known as Akt1-3. While Akt1 is ubiquitously expressed, 
Akt2 is found mostly in insulin sensitive tissues and Akt3 is most highly 
expressed in the brain and testis (Franke, 2008). Akt regulates cell survival in 
several different ways, but most notably by targeting the pro-apoptotic Bcl-2 
related protein, Bcl-2-antagonist of death (BAD), and preventing its activity (Song 
et al., 2005). Akt can also regulate protein synthesis by phosphorylating tuberous 
sclerosis complex 2 (TSC2) within the TSC2-TSC1 complex and inhibiting its 
activity, allowing the activation of mTOR complex 1 (mTORC1). mTORC1 
phosphorylates p70 S6 Kinase (p70S6K) which phosphorylates the ribosomal 
protein S6 and induces protein synthesis (Franke, 2008). Akt can also regulate cell 
proliferation via phosphorylation of downstream targets such as the cell cycle 
regulators p21Cip1/Waf1 and p27Kip1. Phosphorylation of these proteins prevents 
their localisation to the nucleus, which prevents them from inhibiting cell cycle 
progression and, therefore, increases cell proliferation (Manning & Cantley, 2007).  
 In bovine lenses, PI3K was found to be expressed and active throughout 
the lens, with highest activity in the LECs (Chandrasekher & Bazan, 2000). PI3K 
and Akt were also shown to be present in LECs from porcine lenses (Zatechka & 
Lou, 2002a). Inhibition of the PI3K/Akt pathway in quail LECs inhibited 
differentiation and was also shown to reduce survival in differentiated lens fibre 
cells, but not in LECs (Weber & Menko, 2006). Inhibiting the PI3K/Akt pathway 
has also been shown in separate studies to result in a block in proliferation and 
differentiation of rat LECs (Iyengar et al., 2006; Wang et al., 2009b). Activation 
of PI3K signalling was shown to play a role in both proliferation and survival in 
rabbit LECs and differentiation in chick LECs (Chandrasekher & Sailaja, 2003, 
2004). Signalling via PI3K was also shown to play a role in cell migration in 
human LECs (Jiang et al., 2006). These studies indicate that the PI3K/Akt 
pathway is involved in numerous biological responses in LECs including 
differentiation, migration, proliferation and survival. 
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Figure 5.1 – The PI3K/Akt signalling pathway. PI3K is recruited to tyrosine kinase domains 
of phosphorylated RTKs and is brought into close proximity to the membrane where it 
converts PIP2 to PIP3. PIP3 recruits Akt and PDK1 resulting in phosphorylation of Akt at 
T308 by PDK1. Akt must first be phosphorylated by mTORC2 at S473 before it can be fully 
activated by PDK1. Akt regulates many biological processes including protein synthesis via 
mTORC1 and p70S6K; survival via inhibition of the pro-apoptotic protein BAD; and 
proliferation via the cell cycle regulators p21Cip1/Waf1 and p27Kip1. The PI3K/Akt pathway is 
negatively regulated by the tumour suppressor protein PTEN which negatively regulates the 
conversion of PIP2 into PIP3. 
  
 
5.1.2 MAPK signalling pathways  
 Cell signalling via MAPK signalling pathways results in the activation of a 
MAPK, of which there are six distinct groups. The pathway leading to the 
activation of the MAPK ERK1/2 is one of the most characterised, along with c-
Jun NH2-terminal kinase (JNK) and p38. The remaining MAPKs are ERK3/4, 
ERK5 and ERK7/8, however, little information is known about the pathways that 
lead to their activation and therefore these will not be discussed. The three main 
MAPK signalling pathways are well characterised and the signalling cascades 
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consist of three sequentially activated kinases (summarised in figure 5.2). The 
MAPKs ERK1/2, JNK and p38 are activated by phosphorylation of both threonine 
and tyrosine residues within a conserved threonine-proline-tyrosine motif by a 
MAPK kinase (MAPKK, also known as MEK or MKK). The MAPKK itself is 
activated by a MAPK kinase kinase (MAPKKK), which are serine/threonine 
kinases. MAPKKKs are activated by phosphorylation and/or interactions with 
small GTP proteins. Activated MAPKs phosphorylate target substrates on serine 
and threonine residues, including transcription factors and other proteins or 
kinases. MAPK pathways are regulated by the opposing actions of phosphatases 
which deactivate kinases by removing phosphate groups (Krishna & Narang, 
2008). 
 
 
 
Figure 5.2 – A summary of the major MAPK signalling cascades. MAPK cascades are 
initiated by small GTPases and/or other protein kinases and are organised into three tiers: 
initially MAPKKKs are activated which lead to the phosphorylation and activation of 
MAPKKs, which in turn phosphorylate and activate MAPKs. The three major pathways are 
the ERK1/2 pathway, the JNK1/2/3 pathway and the p38α/β/γ/δ pathway, all of which are 
activated by various mitogens and external stimuli. The signalling pathways bring about a 
variety of biological responses including growth, proliferation and survival. 
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5.1.2.1 The MAPK/ERK signalling pathway 
 The MAPK/ERK pathway plays roles in proliferation, differentiation and 
survival in many different cell types (see figure 5.3). The MAPK/ERK pathway is 
most commonly initiated following recruitment of proteins to the membrane 
during RTK activation. Docking proteins such as GRB2 bind to the 
phosphorylated tyrosines of the receptor via SH2 domains. GRB2 recruits SOS 
via Src homology 3 (SH3) domains, enabling SOS to become activated and to 
subsequently activate the small membrane bound G protein Ras by the exchange 
of bound guanosine diphosphate (GDP) for GTP. G protein-coupled receptors 
(GPCRs) can also activate the MAPK/ERK pathway via Ras. Ras activates Raf 
and a cascade of kinase activation is initiated. Raf activates the MAPKKs 
MEK1/2, which activate ERK1/2 (Junttila et al., 2008). Activated ERK1/2 
translocate to the nucleus where they activate several transcription factors, such as 
c-Fos, Elk-1, c-Jun and c-Myc, which regulate the transcription of many genes 
involved in proliferation, differentiation and survival (Krishna & Narang, 2008). 
 In porcine LECs, ERK1/2, Raf-1 and MEK1/2 were all shown to be 
present and in a separate study ERK1/2 and MEK1/2 were shown to be expressed 
and active in human, bovine and rat LECs (Zatechka & Lou, 2002a; Li et al., 
2003). Inhibiting the MAPK/ERK pathway has been shown to result in a block in 
proliferation and differentiation of rat LECs (Lovicu & McAvoy, 2001; Iyengar et 
al., 2006; Wang et al., 2009b). Expression of a dominant-negative form of Ras in 
transgenic mice resulted in the development of smaller lenses due to inhibition of 
cell growth. A small increase in levels of apoptosis and a delay in differentiation 
were also observed (Xie et al., 2006). The activation of ERK in the transgenic 
mice was shown to be significantly reduced, whereas activation of Akt, JNK and 
p38 were not affected. This data reveals that signalling via Ras and the 
MAPK/ERK pathway is essential for cell proliferation and, to a lesser extent, for 
survival and differentiation (Xie et al., 2006). Signalling via the MAPK/ERK 
pathway, as well as via PI3K, was also shown to play a role in cell migration in 
human LECs via an increase in the activity of the matrix metalloproteinase, 
MMP-2 (Jiang et al., 2006). This data indicates that the MAPK/ERK pathway is 
involved in proliferation, differentiation, survival and migration in LECs. 
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Figure 5.3 – The MAPK/ERK signalling pathway. GRB2 binds to tyrosine kinase domains of 
phosphorylated RTKs and recruits and activates SOS, which activates Ras by the exchange 
of bound GDP for GTP. Ras activates Raf and a cascade of kinase activation is initiated. Raf 
activates the MAPKKs MEK1/2, which activate ERK1/2. Activated ERK1/2 translocate to 
the nucleus where they activate several transcription factors, such as c-Fos, Elk-1, c-Jun and 
c-Myc, which regulate the transcription of many genes involved in proliferation, 
differentiation and survival. 
 
 
5.1.2.2 The MAPK/JNK signalling pathway 
The MAPK/JNK pathway is strongly activated by cytokines, UV radiation, 
growth factor deprivation, DNA damaging agents and some growth factors and 
GPCRs (see figure 5.4). For this reason JNKs are also known as stress-activated 
protein kinases (SAPKs). Three genes encode forms of JNK, JNK1-3, and 
alternative splicing leads to ten different isoforms. While JNK1 and JNK2 are 
ubiquitously expressed, JNK3 expression is found only in the brain, heart and 
testis. JNK is activated by the MAPKKs, MKK4/7, which are activated by several 
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upstream kinases such as apoptosis signal-regulating kinase 1 (ASK1), MLK-3 
and MKKK1-4 (Krishna & Narang, 2008). The activation of JNK by cytokine 
receptors is mediated by the tumour necrosis factor receptor associated factor 
(TRAF) family of adaptor proteins. Scaffolding proteins known as JNK 
interacting proteins (JIPs) are thought to help organise the transduction of the 
signal through specific kinase cascades in response to different signals (Davis, 
2000). Many JNK substrates are transcription factors, such as c-Jun, ATF-2, Elk-1, 
c-Myc and p53, and the downstream activation of the transcription factor AP-1 
appears to be regulated by JNK activation following stress. JNK signalling is 
mostly involved in regulating apoptosis and survival. JNK has also been shown to 
target both pro- and anti-apoptotic members of the Bcl-2 family of proteins. The 
opposing effects of JNK signalling are thought to be mediated by the duration and 
magnitude of the signal, with prolonged activation leading to apoptosis and 
transient activation promoting survival (Krishna & Narang, 2008). 
 JNK was shown to be present in LECs from porcine lenses and in LECs 
from human, bovine and rat lenses JNK1/2 were expressed and active (Zatechka 
& Lou, 2002a; Li et al., 2003). The MAPK/JNK pathway is mostly activated 
under stress conditions and has been shown to be activated following exposure of 
human LECs to UV radiation (Bomser, 2002). A subsequent study showed that 
inhibition of the MAPK/JNK pathway following UV radiation resulted in 
increased cell death in human LECs (Long et al., 2004). JNK has also been shown 
to be activated by oxidative stress following addition of hydrogen peroxide to 
human LECs. Activation of JNK, and also of ERK1/2, was linked to cell cycle 
arrest via expression of the cell cycle regulator p21Cip1/Waf1, which is thought to 
help protect against DNA damage (Seomun et al., 2005). This data indicates that 
the MAPK/JNK pathway is primarily involved in survival in LECs.  
 
5.1.2.3 The MAPK/p38 signalling pathway 
 The MAPK/p38 pathway is activated by many of the same stimuli as the 
JNK pathway, i.e. environmental stresses, cytokines and some growth factors and 
GPCRs (see figure 5.4). There are four isoforms of p38, known as p38α,β,γ and δ, 
which are activated by different MAPKKs. All four isoforms are activated by 
MKK6 and all but p38β are activated by MKK3. MKK4/7, which activate the 
JNK pathway, can also activate p38, enabling crosstalk between the two pathways. 
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The MAPKKs are activated by several upstream kinases, including MTK1, 
MLK2/3 and ASK1. Activated p38 can move to the nucleus and activate 
transcription factors such as ATF-1/2/6, CHOP, p53 and Elk-1 and can also 
activate other protein kinases in the cytoplasm such as MNK1/2 and MK2/3. The 
wide range of downstream substrates results in a wide range of biological 
responses such as cell cycle inhibition, apoptosis, inflammatory responses, growth 
and differentiation (Krishna & Narang, 2008).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 – The MAPK/JNK and MAPK/p38 signalling pathways. The MAPK/JNK and 
MAPK/p38 signalling pathways are mostly activated by environmental stressors and 
cytokines which result in activation of upstream kinases, such as ASK-1, MKKK1-4, 
MLK2/3 and MTK1. The MAPKKs MKK4/7 and MKK3/6 are activated and phosphorylate 
and activate JNK and p38 respectively. Activated JNK and p38 translocate to the nucleus 
where they activate several of the same transcription factors, such as ATF-2, Elk-1, c-Myc 
and p53 which regulate the transcription of many genes involved in apoptosis and survival. 
Activated p38 can also activate other kinases in the cytoplasm such as MNK1/2 and MK2/3 
which have roles in translation and stress and inflammatory responses. 
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 The MAPK/p38 pathway is mostly activated under stress conditions and 
has been shown to be activated following exposure of human LECs to UV 
radiation (Bomser, 2002). In porcine lenses, p38 was found to be present and 
active, with greater levels of active p38 being found in lenses subjected to osmotic 
stress (Zatechka & Lou, 2002a). p38 was also shown to be activated in porcine 
LECs treated with a Rho-associated protein kinase inhibitor and its activation was 
linked to an increase in αB-crystallin (Khurana et al., 2002). αB-crystallin was 
shown to localise to the leading edge of migrating porcine LECs which was 
dependent on its phosphorylation by p38 (Maddala & Rao, 2005). Activation of 
p38 was also shown to play a role in the pathway leading to cataract formation 
induced by mechanical stress in embryonic chick lenses via its downstream 
activation of Src kinase (Zhou & Menko, 2004). In a later study it was shown that 
signalling via p38 and Src kinase led to cataract formation due to apoptosis in 
LECs and a loss in cadherin junctions, leading to fibre cell disorganisation (Zhou 
et al., 2007). This data indicates that p38 could play a role in migration and 
apoptosis in LECs. 
 
5.1.3 The PLCγ pathway 
 A further cell signalling pathway which could play roles downstream of 
the growth factors known to be important in the lens is the PLCγ pathway (see 
figure 5.5). PLC is a class of enzymes which cleave phospholipids. There are 13 
mammalian isozymes of PLC, which are divided into six groups, known as PLCβ, 
γ, δ, ε, ζ and η. PLCγ is a subclass of PLC which is activated by receptor and non-
receptor tyrosine kinases. It contains two SH2 domains and an SH3 domain which 
enable it to be activated by the receptor and mediate interactions with other 
proteins (Kim et al., 2000). PLCγ can be phosphorylated and activated by the 
EGF receptor (EGFR), FGFR and PDGF receptor (PDGFR) and once activated it 
hydrolyses PIP2 to form two products: IP3 and DAG. IP3 binds to calcium 
channels on the membrane of the ER, known as IP3 receptors (IP3R), activating 
them and resulting in Ca2+ release and a subsequent rise in intracellular Ca2+ 
levels, whereas DAG remains in the plasma membrane. PKC can be activated by 
a combination of DAG, Ca2+ and a phospholipid such as phosphatidylserine. PKC 
is a family of serine/threonine kinases, which consists of 10 isozymes which are 
divided into three groups known as the conventional PKCs (PKCα, βI, βII and γ), 
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the novel PKCs (PKCδ, ε, η and θ) and the atypical PKCs (PKCζ and ι), based 
upon the composition of their regulatory domain (Newton, 2010). The regulatory 
domains control the sensitivity of different PKC isozymes to DAG, Ca2+ and 
phospholipids.  
 
 
 
Figure 5.5 – The PLC/PKC signalling pathway. PLCγ binds to tyrosine kinase domains of 
phosphorylated RTKs and is activated, enabling it to hydrolyse PIP2 to form two products: 
IP3 and DAG. IP3 binds to IP3Rs, which results in Ca2+ release and a subsequent rise in 
intracellular Ca2+ levels, whereas DAG remains in the plasma membrane. DAG and Ca2+ 
activate PKC which plays roles in proliferation, differentiation and survival via interactions 
with the MAPK/ERK signalling pathway; the structure of the actin cytoskeleton via 
interactions with MARCKS; and receptor desensitisation.  
 
 
 PKC can bind to many different substrates, such as EGFR, which results in 
desensitisation of the receptor; glycogen synthase kinase 3β (GSK-3β), which is 
inactivated by PKC; growth-associated protein 43 (GAP-43), which is specific to 
the nervous system and plays a role in neurite formation; Myristoylated alanine-
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rich protein kinase C substrate (MARCKS), which regulates the structure of the 
actin cytoskeleton; and Raf (Casabona, 1997). PKC activation of Raf activates the 
MAPK/ERK pathway and PLCγ itself can also activate the MAPK/ERK pathway 
via interactions between SOS and its SH3 domain. The PLCγ signalling pathway 
is involved in the processes of secretion, cell proliferation, growth and 
differentiation in many different cell types (Kim et al., 2000). 
 A study in human lenses found expression of PLCγ in LECs with the 
highest levels of expression in cells near the equator of the lens (Maidment et al., 
2004). Proliferation and differentiation are also highest at the equator of the lens, 
which could indicate a role for PLCγ in these processes. PKCα and γ were found 
in bovine LECs, whereas PKCα, γ, ι and ε were found in developing chick lenses 
and were most highly concentrated in the LECs (Gonzalez et al., 1993; Berthoud 
et al., 2000). Overexpression of PKCα and γ in rabbit LECs revealed a role for 
these proteins in the initiation of differentiation as the cells began to elongate and 
express αA- and αB-crystallins (Wagner & Takemoto, 2001). This data indicates a 
role for the PLCγ pathway in differentiation of LECs. 
 
5.1.4 Cross-talk between signalling pathways in the lens 
 Many of the signalling pathways described above result in activation of 
the same proteins and biological processes within a cell. Some signalling 
molecules have been shown to activate more than one pathway within a cell and 
activation of particular pathways can also result in opposing effects such as 
apoptosis and survival. This complexity is the result of cross-talk between 
pathways and the regulation of signal transduction that occurs within cells 
including mechanisms such as the duration and strength of the signal; scaffolding 
proteins; subcellular localisation; and the presence of different isoforms within the 
cascade (Krishna & Narang, 2008). A study investigating the intercommunication 
and cross-talk between pathways in the lens showed that inhibition of the 
MAPK/ERK and MAPK/p38 cascades resulted in an increase in PI3K/Akt 
signalling, most likely due to signalling via Ras. Inhibition of Ras suppressed 
PI3K activation but stimulated the MAPK cascades possibly via the action of p21-
activated kinase. Inhibition of MEK downregulated signalling via ERK and JNK 
when stimulated by bFGF and downregulated signalling via p38 when stimulated 
by osmotic stress. Inhibiting p38 suppressed ERK but stimulated JNK and 
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downregulation of PKC suppressed PI3K and stimulated ERK (Zatechka & Lou, 
2002b). This data highlights the complexity of the signalling network. 
Communication between the signalling systems results in particular pathways 
being upregulated to compensate for the loss of others. It also demonstrates that a 
reduction in a particular component of a given signalling pathway could result in 
the transduction of a signal down a different signalling cascade, which could have 
different effects to those which would usually occur, e.g. apoptosis instead of 
survival. 
 
5.1.5 Signalling pathways in DM1 
 The cell signalling pathways which transduce signals from external stimuli 
into biological responses within the cell are highly complex. Disturbances in the 
regulation of cell signalling pathways are responsible for many diseases from 
cancer to neurological diseases. Studies have shown that the expanded CTG 
repeats in DMPK may result in altered activation of cell signalling pathways 
(Usuki et al., 2000; Usuki et al., 2008; Beffy et al., 2010). Mouse myoblasts 
transfected with DMPK containing small repeats (5 repeats) and large repeats (160 
repeats) were shown to activate different signalling pathways in response to 
oxidative stress caused by the addition of 0.3 µM methylmercury. Cells 
transfected with DMPK containing small repeats activated the MAPK/ERK 
pathway, in comparison to the MAPK/JNK pathway activated in cells transfected 
with DMPK containing large repeats. This difference in activated signalling 
pathways resulted in apoptotic cell death in the cells activating the MAPK/JNK 
pathway and survival in those that activated the MAPK/ERK pathway (Usuki et 
al., 2000). It was subsequently shown that the intracellular concentration of ROS 
accumulated faster in cells expressing larger repeats and that ASK1 was activated 
much earlier and to a greater extent in cells expressing large repeats compared to 
small repeats (Usuki et al., 2008). ASK1 is found upstream of both the 
MAPK/JNK and MAPK/p38 pathways, which are both involved in cell survival 
and apoptosis. The aberrant activation of signalling pathways has also been 
observed in human myoblasts from congenitally affected DM1 foetuses. When the 
DM1 cells were treated with differentiating medium, fewer cells were shown to 
differentiate compared to controls. Differentiation of myoblasts is dependent on 
the activation of the MAPK/p38 pathway and the inactivation of the MAPK/ERK 
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pathway, however, in DM1 myoblasts activation of p38 in response to 
differentiating medium was 50% lower than controls and activation of both MEK 
and ERK1/2 were found to be markedly higher (Beffy et al., 2010). These studies 
indicate that the regulation of cell signalling pathways in DM1 cells may be 
disturbed. 
 Under conditions of serum deprivation, DM1 LECs have been shown to 
have significantly increased levels of apoptosis, despite also being shown to 
release signalling factors capable of significantly increasing growth and/or 
survival in the non-virally transformed cell line, FHL124 (see figures 3.15 and 
4.5). This data would indicate that their responses to these signalling factors are 
somehow impaired. The DM1 LECs may be activating different pathways in 
response to the factors released which could result in the alternative outcome of 
apoptosis. Alternatively, the DM1 LECs may be activating pathways which 
initiate apoptosis in response to the stress caused by serum deprivation and may 
be releasing factors in an attempt to counteract this. Investigating the activation of 
pathways involved in growth, proliferation, survival and apoptosis in DM1 LECs 
may help to elucidate the cause of increased levels of cell death during serum 
deprivation and also of reduced population doubling times when compared to 
control LECs.   
 
5.2 Aims 
 
 The aim of this chapter is to elucidate the signalling pathways which are 
active in the human DM1 lens epithelial cell lines. These will be analysed during 
serum deprivation in order to establish pathways activated by autocrine signalling 
and during normal culture conditions (medium supplemented with 10% FCS). The 
roles that these pathways play in cell growth, proliferation, survival and apoptosis 
will also be investigated. Differences in the activation of particular pathways 
between DM1 and control lens cells could help to identify the cause of reduced 
population doubling times and the increased levels of cell death following serum 
deprivation in DM1 LECs. 
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5.3 Results 
 
5.3.1 Signalling pathways activated in DM1 lens epithelial cells 
cultured in SF medium 
 To establish which downstream signalling pathways are active during 
autocrine signalling, levels of the activated signalling molecules pAkt, pERK, 
pJNK, pp38 and pPKC were measured in CCat1 and DMCat1 cells in response to 
serum deprivation. Activated protein levels were measured throughout the culture 
period shown in figure 3.9 using Western blotting.  
 Levels of pAkt in both cell lines decreased during the culture period (see 
figure 5.6). At all but one time point (day 57) the DMCat1 cells had greater levels 
of pAkt compared to CCat1. Average levels revealed significantly greater levels 
of pAkt in DMCat1 cells compared to CCat1 (p < 0.01). 
 Levels of pERK were detected throughout the culture period in DMCat1 
cells, however, after 43 days in culture pERK was undetectable in CCat1 cells, 
despite a relatively stable expression of total ERK (see figure 5.7). Until that point 
the two cell types had similar levels of pERK and average levels throughout the 
culture period did not reveal a significant difference despite DMCat1 having 
greater levels. 
 Levels of pJNK in both cell lines decreased during the culture period (see 
figure 5.8). At each time point the DMCat1 cells had much greater levels of pJNK 
compared to CCat1. Average levels revealed that DMCat1 had significantly 
greater levels of pJNK (p < 0.01). 
 Levels of pp38 decreased in both cell types during the culture period and 
could not be detected at later passages (see figure 5.9). There was no significant 
difference in the levels of pp38 between CCat1 and DMCat1 cells. 
 Levels of pPKC and PKC varied during the culture period in both CCat1 
and DMCat1 cells (see figure 5.10). After 36 days in culture, the levels of both 
pPKC and PKC were barely detectable in CCat1 cells, whereas both were still 
detected in DMCat1 cells. Average levels throughout the culture period reveal 
greater levels of pPKC in DMCat1 cells, however, this was not significant. 
 Differences in the levels of activated signalling molecules in DMCat1 cells 
compared to CCat1 cells are summarised in table 5.1. 
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Figure 5.6 – Activation of Akt in DM1 lens epithelial cells cultured in SF medium. (a) An 
example Western blot showing levels of pAkt and total Akt from a selection of samples. β 
actin is included as a loading control. (b) Bands were analysed densitometrically and levels of 
pAkt were normalised to total Akt. (c) Average pAkt levels show that DMCat1 has 
significantly greater levels of pAkt compared to CCat1 (n = 13, data expressed as mean ± 
SEM of thirteen independent experiments, statistical analysis was performed by Student’s T 
test, ** p < 0.01 relative to CCat1).   
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Figure 5.7 – Activation of ERK in DM1 lens epithelial cells cultured in SF medium. (a) An 
example Western blot showing levels of pERK and total ERK from a selection of samples. β 
actin is included as a loading control. (b) Bands were analysed densitometrically and levels of 
pERK were normalised to total ERK. (c) Average pERK levels show that DMCat1 has 
greater levels of pERK, but this is not significant (n = 13, data expressed as mean ± SEM of 
thirteen independent experiments, statistical analysis was performed by Student’s T test). 
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Figure 5.8 – Activation of JNK in DM1 lens epithelial cells cultured in SF medium. (a) An 
example Western blot showing levels of pJNK and total JNK from a selection of samples. β 
actin is included as a loading control. (b) Bands were analysed densitometrically and levels of 
pJNK were normalised to total JNK. (c) Average pJNK levels show that DMCat1 has 
significantly greater levels of pJNK compared to CCat1 (n = 7, data expressed as mean ± 
SEM of seven independent experiments, statistical analysis was performed by Student’s T 
test, ** p < 0.01 relative to CCat1).   
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Figure 5.9 – Activation of p38 in DM1 lens epithelial cells cultured in SF medium. (a) An 
example Western blot showing levels of pp38 and total p38 from a selection of samples. β 
actin is included as a loading control. (b) Bands were analysed densitometrically and levels of 
pp38 were normalised to total p38. (c) Average pp38 levels reveal no significant difference 
between CCat1 and DMCat1 cells (n = 13, data expressed as mean ± SEM of thirteen 
independent experiments, statistical analysis was performed by Student’s T test). 
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Figure 5.10 – Activation of PKC in DM1 lens epithelial cells cultured in SF medium. (a) An 
example Western blot showing levels of pPKC and total PKC from a selection of samples. β 
actin is included as a loading control. (b) Bands were analysed densitometrically and levels of 
pPKC were normalised to total PKC. (c) Average pPKC levels show that DMCat1 has 
greater levels of pPKC compared to CCat1 but this is not significant (n = 7, data expressed 
as mean ± SEM of seven independent experiments, statistical analysis was performed by 
Student’s T test).   
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5.3.2 Signalling pathways activated in DM1 lens epithelial cells 
cultured in medium supplemented with 10% FCS 
 To establish which signalling pathways are active under normal culture 
conditions, levels of the activated signalling molecules pAkt, pERK, pJNK, pp38 
and pPKC were measured in CCat1 and DMCat1 cells grown in medium 
supplemented with 10% FCS, throughout the culture period shown in figure 3.9 
using Western blotting. 
 As was seen with cells cultured in SF medium, the levels of pAkt in CCat1 
cells decreased during the culture period, however, this was not as noticeable in 
DMCat1 cells (see figure 5.11). At all but one time point (85 days) the DMCat1 
cells had greater levels of pAkt. Average levels throughout the culture period 
reveal significantly greater levels in DMCat1 cells compared to CCat1 cells, 
which was also observed in SF medium (p < 0.01). 
 Levels of pERK and ERK varied during the culture period in both cell 
types (see figure 5.12). After 57 days in culture, pERK was rarely detected in 
CCat1 cells, whereas pERK was found at each time point in DMCat1 cells. 
Average levels throughout the culture period show that DMCat1 cells have 
significantly greater levels of pERK compared to CCat1 cells (p < 0.01).  
 Levels of pJNK were significantly greater in DMCat1 cells compared to 
CCat1 cells (p < 0.01) (see figure 5.13). This was also observed in cells cultured 
in SF medium, however, activation of JNK appeared to be lower in both cell types 
when cultured in medium supplemented with 10% FCS. After 43 days in culture, 
activation of JNK was no longer seen in CCat1 cells, whereas pJNK was detected 
at each time point in DMCat1 cells. 
 In medium supplemented with 10% FCS, levels of pp38 were very low 
(see figure 5.14). The levels were greater at earlier time points in the culture 
period, which was also observed in SF medium, however, levels appeared to be 
much lower than those observed in SF medium. There was no difference in levels 
of pp38 between the two cell types. 
 In medium supplemented with 10% FCS, levels of pPKC were lower in 
DMCat1 cells compared to CCat1 cells, however, this was not significant (see 
figure 5.15). This was the opposite of what was observed in cells following 
addition of SF medium. Differences in the levels of activated signalling molecules 
in DMCat1 cells compared to CCat1 cells are summarised in table 5.1. 
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Figure 5.11 – Activation of Akt in DM1 lens epithelial cells cultured in medium 
supplemented with 10% FCS. (a) An example Western blot showing levels of pAkt and total 
Akt from a selection of samples. β actin is included as a loading control. (b) Bands were 
analysed densitometrically and levels of pAkt were normalised to total Akt. (c) Average pAkt 
levels show that DMCat1 has significantly greater levels of pAkt compared to CCat1 (n = 13, 
data expressed as mean ± SEM of thirteen independent experiments, statistical analysis was 
performed by Student’s T test, ** p < 0.01 relative to CCat1).   
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Figure 5.12 – Activation of ERK in DM1 lens epithelial cells cultured in medium 
supplemented with 10% FCS. (a) An example Western blot showing levels of pERK and 
total ERK from a selection of samples. β actin is included as a loading control. (b) Bands 
were analysed densitometrically and levels of pERK were normalised to total ERK. (c) 
Average pERK levels show that DMCat1 has significantly greater levels of pERK compared 
to CCat1 (n = 13, data expressed as mean ± SEM of thirteen independent experiments, 
statistical analysis was performed by Student’s T test, ** p < 0.01 relative to CCat1). 
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Figure 5.13 – Activation of JNK in DM1 lens epithelial cells cultured in medium 
supplemented with 10% FCS. (a) An example Western blot showing levels of pJNK and total 
JNK from a selection of samples. β actin is included as a loading control. (b) Bands were 
analysed densitometrically and levels of pJNK were normalised to total JNK. (c) Average 
pJNK levels show that DMCat1 has significantly greater levels of pJNK compared to CCat1 
(n = 13, data expressed as mean ± SEM of thirteen independent experiments, statistical 
analysis was performed by Student’s T test, ** p < 0.01 relative to CCat1).   
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Figure 5.14 – Activation of p38 in DM1 lens epithelial cells cultured in medium 
supplemented with 10% FCS. (a) An example Western blot showing levels of pp38 and total 
p38 from a selection of samples. β actin is included as a loading control. (b) Bands were 
analysed densitometrically and levels of pp38 were normalised to total p38. (c) Average pp38 
levels reveal no significant difference between CCat1 and DMCat1 cells (n = 13, data 
expressed as mean ± SEM of thirteen independent experiments, statistical analysis was 
performed by Student’s T test). 
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Figure 5.15 – Activation of PKC in DM1 lens epithelial cells cultured in medium 
supplemented with 10% FCS. (a) An example Western blot showing levels of pPKC and total 
PKC from a selection of samples. β actin is included as a loading control. (b) Bands were 
analysed densitometrically and levels of pPKC were normalised to total PKC. (c) Average 
pPKC levels show that DMCat1 has lower levels of pPKC compared to CCat1 but this is not 
significant (n = 13, data expressed as mean ± SEM of thirteen independent experiments, 
statistical analysis was performed by Student’s T test).   
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Signalling molecule SF medium Medium supplemented 
with 10% FCS
pAkt ↑** ↑**
pERK ↑ ↑**
pJNK ↑** ↑**
pp38 − −
pPKC ↑ ↓
 
 
Table 5.1 – Differences in levels of activated signalling molecules in DMCat1 cells compared 
to CCat1 cells.  = a significant increase (p < 0.01), = an increase, = no difference, 
= a decrease. 
 
 
5.3.3 Inhibition of signalling pathways in DM1 lens epithelial cells 
cultured in SF medium 
 In order to establish the role of particular signalling pathways in autocrine 
signalling in DM1 lens epithelial cells, inhibitors were applied to CCat1 and 
DMCat1 cells cultured in SF medium for 48 hours. 
 Signalling via the PI3K/Akt signalling pathway was inhibited using the 
PI3K inhibitor, LY294002 (25 µM) (see figure 5.16). A significant reduction in 
growth was observed in both cell lines following addition of the inhibitor (p < 
0.01), however, levels of cell growth were significantly lower in DMCat1 cells 
compared to CCat1 (p < 0.01). Despite the significant reduction in cell growth, no 
change was seen in levels of cell death measured using the LDH assay in CCat1 
cells. Although levels of cell death were elevated in DMCat1 cells, this was not 
found to be statistically significant. Signalling via the MAPK/ERK signalling 
pathway was inhibited using the MEK1 inhibitor, PD98059 (10 µM) (see figure 
5.17). Neither cell growth nor cell death was significantly affected in either cell 
line following addition of the inhibitor. Signalling via the MAPK/JNK signalling 
pathway was inhibited using the JNK inhibitor, SP600125 (1 µM and 10 µM) (see 
figure 5.18). Levels of cell growth and death were not affected in either CCat1 or 
DMCat1 cells following addition of SP600125 (1 µM), however, a significant 
reduction in growth was observed in CCat1 cells following addition of SP600125 
(10 µM) (p < 0.05). Although a reduction in growth was observed in CCat1 cells 
at this concentration, no significant effect was seen in levels of cell death. 
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Figure 5.16 - The effect of PI3K inhibition on DM1 lens epithelial cells over 48 hours. (a) Cell 
growth was measured by calculating the total protein (µg/ml) in cell lysates after 48 hours. 
Protein values were normalised to the T = 0 value for each cell line and averages were 
calculated. Addition of LY294002 (25 µM) resulted in a significant decrease in cell growth in 
both CCat1 and DMCat1 cells, however, DMCat1 had significantly lower levels of cell 
growth following LY294002 addition compared to CCat1 (n = 4, data expressed as mean ± 
SEM of four independent experiments, statistical analysis was performed by one-way 
ANOVA with Tukey’s test, ** p < 0.01 relative to the relevant DMSO control, # # p < 0.01 
relative to CCat1 treated with LY294002 (25 µM)). (b) LDH release was measured to analyse 
cell death and levels were normalised to the total protein levels at T = 0. Addition of 
LY294002 resulted in an increase in cell death in DMCat1 cells but this was not statistically 
significant (n = 3, data expressed as mean ± SEM of three independent experiments, 
statistical analysis was performed by one-way ANOVA with Tukey’s test). 
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Figure 5.17 - The effect of MEK1 inhibition on DM1 lens epithelial cells over 48 hours. (a) 
Cell growth was measured by calculating the total protein (µg/ml) in cell lysates after 48 
hours. Protein values were normalised to the T = 0 value for each cell line and averages were 
calculated. Addition of PD98059 (10 µM) had no effect on cell growth (n = 3, data expressed 
as mean ± SEM of three independent experiments, statistical analysis was performed by one-
way ANOVA with Tukey’s test). (b) LDH release was measured to analyse cell death and 
levels were normalised to the total protein levels at T = 0. Addition of PD98059 had no 
significant effect on cell death (n = 3, data expressed as mean ± SEM of three independent 
experiments, statistical analysis was performed by one-way ANOVA with Tukey’s test). 
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Figure 5.18 - The effect of JNK inhibition on DM1 lens epithelial cells over 48 hours. (a) Cell 
growth was measured by calculating the total protein (µg/ml) in cell lysates after 48 hours. 
Protein values were normalised to the T = 0 value for each cell line and averages were 
calculated. Addition of SP600125 (1 µM) had no effect on cell growth, however, addition of 
SP600125 (10 µM) significantly reduced growth in CCat1 cells (n = 3, data expressed as 
mean ± SEM of three independent experiments, statistical analysis was performed by one-
way ANOVA with Tukey’s test, * p < 0.05 relative to CCat1 DMSO control). (b) LDH release 
was measured to analyse cell death and levels were normalised to the total protein levels at T 
= 0. Addition of SP600125 (1 µM and 10 µM) had no effect on cell death (n = 3, data 
expressed as mean ± SEM of three independent experiments, statistical analysis was 
performed by one-way ANOVA with Tukey’s test). 
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To verify that LY294002, PD98059 and SP600125 inhibited signalling 
downstream of their targets, Western blots were performed on protein samples 
collected 24 hours after addition of the inhibitors. Levels of pAkt were shown to 
be markedly reduced following addition of LY294002 (25 µM) as were levels of 
pERK following addition of PD98059 (10 µM), however, levels of pJNK were 
not reduced by SP600125 (1 µM and 10 µM) at either concentration (see figure 
5.19). At the greater concentration, SP600125 (10 µM) was actually shown to 
increase levels of pJNK. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.19 – The effects of PI3K, MEK1 and JNK inhibition on downstream signalling in 
DM1 lens epithelial cells after 24 hours. Levels of (a) pAkt (b) pERK1/2 and (c) pJNK were 
examined by Western blotting following addition of LY294002 (25 µM), PD98059 (10 µM) 
and SP600125 (1µM and 10 µM) respectively. Bands were analysed densitometrically and 
graphs show the activated protein levels normalised to their total protein control. Addition of 
LY294002 and PD98059 inhibited activation of Akt and ERK1/2 respectively in both CCat1 
and DMCat1 cells, however, SP600125 failed to inhibit the activation of JNK. 
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Figure 5.19 – see previous page for figure legend. 
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5.3.3.1 Apoptotic cell death following inhibition of signalling 
pathways in DM1 lens epithelial cells cultured in SF medium  
 Inhibition of the PI3K/Akt pathway caused a significant reduction in cell 
growth in both CCat1 and DMCat1 cells, however, no increase in cell death as 
measured using the LDH assay was observed in CCat1 cells and the increase in 
DMCat1 cells was not significant. We therefore used the more sensitive technique 
of the TUNEL assay to look specifically at levels of apoptotic cell death. The 
inhibitors, LY294002 (25 µM) and PD98059 (10 µM) were applied to CCat1 and 
DMCat1 cells for 24 hours before levels of apoptotic cell death were analysed. 
Inhibition of the PI3K/Akt pathway using LY294002 resulted in a 
significant increase in the level of apoptotic cell death in DMCat1 cells from 
17.0% ± 0.9% in the DMSO control (2.5 µl/ml) to 30.9%  ± 3.8% in LY294002 (p 
< 0.05) (see figure 5.20). Interestingly, there was no difference in the levels of 
apoptotic cell death in CCat1 cells with 12.2% ± 4.7% apoptotic cells in the 
DMSO control compared to 11.5% ± 4.1% in LY294002. This data indicates that 
inhibition of the PI3K/Akt pathway using LY294002 does increase levels of cell 
death in DMCat1 cells and that cell death occurs via apoptosis, however, it does 
not increase levels of cell death in CCat1 cells.  
Levels of apoptotic cell death were also analysed following inhibition of 
the MAPK/ERK pathway using PD98059 (see figure 5.21). No significant 
difference in levels of apoptotic cell death was observed between the DMSO 
control (1 µl/ml) and PD98059 in CCat1 or DMCat1 cells. Apoptotic cell death 
did increase in CCat1 cells following addition of PD98059 from 10.9% ± 2.5% to 
17.4% ± 2.8%, however, the variability in the samples did not make this 
significant. In DMCat1 cells there were 16.7% ± 0.7% apoptotic cells in the 
DMSO control compared to 15.4% ± 2.4% in PD98059. 
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Figure 5.20 – Apoptotic cell death in DM1 lens epithelial cells following PI3K inhibition. 
CCat1 and DMCat1 cells were treated with DMSO (2.5 µl/ml) or LY294002 (25 µM) for 24 
hours. (a) Fluorescent micrographs showing nuclei labelled with DAPI (blue), apoptotic cells 
labelled using a TUNEL assay (green) and F-actin labelled with Texas red-X phalloidin (red) 
(bar = 200 µm). (b) Analysis of TUNEL positive apoptotic cells shows that addition of 
LY294002 significantly increases apoptosis in DMCat1 cells (n = 3, data expressed as mean ± 
SEM of three independent experiments, statistical analysis was performed by Student’s T 
test, * p < 0.05 relative to DMSO control and CCat1 cells treated with LY294002). 
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Figure 5.21 – Apoptotic cell death in DM1 lens epithelial cells following MEK1 inhibition. 
Cells were treated with DMSO (1 µl/ml) or PD98059 (10 µM) for 24 hours. (a) Fluorescent 
micrographs of cells showing nuclei labelled with DAPI (blue), apoptotic cells labelled using 
a TUNEL assay (green) and F-actin labelled with Texas red-X phalloidin (red) (bar = 200 
µm). (b) Analysis of TUNEL positive apoptotic cells shows that addition of PD98059 has no 
significant effect on levels of apoptotic cell death (n = 3, data expressed as mean ± SEM of 
three independent experiments, statistical analysis was performed by Student’s T test). 
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5.3.4 Investigation of the Akt pathway in DM1 lens epithelial cells 
The Akt pathway appears to be critical for survival in DM1 lens epithelial 
cells and was therefore investigated in more detail.  
The PI3K activator, 740 Y-P (50 mg/ml), was applied to CCat1 and 
DMCat1 cells for 48 hours (see figure 5.22). A minor increase in protein levels 
was observed in DMCat1 cells indicating a slight increase in growth, however, the 
increase was not significant. No difference in protein levels was observed in 
CCat1 cells. LDH release was also measured and revealed a significant increase in 
cell death in both CCat1 and DMCat1 cells (p < 0.01).  
 Levels of the negative regulator of the PI3K/Akt pathway, PTEN, were 
analysed in DMCat1 and CCat1 cells following addition of SF medium 
throughout the culture period shown in figure 3.9 (see figure 5.23). Levels of 
PTEN remained relatively consistent throughout the culture period in DMCat1 
cells, however, levels of PTEN increased considerably in CCat1 cells. Average 
levels of PTEN throughout the culture period revealed significantly lower levels 
of PTEN in DMCat1 cells compared to CCat1 cells (p < 0.01).  
 In order to establish whether DM1 LECs do have lower levels of PTEN or 
whether the previous result was just a consequence of the increase in levels seen 
in the control, the levels of PTEN were analysed in all eight of the cell lines at 
early time points (between days 29 and 36 of the culture period shown in figure 
3.9) during the culture period (see figure 5.24). The data revealed that CCat1 cells 
actually had the lowest level of PTEN compared to the other control cell lines and 
that it was the only cell line with similar levels of PTEN to the DM1 cell lines. 
Average levels revealed that DM1 cell lines had lower levels of PTEN compared 
to the controls, however, this was not statistically significant due to the variability 
in the cell lines. 
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Figure 5.22 - The effect of Akt activation on DM1 lens epithelial cells over 48 hours. (a) Cell 
growth was measured by calculating the total protein (µg/ml) in cell lysates after 48 hours. 
Protein values were normalised to the T = 0 value for each cell line and averages were 
calculated. Addition of 740 Y-P (50 ng/ml) had no significant effect on cell growth (n = 4, 
data expressed as mean ± SEM, statistical analysis was performed by one-way ANOVA with 
Tukey’s test). (b) LDH release was measured to analyse cell death and levels were 
normalised to the total protein levels at T = 0. Addition of 740 Y-P significantly increased cell 
death in both CCat1 and DMCat1 cells (n = 4, data expressed as mean ± SEM, statistical 
analysis was performed by one-way ANOVA with Tukey’s test, ** p < 0.01 relative to SF 
control). 
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 Figure 5.23 – Levels of PTEN in DM1 lens epithelial cells cultured in SF medium. (a) An 
example Western blot showing levels of PTEN from a selection of samples. β actin is included 
as a loading control. (b) Bands were analysed densitometrically and levels of PTEN were 
normalised to β actin. (c) Average PTEN levels revealed that DMCat1 cells had significantly 
lower levels of PTEN compared to CCat1 cells (n = 13, data expressed as mean ± SEM of 
thirteen independent experiments, statistical analysis was performed by Student’s T test, ** 
p < 0.01 relative to CCat1). 
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Figure 5.24 – Levels of PTEN in DM1 lens epithelial cells. An example Western blot is shown 
with β actin included as a loading control. Bands were analysed densitometrically and levels 
of PTEN were normalised to β actin. PTEN levels were greater in the majority of the control 
cell lines, however, this was not statistically significant (n = 3, data expressed as mean ± SEM 
of three independent experiments, statistical analysis was performed by Student’s T test). 
 
 
5.3.4.1 Protein synthesis downstream of Akt in DM1 lens 
epithelial cells 
 Akt activates mTORC1, which is a key regulator of protein synthesis (see 
figure 5.1). The signalling pathway downstream of Akt which is involved in 
protein synthesis was inhibited using the mTOR inhibitor, Rapamycin (25 nM and 
50 nM), which blocks the activity of mTORC1 (see figure 5.25). Levels of cell 
growth decreased in both CCat1 and DMCat1 cells following addition of the 
inhibitor, however, neither was statistically significant. Levels of cell death were 
not significantly affected in either CCat1 or DMCat1 cells following addition of 
Rapamycin (25 nM and 50 nM). 
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Figure 5.25 - The effect of mTOR inhibition on DM1 lens epithelial cells over 48 hours. (a) 
Cell growth was measured by calculating the total protein (µg/ml) in cell lysates after 48 
hours. Protein values were normalised to the T = 0 value for each cell line and averages were 
calculated. Addition of Rapamycin (25 nM and 50 nM) had no significant effect on cell 
growth (n = 3, data expressed as mean ± SEM of three independent experiments, statistical 
analysis was performed by one-way ANOVA with Tukey’s test). (b) LDH release was 
measured to analyse cell death and levels were normalised to the total protein levels at T = 0. 
Addition of Rapamycin (25 nM and 50 nM) had no effect on cell death (n = 3, data expressed 
as mean ± SEM of three independent experiments, statistical analysis was performed by one-
way ANOVA with Tukey’s test). 
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Figure 5.26 – Levels of pp70S6K in DM1 lens epithelial cells cultured in SF medium. (a) An 
example Western blot showing levels of pp70S6K from a selection of samples. β actin is 
included as a loading control. (b) Bands were analysed densitometrically and levels of 
pp70S6K were normalised to β actin. (c) Average pp70S6K levels show that DMCat1 has 
greater levels of pp70S6K compared to CCat1, however, this is not statistically significant (n 
= 13, data expressed as mean ± SEM of thirteen independent experiments, statistical analysis 
was performed by Student’s T test). 
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 Levels of activated p70S6K (pp70S6K), which is found downstream of 
mTORC1, were analysed in DMCat1 and CCat1 cells following addition of SF 
medium throughout the culture period shown in figure 3.9 (see figure 5.26). 
Levels of pp70S6K were higher at early time points during the culture period. 
After 64 days pp70S6K could no longer be detected in CCat1 cells, however, low 
levels were still found in DMCat1 cells. Average levels throughout the culture 
period revealed that DMCat1 had greater levels of pp70S6K, however, the 
difference was not significant. 
 To confirm that inhibition of mTORC1 using Rapamycin inhibited the 
activation of p70S6K, levels of pp70S6K in CCat1 and DMCat1 cells treated with 
Rapamycin (50 nM) for 24 hours were analysed using Western blotting. 
Rapamycin completely inhibited the activation of p70S6K (see figure 5.27). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.27 – Levels of pp70S6K in DM1 lens epithelial cells following inhibition of mTOR. 
Protein levels of pp70S6K were examined by Western blotting and analysed 
densitometrically. Graph shows the activated protein levels normalised to β actin. Addition 
of Rapamycin (50 nM) for 24 hours completely inhibited the activation of p70S6K. 
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5.4 Discussion 
 
 Analysis of activated signalling pathways in both SF medium and medium 
supplemented with 10% FCS revealed not only differences between the two cell 
lines, but also differences during the culture period within each cell line (see 
figures 5.6-5.15). Interestingly, there was relatively little difference in levels of 
activated proteins between cells cultured in SF medium and those cultured in 
medium supplemented with 10% FCS. Under both conditions the DM1 cell line, 
DMCat1, had significantly greater levels of activated Akt and JNK compared to 
the control cell line, CCat1. Levels of pERK were also greater in DMCat1 cells 
under both conditions, however, the difference was only significant in medium 
supplemented with 10% FCS. In SF medium, levels of pPKC were greater in 
DMCat1 cells compared to CCat1 cells, but this was not significant. The opposite 
was found in medium supplemented with 10% FCS, as levels of pPKC were lower 
in DMCat1 cells compared to CCat1 cells, but this was also not significant. No 
difference was found between pp38 levels in CCat1 and DMCat1 cells under 
either condition. Surprisingly, the pattern of activated protein levels appeared 
similar between the two culture conditions (see figures 5.7 and 5.12 for an 
example). Only active levels of p38 and JNK appeared to be reduced when 
cultured in medium supplemented with 10% FCS compared to SF medium. As 
p38 and JNK are involved in stress signalling it is likely that levels would be 
higher in the absence of added serum as this has been shown to induce apoptosis 
(see figure 3.15). 
 In the majority of cases, levels of both activated protein and total protein 
decreased during the culture period despite levels of β actin remaining relatively 
stable. This could indicate that the expression of cell signalling proteins decreases 
as the cells age. Expression of other proteins, such as the receptors known to 
activate the signalling pathways that have been analysed, including FGFR-2 and 
IGFR-1, have previously been shown to decrease in the human lens in later life 
(Bhuyan et al., 2000). The response of LEC explants to bFGF was also shown to 
reduce with age in rats, with those from older rats undergoing a slower 
progression through the differentiation process in response to bFGF (Lovicu & 
McAvoy, 1992). Reduced expression of signalling molecules in our cell lines 
could therefore result from a reduction in expression of the receptors which 
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trigger their activation or could reveal a general trend in protein expression which 
reduces with age. Studies analysing gene expression in the human lens have 
revealed that epithelial cells from lenses with age-related cataract have 
significantly reduced gene expression compared to those of clear lenses (Zhang et 
al., 2002; Ruotolo et al., 2003). The first study used RT-PCR to show that 
expression of ribosomal proteins was reduced in LECs from lenses with age-
related cataract. Ribosomal proteins are required for the translation of mRNA into 
proteins, indicating that protein synthesis would also be reduced in cataractous 
lenses (Zhang et al., 2002). A further study used microarrays to analyse 
expression of over 4000 genes and found that 262 were downregulated in LECs 
from lenses with age-related cataract. Interestingly, the largest class of genes 
found to be downregulated were those involved in signal transduction (Ruotolo et 
al., 2003). A reduction in protein expression can therefore be linked to both 
ageing and cataract development. Despite this, the CCat1 cells which showed the 
greatest variability in levels of activated proteins with some being undetectable 
halfway through the culture period, had relatively constant growth rates 
throughout culture, indicating that a reduction in cell signalling did not affect the 
ability to proliferate (see figure 3.9a). This data highlights the variability in cell 
lines and the requirement to analyse levels throughout the culture period, as is 
seen here, in order to obtain the most accurate results. 
 Signalling via the PI3K/Akt pathway appears to be critical to the survival 
of DMCat1 cells. Firstly, the DM1 cells release factors capable of activating the 
PI3K/Akt pathway in FHL124 cells (see figure 4.7), secondly, DMCat1 cells have 
been shown to have significantly greater levels of pAkt when compared to CCat1 
cells (see figures 5.6 and 5.11), and thirdly, when signalling via the PI3K/Akt 
pathway is blocked a significant decrease in cell growth is observed (see figure 
5.16) and the DMCat1 cells were shown to have significantly greater levels of 
apoptotic cell death (see figure 5.20). This data reveals that signalling via the 
PI3K/Akt pathway is necessary for survival in DMCat1 cells. Interestingly, levels 
of pAkt were significantly higher in DMCat1 cells cultured in both SF medium 
and medium supplemented with 10% FCS. This data could indicate that autocrine 
signalling via the PI3K/Akt pathway is not only important for survival during 
serum deprivation, but may also be required for survival in the presence of added 
growth factors and serum. Further experiments inhibiting signalling via the 
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PI3K/Akt pathway in the presence of serum would be required to confirm this. 
However, in the presence of the many growth factors found in serum, it is unlikely 
that additional autocrine signalling would be required, and therefore this could 
indicate that activation of Akt is independent of the addition or absence of 
extracellular signalling molecules and is instead somehow more directly linked to 
the triplet repeat mutation. 
 Akt requires phosphorylation of S473 by mTORC2 and T308 by PDK1 for 
full activation (see figure 5.1). In this study we detected phosphorylation at S473 
as a marker of Akt activity. Phosphorylation of this site is therefore not directly 
linked to signalling via PI3K, however, inhibition of PI3K using the specific 
inhibitor, LY294002, blocks phosphorylation of S473, indicating that it is also 
regulated by PI3K activity (see figure 5.19a). This agrees with other studies which 
have also shown that phosphorylation of Akt by mTORC2 at S473 is regulated by 
PI3K activity (Sarbassov et al., 2005). This data shows that signalling via both 
mTORC2 and PI3K could be responsible for increased levels of Akt activation in 
DM1 LECs. The mechanisms by which mTORC2 activity is stimulated and 
regulated is largely unknown, however, PI3K is activated mainly by nutrient and 
growth factor stimulation, but may also be activated by some GPCRs (Franke, 
2008). If the triplet repeat mutation triggers Akt activation, this could occur via a 
more direct mechanism intracellularly or via the release of factors which activate 
the pathway extracellularly. A number of intracellular regulators of the PI3K/Akt 
pathway exist, however, the main intracellular regulator is PTEN. 
 PTEN is a tumour suppressor which functions by negatively regulating the 
PI3K/Akt pathway. PTEN dephosphorylates PIP3 and converts it back to PIP2, 
preventing the activation of Akt by PDK1. DMCat1 cells were shown to have 
significantly lower levels of PTEN compared to CCat1 cells and analysis of all 
eight cell lines also revealed reduced levels in the DM1 cell lines, however, this 
was not significant (see figures 5.23 and 5.24). This data is interesting as DMCat1 
was shown to have greater levels of pAkt compared to CCat1 and this could 
therefore be due to a reduction in the levels of PTEN. PTEN levels increased in 
CCat1 cells during the culture period, which coincided with a decrease in pAkt 
levels and underlines PTENs role as a key regulator of the PI3K/Akt pathway. 
PTEN levels could be reduced in DM1 cells in order to increase PI3K/Akt 
signalling and improve survival rates. PTEN itself is regulated both 
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transcriptionally and post-translationally. Analysis of PTEN expression levels 
using QRT-PCR may help to elucidate whether the reduction in PTEN protein is 
due to a reduction in transcription of the gene. PTEN is subject to many types of 
post-translational regulation, including interactions with other proteins, 
phosphorylation, ubiquitination, oxidation and acetylation, which can affect its 
activity, breakdown and turnover (Wang & Jiang, 2008). Further experiments 
would be required to assess any possible role that these modifications may play in 
the reduction of PTEN in DM1 LECs. As CM from DM1 cell lines was shown to 
increase signalling via Akt in the non-virally transformed cell line, FHL124, it is 
unlikely that a reduction in PTEN alone is responsible for the increase in pAkt in 
DMCat1. A factor must also be released which activates the PI3K/Akt pathway 
extracellularly, however, the identity of this factor is unknown. 
Activation of the PI3K/Akt pathway using the activator 740 Y-P (50 
mg/ml) caused a significant increase in cell death in both CCat1 and DMCat1 
cells (see figure 5.22). This was a surprising result as inhibiting PI3K using 
LY294002 (25 µM) was shown to cause a significant decrease in growth in both 
CCat1 and DMCat1 cells and a significant increase in apoptotic cell death in the 
DMCat1 cells. This data reveals that signalling via the PI3K/Akt pathway could 
play roles in both survival and apoptosis in human lens epithelial cells. Addition 
of the PI3K activator may have caused an increase in the activation of Akt which 
could have switched downstream signalling from survival to apoptosis via 
crosstalk with other signalling pathways. Alternatively, 740 Y-P may not be a 
specific activator of PI3K and may therefore interact with other proteins to 
activate or inhibit other pathways which may be responsible for the increase in 
cell death (Derossi et al., 1998). 
Inhibition of PI3K resulted in a significant decrease in levels of total 
protein in both CCat1 and DMCat1 cells which may be due to a reduction in 
protein synthesis or in cell number. A reduction in cell number could either be due 
to increased levels of cell death or decreased levels of proliferation. Levels of 
LDH revealed an increase in cell death in the DMCat1 cells, but not in the CCat1 
cells, although this was not significant (see figure 5.16b). As the LDH assay did 
not appear to be sensitive enough to find a significant difference in the levels of 
cell death, we used the more sensitive technique of TUNEL to specifically analyse 
levels of apoptotic cell death. Levels of apoptosis were subsequently shown to be 
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significantly increased in the DMCat1 cells following addition of the PI3K 
inhibitor, LY294002 (see figure 5.20). This data indicates that signalling 
downstream of PI3K/Akt is primarily involved in survival in DMCat1 cells and 
that the decrease in levels of total protein following PI3K inhibition was therefore 
due to a reduction in cell number due to increased levels of cell death. This could 
be confirmed by analysing the phosphorylation of downstream proteins involved 
in the survival pathway such as BAD. BAD is a pro-apoptotic protein which 
targets the anti-apoptotic proteins Bcl-2 and Bcl-xL in the mitochondria and 
inactivates them. Phosphorylation of BAD by Akt creates a binding site for 14-3-3 
proteins which bind to and sequester BAD in the cytoplasm. This results in the 
release of Bcl-2 and Bcl-xL and therefore promotes survival (Manning & Cantley, 
2007). As increased levels of cell death does not appear to underlie the decrease in 
levels of total protein following PI3K inhibition in CCat1 cells, signalling must 
therefore be involved in either protein synthesis or proliferation in normal LECs 
(see figure 5.1). 
 The signalling pathway downstream of Akt which is involved in protein 
synthesis signals via mTORC1 and p70S6K (see figure 5.1). This pathway was 
inhibited using the mTOR inhibitor, Rapamycin, which binds to and inhibits the 
mTORC1 complex. Surprisingly, no significant decrease in total protein was 
observed in either CCat1 or DMCat1 cells, indicating that blocking the pathway 
did not affect cell growth (see figure 5.25). Inhibition of mTORC1 by Rapamycin 
was shown to prevent the activation of p70S6K which would inhibit the activation 
of S6 Kinase and should therefore have blocked protein synthesis (see figure 
5.27). A more direct method to analyse levels of protein synthesis, such as 
addition of radioactive amino acids and measuring their incorporation into newly 
synthesised proteins, may have given a more accurate measure of the effects of 
Rapamycin and may therefore have shown that the PI3K/Akt pathway is involved 
in protein synthesis in human LECs. However, the data presented here suggests 
that signalling via the PI3K/Akt pathway does not significantly affect protein 
synthesis in either cell type.  
 Inhibition of PI3K signalling resulted in a significant decrease in levels of 
total protein extracted from dishes of both CCat1 and DMCat1 cells. In DMCat1 
cells this was shown to be due to increased levels of apoptosis, therefore 
indicating that downstream signalling of the PI3K/Akt pathway was primarily 
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driven via the survival pathway. However, this was not the case in CCat1 cells, 
which did not show increased levels of cell death. Signalling via the downstream 
pathway involved in protein synthesis was also shown to have no significant role 
in the CCat1 cells. This leaves the downstream pathway involved in proliferation 
as the only remaining possible cause for reduced levels of total protein in CCat1 
cells following PI3K inhibition. This pathway was not investigated in the cell 
lines and therefore cannot conclusively be described as the pathway by which 
PI3K/Akt primarily signals via in the CCat1 cells, however, it is likely that 
inhibition of PI3K prevented the inhibition of the cell cycle regulators p21Cip1/Waf1 
and p27Kip1 by Akt and these would therefore continue to block cell cycle 
progression. Analysis of levels of phosphorylated p21Cip1/Waf1 and p27Kip1 
following PI3K inhibition would confirm the role of the cell proliferation pathway 
downstream of Akt in CCat1 cells. Interestingly, expression of p21Cip1/Waf1 and 
p27Kip1 has been shown to be downregulated in DM1 myoblasts (Timchenko et 
al., 2001b; Salisbury et al., 2008). Downregulation of p21Cip1/Waf1 expression was 
found to result from increased levels of pAkt, which phosphorylate CUG-BP1 and 
prevent it from upregulating translation of p21Cip1/Waf1 mRNA (Salisbury et al., 
2008). Downregulation of p21Cip1/Waf1 and p27Kip1 prevents DM1 myoblasts from 
exiting the cell cycle and initiating differentiation. It would therefore also be 
interesting to analyse levels of total p21Cip1/Waf1 and p27Kip1 in DM1 LECs. If 
p21Cip1/Waf1 and p27Kip1 are found to be downregulated in DM1 LECs, signalling 
via Akt would be less important for the prevention of cell cycle inhibition and this 
could explain why signalling is primarily involved in survival in DM1 LECs but 
not in control LECs.  
 As well as pAkt, levels of pERK (see figures 5.7 and 5.12) and pJNK (see 
figures 5.8 and 5.13) were also found to be elevated in DMCat1 cells. The 
MAPK/ERK pathway is mainly associated with proliferation and differentiation 
in the lens (Lovicu & McAvoy, 2001; Iyengar et al., 2006; Wang et al., 2009b). 
Inhibition of the MAPK/ERK pathway had no significant effect on levels of total 
protein or cell death as shown by LDH release and the TUNEL apoptosis assay in 
DMCat1 or CCat1 cells (see figures 5.17 and 5.21). MAPK/JNK signalling in the 
lens has previously been associated with survival (Long et al., 2004; Seomun et 
al., 2005). Interestingly, inhibition of signalling via JNK did not affect survival in 
DMCat1 cells and only affected cell growth and/or proliferation in CCat1 cells 
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when added at a much greater concentration (10 µM) than its IC50 value (see table 
2.1 and figure 5.18). However, at greater concentrations (> 10 µM) the JNK 
inhibitor SP600125 can also inhibit the activity of other signalling molecules such 
as isoforms of ERK, p38 and PKC, which could therefore have caused the 
decrease in cell growth and/or cell proliferation (Bennett et al., 2001). Levels of 
pJNK were analysed following addition of SP600125 in both cell lines and 
revealed that JNK activation was not inhibited and at higher concentrations 
SP600125 actually increased pJNK levels (see figure 5.19c). This could either 
indicate that the inhibitor does not block JNK activation or that the cells are able 
to overcome its effects through, for example, the breakdown or removal of the 
inhibitor. SP600125 is an adenosine trisphosphate (ATP)-competitive inhibitor 
and therefore competes with ATP to prevent the activation of JNK. If ATP levels 
are greater in LECs compared to other cell types tested using the inhibitor, then 
greater concentrations may be required to prevent JNK activation. The role of 
increased levels of pJNK in DMCat1 cells is therefore unknown and requires 
further investigation with a more specific inhibitor or greater concentrations of 
SP600125. The JNK pathway is associated with cellular stress as it is activated in 
response to stressors such as UV radiation, cytokines, growth factor deprivation 
and DNA damaging agents. The JNK pathway can promote both survival and 
apoptosis, with these opposing effects thought to be mediated by the length and 
strength of the activating signals (Krishna & Narang, 2008). Significantly 
increased levels of pJNK in DM1 cells could indicate increased exposure to 
cellular stress which may be linked to the triplet repeat mutation. Although JNK 
activation in the lens has been associated with survival following exposure to UV 
radiation and oxidative stress, it is possible that its sustained activation results in 
increased levels of apoptosis in the DM1 LECs (Long et al., 2004; Seomun et al., 
2005). Further experiments are required to investigate the role of JNK signalling 
in DM1 LECs. 
 Analysis of signalling pathways activated in cells grown in SF medium 
and medium supplemented with 10% FCS revealed that signalling via JNK, p38 
and PKC appeared to be greater under conditions of serum deprivation. This is not 
surprising as activation of both the MAPK/JNK and MAPK/p38 pathways is 
associated with cellular stress. We did not find any differences between SF 
medium and medium supplemented with 10% FCS in levels of activation of Akt 
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or ERK which would indicate autocrine activation. Although levels of pPKC were 
greater in DMCat1 cells in SF medium and lower in medium supplemented with 
10% FCS, neither was significantly different from CCat1 cells. Further 
experiments are required to investigate any possible role that the PLC/PKC 
signalling pathway may play in increased levels of apoptotic cell death in DM1 
LECs in SF medium. As signalling via PLC results in a rise in intracellular Ca2+ 
levels, leading to PKC activation, the role of increased Ca2+ in the DM1 cells 
would also need to be investigated. Rhodes et al. (2006) observed increased levels 
of cell death in the DM1 LECs used in this study following addition of the Ca2+ 
ionophore, ionomycin, when compared to controls. Ionomycin results in 
prolonged high levels of intracellular calcium, which the DM1 LECs were more 
susceptible to (Rhodes et al., 2006). Elevated levels of active PKC have also been 
linked to the presence of expanded CUG repeats in DM1 and were shown to be 
responsible for the increased activation of CUG-BP1 observed in the disease 
(Kuyumcu-Martinez et al., 2007). Inhibition of PKC in a heart-specific mouse 
model was shown to increase survival rates by reducing CUG-BP1 steady-state 
levels, which ameliorated the cardiac conduction defects and contraction 
abnormalities observed in the mouse model (Wang et al., 2009a). Increased levels 
of apoptotic cell death could therefore result from increased signalling via PLC 
leading to Ca2+ release and elevated levels of activated PKC, however, this 
requires further investigation. Levels of pp38 increased in DMCat1 cells in SF 
medium, however, this was also observed in CCat1 cells resulting in no 
significant difference in pp38 levels. Active p38 was also only detected early in 
the culture period when both cell types were growing well, indicating that 
signalling via p38 does not play a role in apoptotic cell death. Levels of pJNK 
increased in DMCat1 cells in SF medium and were significantly higher compared 
to CCat1 cells, indicating that increased activation of JNK may be responsible for 
the increased levels of apoptotic cell death in DM1 cells when cultured in SF 
medium.  
From the data described in this chapter, it is clear that signalling via the 
PI3K/Akt pathway is critical to the survival of DMCat1 cells, but it is not as 
important for survival in CCat1 cells. In the absence of PI3K/Akt signalling, 
DMCat1 cells undergo apoptosis. During culture, the levels of both Akt and pAkt 
were shown to decline, which coincides with a reduction in cell populations 
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observed in DMCat1 cells. It is possible that as the DMCat1 cells age, they are no 
longer able to maintain the level of signalling via Akt that is required to maintain 
survival. The reduced population doubling times and shorter lifespan of DM1 
LECs may result from sustained activation of JNK and a reduction in the 
activation of Akt during culture respectively.   
 DM1 cataract patients have been shown to have reduced LEC densities, 
with larger cells maintaining coverage of the epithelium over the lens (Abe et al., 
1999). As the lens epithelium maintains the balance of ions and water which is 
vital to lens transparency, a loss of cells from this layer could result in loss of 
transparency and cataract development. Cataracts in DM1 patients form in later 
life and even in congenitally affected patients they can take over a decade to 
develop. It is possible that as the cells age they express lower levels of either the 
receptors that are responsible for Akt activation, or of Akt itself, resulting in a 
reduction in pAkt levels and a subsequent increase in apoptotic cell death in DM1 
LECs. Increased levels of cellular stress causing sustained activation of JNK may 
also contribute to increased levels of apoptotic cell death. Greater levels of 
apoptosis caused by reduced levels of pAkt and sustained activation of JNK could, 
therefore, underlie the formation of cataracts in DM1. 
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CHAPTER 6 
GENERAL DISCUSSION 
 
6.1 General discussion 
 
The development of pre-senile cataracts is one of the most distinctive and 
key features of DM. The characteristic, iridescent opacities present in patients 
affected both minimally and congenitally. Despite the prominence of cataracts in 
the disease, very little is known about the mechanisms behind their development. 
Three main hypotheses have been proposed to explain the development of DM1 in 
general: firstly, a reduction in DMPK expression; secondly, a reduction in 
expression of the neighbouring genes, SIX5 and DMWD; and thirdly a gain of 
function by the mutant DMPK mRNA. In the lens, the hypothesis with the 
greatest support to explain cataract development was reduced expression of SIX5. 
In two separate studies using knock-out mice, partial (Six5+/-) or complete (Six5-/-) 
loss of Six5 resulted in the development of cataracts and the incidence and 
severity of lens opacities increased with decreasing Six5 dosage (Klesert et al., 
2000; Sarkar et al., 2000). However, the cataracts which formed did not have the 
characteristic features of DM1 cataracts as no iridescent, dust-like opacities were 
found and the cataracts formed in the nucleus as opposed to the posterior 
subcapsular region where they are found in DM1 patients. Further to this, similar 
cataracts are also found in DM2, which is caused by a repeat expansion mutation 
found at a different gene locus and the SIX5 gene is unaffected in this form of the 
disease. As no conclusive mechanism had been identified to explain the 
development of cataracts in DM1, this study aimed to investigate the underlying 
mechanism in the lens using human LECs derived from DM1 cataract patients.  
 Previous work in this laboratory characterised the human lens epithelial 
cell lines used in this study and showed that the DMPK gene contained large 
triplet repeat expansions only in the DM1 cell lines. DMPK was shown to be 
expressed in the control and DM1 LECs as well as SIX5 and DMWD. SIX5 
expression was found to be significantly reduced in the DM1 cell lines compared 
to the controls (Rhodes et al., 2006). In this study we employed two further 
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control cell lines and found that SIX5 expression was also low in these cell lines, 
indicating that the expression of this gene is highly variable in LECs and the 
haploinsufficiency of SIX5 that has been observed previously in DM1 may not be 
a true result of the DM1 mutation (see figure 3.2). This data adds further weight to 
the argument against SIX5 haploinsufficiency as the cause of DM1 cataract. In 
this study we also found expression of DMPK in all of the cell lines and revealed 
that the transcripts from the mutant allele in DM1 cells formed foci which are 
trapped within the nucleus (see figures 3.3 and 3.4). This is a significant finding 
because the formation of nuclear foci of DMPK transcripts is a common feature in 
cells affected by DM1 and is linked to the sequestration of MBNL proteins and 
the increased activation of CUG-BPs which are involved in the regulation of 
splicing events (Timchenko et al., 2001a; Fardaei et al., 2002). Although foci 
were shown to form and the LECs were found to express MBNL1, MBNL2, CUG-
BP1 and CUG-BP2 (see figures 3.5 and 3.6), we found no difference in levels of 
alternatively spliced isoforms of transcripts commonly affected in DM1. 
Alternative splicing has been used to explain many of the symptoms of DM1, for 
example, the altered splicing of the chloride channel ClC-1 is thought to cause the 
myotonia which is a characteristic feature of the disease and altered splicing of IR 
is likely to underlie insulin resistance and diabetes which is often observed in 
DM1 (Savkur et al., 2001; Mankodi et al., 2002). As no aberrant splicing patterns 
were observed in the DM1 LECs used in this study, the symptom of cataract does 
not appear to result from this mechanism. The triplet repeat mutation in DMPK 
must therefore exert its effects via a different mechanism in the lens. 
 The repeat regions that cause DM are unstable and biased towards 
expansion. The repeats not only expand when passed between generations, but 
also expand in the somatic cells of an individual during their lifetime. This is 
known as somatic mosaicism and the level of expansion varies depending on cell 
and tissue type, for example, cells in skeletal muscle, heart and brain have 
significantly larger repeat expansions than leukocytes (Thornton et al., 1994). 
Lens cells from DM1 cataract patients have also been shown to have larger 
repeats than those found in peripheral blood samples from the same patient (Abe 
et al., 1999). The cultured human DM1 LECs used in this study have also 
previously been shown to contain large repeats (> 1400) even at the earliest 
passage sampled and these were found to expand during culture (Rhodes et al., 
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2006). The size of the triplet repeat in the lens could explain the development of 
cataracts even in mildly affected patients, as larger repeats would make the lens 
more susceptible to their downstream effects. Cataracts do not develop in mildly 
affected patients until later in life and do not develop in congenitally affected 
patients until at least 10 years of age (Harper, 2001). The accumulation of repeats 
in the lens during the lifetime of an individual could explain why this is observed.  
 An interesting study by Khajavi et al. (2001) aimed to investigate the 
mechanism behind the expansion of the triplet repeat in DM1 and showed that the 
repeat containing alleles of DM1 lymphoblastoid cells derived from blood, shifted 
towards expansion via multiple ‘step-wise’ mutations and also through rarer 
‘gross’ mutations. Rare gross mutants which gained large repeats (40-290 repeats) 
were shown to eventually replace the progenitor allele population. It was 
hypothesised that this was due to a growth advantage of the mutant with the larger 
CTG repeat size over the progenitor population. The authors showed that this was 
the case by mixing cell lines containing different sizes of the expanded repeat 
which consistently resulted in survival of the cell line containing the larger repeat. 
The growth advantage was attributed to the increased proliferation rate of the cells 
containing larger repeat expansions, which was found to be due to downregulation 
of p21Cip1/Waf1 expression. As p21Cip1/Waf1 inhibits cell cycle progression, lower 
levels result in an increased proliferation rate. Repeat number was therefore 
shown to correlate inversely with cell doubling times (Khajavi et al., 2001). In 
this study we found similar population doubling times in all DM1 LECs which did 
not appear to correlate with the previously published repeat sizes for these cell 
lines (summarised in figure 3.1a) which contradicts the data from Khajavi et al. 
(2001) (Rhodes et al., 2006). Khajavi et al. (2001) only compared the growth 
rates of DM1 cell lines with varying repeat sizes and did not show whether DM1 
cell lines proliferated faster than controls, however, the lifespan of DM1 
lymphoblastoid cell lines was shown to be significantly shorter than controls as 
DM1 cell lines reached an average of 10.5 passages compared to controls which 
reached over 25 passages (Khajavi et al., 2001). In this study we have shown that 
the contol cell lines proliferate at a faster rate than the DM1 cell lines as the 
controls have shorter population doubling times compared to DM1 LECs. We 
have also shown that the lifespan of our DM1 lens epithelial cell lines is 
significantly shorter than the controls, as DM1 LECs survived for an average of 
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79.5 days in culture compared to control LECs which survived for over 101 days 
(see figure 3.9). Furling et al. (2001a) have also shown that the lifespan of 
satellite cells derived from muscle biopsies of congenital DM1 foetuses was also 
reduced. Lifespan was measured by counting the number of divisions the cells 
could go through before reaching growth arrest, which was found to be between 
50 and 60 divisions for control cells but a maximum of only 31 divisions was 
observed in DM1 cells. The number of divisions was also shown to be lower in 
cells derived from a foetus showing more severe signs of the disease (Furling et 
al., 2001a).  
 DM1 has been described as a premature ageing disorder as many of its 
symptoms are often commonly associated with ageing, such as cataract, erectile 
dysfunction, frontal balding, insulin resistance, cardiac arrhythmias and muscle 
weakness (Harper, 2001; Antonini et al., 2009). If expansion of the CTG repeat 
confers a proliferative advantage, as shown by Khajavi et al. (2001), this may 
indicate that DM1 cells proliferate faster and could therefore reach growth arrest 
earlier which could underlie the suggestions of premature ageing and senescence 
observed in the disease. However, this is unlikely as it would lead to greater cell 
numbers which has not been observed in the disease, unless cell death is also 
greater. A further study using satellite cells from congenital DM1 foetuses showed 
that neither proliferation nor cell death was greater in DM1 cells compared to 
controls. A 59% increase in loss of telomere length per cell division was, however, 
observed and DM1 cells stopped dividing with longer telomeres than controls. 
This was shown to result in the premature senescence of the cells which could be 
overcome by blocking the p16 cyclin-dependent kinase inhibitor. p16 is a key 
regulator of replicative senescence and can be upregulated in response to telomere 
shortening and stress mechanisms including DNA damage and oxidative stress. 
p16 was activated earlier in DM1 cells compared to controls, however, increased 
levels of telomere shortening was shown to be independent of p16 activation and 
was suggested to result from increased susceptibility to reactive oxygen species in 
DM1 cells as this has previously been shown to correlate with CTG repeat length 
(Usuki & Ishiura, 1998; Bigot et al., 2009).  
 A number of studies have reported that DM1 cells and cells containing 
expanded CTG repeats have a reduced tolerance to stress (Usuki & Ishiura, 1998; 
Usuki et al., 2000; O'Cochlain et al., 2004; Rhodes et al., 2006; Usuki et al., 
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2008). A recent study has shown that myoblasts from DM1 patients have 
increased levels of stress. This was shown to be due to the activation of PKR by 
CUG repeats which inactivates eukaryotic initiation factor 2 α (eIF2α) and 
prevents translation of downstream mRNAs, resulting in formation of stress 
granules (Huichalaf et al., 2010). Transgenic mice expressing over 25 extra copies 
of a complete DMPK gene with normal sized repeats revealed DM1-like 
symptoms upon ageing. The accumulation of DMPK transcripts was shown to 
cause severe cellular distress which affected cardiac, skeletal and smooth muscles. 
Symptoms included workload intolerance, hypertrophic cardiomyopathy and 
myotonic myopathy, which are all characteristic of DM1 (O'Cochlain et al., 2004). 
Rhodes et al. (2006) showed that DM1 LECs have increased expression levels of 
the Ca2+-activated K+ channel, SK3, which led to increased levels of cell death in 
conditions of calcium overload. Mouse myoblasts transfected with DMPK 
containing varying numbers of CTG repeats, showed CTG repeat number-
dependent susceptibility to oxidative stress, resulting in apoptosis (Usuki & 
Ishiura, 1998; Usuki et al., 2000). In this study, we have shown that DM1 LECs 
are less able to withstand the stress of being grown in SF medium compared to 
control LECs. SF medium contains no added growth factors and therefore the 
cells rely on autocrine signalling to maintain survival. We have shown that DM1 
cells have significantly increased levels of apoptotic cell death when cultured in 
SF medium compared to controls, indicating that autocrine signalling was 
somehow impaired in these cells leading to increased susceptibility to stress (see 
figure 3.15). Reduced lifespan, premature senescence and increased susceptibility 
to stress can all result in a reduction in cell number in DM1 tissues which could 
contribute to some of the symptoms observed in the disease, such as muscle 
atrophy and cataract formation. 
 Lens epithelial cell density has been shown to decrease with age and as the 
incidence of cataract increases with age, this could indicate a link between the two 
(Konofsky et al., 1987; Guggenmoosholzmann et al., 1989). It has been suggested 
that LECs in vivo accumulate damage from agents to which the lens is exposed to 
throughout life, such as UV radiation and hydrogen peroxide, and this damage 
impairs their function and leads to cell death (Harocopos et al., 1998). Studies 
have shown that cataractous lenses contain greater numbers of apoptotic cells and 
that cell death precedes cataract development (Konofsky et al., 1987; Li et al., 
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1995; Li & Spector, 1996). Analysis of the lens epithelium in DM1 cataract 
patients revealed reduced population densities of lens epithelial cells (Abe et al., 
1999). The decrease in cell density appeared to be dependent on the age of onset 
of disease symptoms, with lower densities observed in patients with an earlier 
onset. The lens epithelium contained larger cells to maintain coverage of the lens; 
however, fewer cells may not be capable of maintaining homeostasis in levels of 
ions and water and may not offer enough protection to the underlying fibre cells 
from damaging agents such as UV radiation and oxidative insults, which could 
lead to the development of cataract. Whether decreased levels of proliferation or 
increased levels of cell death caused the reduced cell densities in lenses from 
DM1 cataract patients is unknown. However, if the CTG repeats in DM1 LECs 
make them more susceptible to stress, then it could be hypothesised that exposure 
of the lens to normal levels of damaging agents may cause cell death earlier than 
in normal controls.  
 Increased levels of cell death could underlie cataract formation in DM1, 
however, the mechanisms that lead to increased cell death are unknown. In this 
study we have shown that DM1 LECs have greater levels of cell death compared 
to controls when grown in both SF medium and medium supplemented with 10% 
FCS (see figure 3.12). We have also shown that DM1 LECs have greater levels of 
apoptosis when cultured in SF medium (see figure 3.15). We hypothesised that 
autocrine signalling is impaired in DM1 LECs leading to increased levels of 
apoptotic cell death when cultured in SF medium. We investigated the release of 
autocrine signalling factors in DM1 LECs by collecting conditioned medium (CM) 
and applying it to the non-virally transformed lens epithelial cell line, FHL124. 
We found that DM1 CM significantly increased growth and/or survival in 
FHL124 cells and activated signalling pathways resulting in greater levels of Akt 
activation compared to controls (see figures 4.5 and 4.7). We investigated the role 
of the FGF and IGF signalling pathways in autocrine signalling in DM1 LECs as 
both pathways have been shown to activate signalling via PI3K and Akt in the 
lens (Chandrasekher & Bazan, 2000; Chandrasekher & Sailaja, 2003, 2004; Wang 
et al., 2009b). Inhibition of FGFR1 in DM1 LECs cultured in SF medium resulted 
in a significant decrease in growth, however, no difference was found in levels of 
cell death (see figure 4.14). No difference was found in either cell growth or cell 
death following IGFR-1 inhibition (see figure 4.15). Inhibition of FGFR1 in 
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FHL124 cells during DM1 CM addition resulted in a decrease in growth and 
levels of pAkt, however, both were still elevated compared to addition of SF 
medium, indicating that other factors were also released by the DM1 cells (see 
figures 4.11 and 4.12). Low levels of bFGF were found in the DM1 CM, however, 
addition of greater levels of bFGF to FHL124 cells did not increase growth and/or 
survival or levels of pAkt to the same extent as was observed following DM1 CM 
addition (see figures 4.5, 4.8 and 4.12). This data indicates that other factors are 
responsible for the increase in growth and levels of pAkt in FHL124 cells. As 
DM1 cells were shown to release factors capable of increasing growth and/or 
survival, this would indicate that their responses to these factors are impaired as 
cell death is increased in these cells compared to controls. In order to investigate 
this, we analysed the activation of signalling pathways in DM1 LECs which are 
known to be involved in growth, proliferation, survival and apoptosis within the 
lens.  
 Studies have shown that CTG repeats can lead to the aberrant activation 
and/or regulation of signalling pathways in DM1 cells (Hernandez-Hernandez et 
al., 2006; Usuki et al., 2008; Beffy et al., 2010). Usuki et al. (2008) showed that 
aberrant activation of the MAPK/JNK pathway in cells containing large triplet 
repeats instead of the MAPK/ERK pathway led to cell death rather than survival 
when exposed to oxidative stress. Beffy et al. (2010) showed that sustained 
activation of the MAPK/ERK pathway along with reduced activation of the 
MAPK/p38 pathway prevented differentiation in myoblasts from congenitally 
affected DM1 foetuses compared to controls, which could play a role in the 
impaired muscle development observed in congenital DM1. The study also 
showed that enlarged vacuoles formed in the DM1 cells, which were not observed 
in controls. These were found to be autophagic vacuoles, which are double-
membraned vesicles which fuse with lysosomes to degrade cellular components. 
Autophagy is regulated by mTOR and is suppressed by activation of the PI3K/Akt 
signalling pathway, which could also indicate that regulation of the PI3K/Akt 
signalling pathway is disturbed in these cells (Glick et al., 2010). A further study 
has also identified disturbances in the PI3K/Akt pathway in a neuronal cell line 
expressing 90 CUG repeats (CTG90 cells) (Hernandez-Hernandez et al., 2006). 
Hernandez-Hernandez et al. (2006) showed that the failure of CTG90 cells to 
differentiate in response to nerve growth factor was likely due to the altered 
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activity of microtubule-associated protein tau (τ) and the impaired activation of 
glycogen synthase kinase 3β (GSK3β) which regulates τ phosphorylation. GSK3β 
activity is negatively regulated by phosphorylation at residue S9 by pAkt. Levels 
of pAkt were found to be reduced in the CTG90 cells leading to an increase in 
GSK3β activity and hyperphosphorylation of τ, which could be linked to 
symptoms observed in the CNS in DM1, such as mental retardation. Aberrant 
activation of signalling pathways could therefore play a role in some of the 
symptoms observed in DM1. 
 To investigate whether aberrant activation of signalling pathways led to 
increased levels of apoptosis in DM1 cells cultured in SF medium, we analysed 
pathways activated in response to both SF medium and medium supplemented 
with 10% FCS. Signalling via the MAPK/JNK, MAPK/p38 and PLC/PKC 
pathways appeared to increase in SF medium in DM1 LECs compared to levels 
observed in medium supplemented with 10% FCS (see figures 5.8 to 5.10 and 
5.13 to 5.15). As the MAPK/JNK and MAPK/p38 pathways are activated under 
stress conditions, it is not surprising that activation is higher during serum 
deprivation. Active levels of p38 were only detected early in the culture period 
and as levels of p38 also increased in control LECs in SF medium, no difference 
was found in the levels observed in DM1 LECs compared to controls. Active 
levels of JNK, however, were found throughout the culture period and were 
significantly higher in DM1 LECs compared to controls. Sustained activation of 
JNK can lead to apoptosis and therefore requires further investigation in DM1 
LECs as it may play a role in the increased levels of apoptotic cell death in SF 
medium compared to controls. Although levels of active PKC were found to be 
higher in DM1 LECs when cultured in SF medium compared to medium 
supplemented with 10% FCS, levels were not significantly different to those 
observed in the control LECs. Signalling via PLC activates PKC by increasing 
levels of DAG and intracellular Ca2+. Elevated levels of intracellular Ca2+ have 
previously been shown to cause increased levels of cell death in human DM1 
LECs (Rhodes et al., 2006). Transgenic mice which express 25 extra copies of the 
DMPK gene with normal repeat sizes also demonstrated intracellular Ca2+ 
overload which promoted nuclear translocation of transcription factors responsible 
for changes in gene expression leading to hypertrophic cardiomyopathy 
(O'Cochlain et al., 2004). Increased signalling via PLC could therefore also play a 
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role in apoptotic cell death in DM1 LECs cultured in SF medium via increased 
levels of intracellular Ca2+ and pPKC, however, this requires further investigation.  
 Cell death was also greater in DM1 cells cultured in medium 
supplemented with 10% FCS compared to controls (see figure 3.12), however, the 
increase in apoptotic cell death was not significant (see figure 3.15). Analysis of 
activated signalling pathways in medium supplememented with 10% FCS 
revealed that DM1 LECs had significantly increased activation of the PI3K/Akt 
and MAPK/JNK pathways compared to controls, which was also observed in SF 
medium (see figures 5.6, 5.8, 5.11 and 5.13). Increased activation of the PI3K/Akt 
pathway in DM1 LECs was shown to encourage their survival as inhibiting the 
pathway led to increased levels of apoptosis (see figure 5.20). Increased activation 
of the MAPK/JNK pathway could have the opposite effect as this can lead to 
increased levels of apoptosis, however, the role of signalling via the MAPK/JNK 
pathway was not elucidated as the JNK inhibitor, SP600125, was found not to 
inhibit the MAPK/JNK pathway in this study. The sustained activation of JNK 
indicates that the DM1 LECs are exposed to increased levels of cellular stress, 
which is known to activate the pathway, even when cultured in medium with 
serum. Signalling via the MAPK/JNK pathway could therefore be responsible for 
the reduced population doubling times observed in DM1 LECs by increasing cell 
death (see figure 3.9).  
 As no single pathway was shown to be significantly upregulated in only 
SF medium in DM1 LECs compared to controls, it appears unlikely that the 
increase in apoptotic cell death in SF medium is due to the aberrant activation of 
signalling pathways. However, the PI3K/Akt and MAPK/JNK pathways are 
aberrantly activated in DM1 LECs in both SF medium and medium supplemented 
with 10% FCS. The JNK signalling pathway has been shown to be activated by 
serum deprivation and we found that levels of pJNK increased in both cell types 
in SF medium (Huang et al., 1997). As DM1 LECs had greater levels of pJNK in 
medium supplemented with 10% FCS, it is likely that serum deprivation caused a 
further increase in signalling via the MAPK/JNK pathway which resulted in 
greater levels of cell death when compared to control LECs.   
 Although an increase in signalling via the PI3K/Akt pathway appeared to 
be protective in DM1 LECs, this may not be the case in other cell types. Increased 
levels of pAkt have also been demonstrated in both cultured and primary DM1 
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myoblasts (Salisbury et al., 2008). Activated Akt was shown to phosphorylate 
CUG-BP1 at serine residue S28, which increased the interactions of CUG-BP1 
with mRNA of the cell cycle regulator, cyclin D1. Translation of cyclin D1 
mRNA is increased by interactions with CUG-BP1, resulting in increased levels 
of proliferation. CUG-BP1 was also shown to be phosphorylated by cyclin D3-
cdk4/6 at serine residue S302, which increases CUG-BP1 binding with 
p21Cip1/Waf1 and CCAAT-enhancer-binding protein β (C/EBPβ) mRNAs. An 
increase in translation of p21Cip1/Waf1 and C/EBPβ by CUG-BP1 is required to 
block cell cycle progression and enable differentiation in myoblasts. Therefore, 
phosphorylation of CUG-BP1 can play an important role in regulating both 
proliferation and differentiation in myoblasts. Levels of cyclin D3 were found to 
be lower in DM1 myoblasts and along with elevated levels of pAkt, which 
increased phosphorylation of CUG-BP1 at S28 and encouraged CUG-BP1 to  
bind to cyclin D1 mRNA rather than p21Cip1/Waf1 and C/EBPβ mRNAs, these 
resulted in a block in differentiation in DM1 myoblasts. Increased levels of pAkt 
could therefore contribute to the impaired differentiation of skeletal muscle in 
DM1 patients. If the triplet repeat mutation is responsible for increasing Akt 
activity in other cell types affected by DM1, then the response will be cell type 
specific. In LECs, increased levels of pAkt increase survival which confers an 
advantage, whereas in myoblasts it leads to impaired differentiation which is 
detrimental.  
 Here we have shown that DM1 LECs require signalling via the PI3K/Akt 
pathway for survival in culture. However, we have also shown that levels of both 
total Akt and active Akt in control and DM1 LECs reduced over time during a 
four month culture period (see figures 5.6 and 5.11). Levels of other downstream 
signalling molecules such as ERK and PKC also appeared to decrease (see figures 
5.7, 5.10, 5.12 and 5.15). Interestingly, studies have shown that expression of 
receptors such as FGFR-2 and IGFR-1 decrease in the human lens in later life and 
the response of rat LEC explants to bFGF also reduces with age (Lovicu & 
McAvoy, 1992; Bhuyan et al., 2000). Expression of proteins involved in signal 
transduction have also been found to be lower in lenses with age-related cataract 
(Ruotolo et al., 2003). This data could therefore indicate that either protein 
expression in general decreases with age in the lens, or that a reduction in levels 
of receptors that respond to growth factors results in a reduction in protein levels 
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of downstream signalling molecules. Either way, a reduction in signalling 
molecules could prevent the signals from growth and survival factors reaching 
their destination. As DM1 LECs appear to rely on signalling via the PI3K/Akt 
pathway for survival, this could explain the reduction in population doubling 
times observed during the culture of DM1 LECs and their limited lifespan 
compared to controls (see figure 3.9).  
 Although the cause of increased activation of Akt and JNK in DM1 LECs 
is unknown, it appears to result from the presence of the triplet repeat. However, 
we could speculate a possible mechanism which would link the triplet repeat 
mutation to the activation of Akt and JNK in the disease. Transcription of the 
mutant DMPK allele found in DM1 results in the production of RNA containing 
CUG repeats. The expanded CUG repeats have been shown to form stable hairpin 
structures where the repeat tract folds back on itself and results in formation of 
dsRNA with G·C and C·G base pairs separated by U·U mismatches. These hairpin 
structures have been shown to activate PKR, which is a protein kinase activated 
by dsRNA of over 30 bp in length which is usually only found in cells following 
infection by viruses which contain dsRNA (Tian et al., 2000). PKR initiates anti-
viral responses by phosphorylating eIF-2α which prevents its recycling and results 
in a block in protein synthesis (Garcia et al., 2006). PKR can also regulate 
translation, cell cycle progression and apoptosis via interactions with other 
proteins including protein phosphatase 2A, nuclear factor κB (NF-κB) and p53. 
Interestingly, PKR has also been shown to regulate the activity of Akt, ERK, JNK 
and p38 (Iordanov et al., 2000; Takada et al., 2007; Alisi et al., 2008). Signalling 
induced by the cytokine, tumour necrosis factor (TNF) has been shown to be 
regulated by PKR which was required for TNF induced activation of Akt and JNK, 
however, it was shown to negatively regulate activation of ERK and p38 (Takada 
et al., 2007). In a separate study, the activation of JNK by dsRNA was shown to 
require PKR-mediated inhibition of protein synthesis by a mechanism which 
activated the upstream kinase, MKK4 (Iordanov et al., 2000). PKR has also been 
shown to directly interact with Akt and p38 to regulate their activity, with the 
interaction with Akt encouraging its activation and the interaction with p38 
resulting in its inhibition. Through its interactions with Akt and p38, PKR was 
shown to play a role in regulating muscle differentiation, which could also link to 
the muscle symptoms observed in DM1 (Alisi et al., 2008). Beffy et al. (2010) 
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showed that DM1 myoblasts had reduced activity of MAPK/p38 which could be 
responsible for impaired muscle differentiation in the disease. Activation of PKR 
by the expanded CUG repeats found in DM1 could therefore underlie the 
reduction in p38 that is observed in DM1 myoblasts from congenitally affected 
foetuses (Beffy et al., 2010). A recent study has confirmed that PKR levels are 
elevated in primary DM1 myoblasts and found that this led to increased levels of 
phosphorylated eIF2α, resulting in cellular stress (Huichalaf et al., 2010). If the 
unusual hairpin structures that are formed by the expanded CUG repeats are 
confirmed to activate PKR in DM1 LECs, then through these interactions PKR 
could cause the increase in pAkt and pJNK levels, with pAkt encouraging survival 
and pJNK likely leading to increased levels of apoptotic cell death. It is also 
possible that the hairpin structures formed by the CUG repeats may activate other 
sensors of dsRNA that are present in cells. These include receptors such as toll-
like receptor 3 (TLR3), which is located in endosomal compartments, and retinoic 
acid-inducible gene 1 (RIG-1) and melanoma differentiation-associated gene 5 
(MDA5) which are cytoplasmic sensors. These sensors activate signalling 
pathways which result in the nuclear translocation of NF-κB and interferon 
regulatory factor 3 (IRF3), resulting in the production of the type I interferons 
(IFNs), IFNα and IFNβ. IFNs are cytokines which are released by cells and induce 
autocrine and paracrine signalling via the type I interferon receptor (IFNAR) 
which results in transcription of IFN stimulated genes (ISGs) (Baum & Garcia-
Sastre, 2010). ISGs regulate many cellular processes to protect the host cell from 
infection and prevent the spread of viruses, for example, by inhibiting cell growth 
and proliferation, and by activating apoptosis (Sen, 2001). IFNs have been shown 
to activate the PI3K/Akt pathway resulting in mTOR activation, which was found 
to be essential for translation of some ISG mRNAs and IFNs have also been 
shown to induce sustained activation of the MAPK/JNK pathway leading to 
apoptosis (Yanase et al., 2005; Kaur et al., 2008). IFN activation of the PI3K/Akt 
pathway has also been shown to promote survival via activation and nuclear 
translocation of NF-κB, which counteracts the apoptotic effects of IFN in some 
cell types (Yang et al., 2001). An increase in levels of pAkt in the DM1 LECs 
may therefore be induced by IFN to counteract increased levels of pJNK and 
maintain survival. If the hairpin structures formed by the CUG repeats are found 
to stimulate IFN production, this could also be found to underlie increased levels 
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of cell death in DM1 LECs. Release of IFN could also be responsible for the 
effects observed following addition of DM1 CM to FHL124 cells as growth 
and/or survival and levels of pAkt were found to increase. If DM1 CM contains 
IFN, addition of DM1 CM to FHL124 cells could promote survival via Akt, 
however, long term addition could result in increased levels of cell death via the 
sustained activation of JNK, which may not have been observed in the short term 
experiments performed in this study. The role of PKR and other dsRNA sensors in 
DM1 lens epithelial cell death, and in DM1 in general, requires further 
investigation. 
 DM1 cataractous lenses have reduced LEC density (Abe et al., 1999). A 
reduction in cell number could result from increased levels of cell death or 
reduced levels of proliferation. From this study, we have shown that DM1 LECs 
are subject to increased levels of cell death compared to control LECs. As 
cataracts form later in life in minimally affected DM1 patients and take at least a 
decade to form in congenitally affected patients, this suggests that the underlying 
cause of cataract formation takes a while to develop or exert its affects. If levels of 
active signalling pathways are age dependent, as is observed in the cultured 
human LECs, then a reduction in active signalling molecules could underlie DM1 
cataract. An increase in levels of cell death, and specifically apoptosis, as a 
consequence of reduced signalling via PI3K/Akt and sustained activation of the 
MAPK/JNK pathway throughout the life of DM1 patients could therefore result in 
cataract development in the disease.  
  
6.2 Summary of major conclusions 
 
 The data presented in this thesis has revealed some novel and important 
findings that may help to further the field of research into cataract formation in 
DM1. We have shown that SIX5 levels are not affected by the triplet repeat 
mutation and that DMPK is expressed in the lens where transcripts form foci in 
the nuclei of DM1 LECs. This data may help to shift the emphasis of research into 
DM1 cataracts away from the current hypothesis of SIX5 haploinsufficiency and 
towards possible mechanisms downstream of mutant transcript production. 
Although we found no evidence for alternative splicing in the proteins that we 
investigated, there are many more that have been observed in other tissues in 
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DM1 that we did not analyse, but could be potential causes of cataract formation 
in DM1, such as the sarcoplasmic/endoplasmic reticulum calcium ATPase 
(SERCA). Two isoforms of SERCA, SERCA1 and SERCA2 are alternatively 
spliced in DM1 muscle cells and have been linked to impaired Ca2+ homeostasis 
in the disease (Kimura et al., 2005). The SERCA isoforms SERCA2 and SERCA3 
are present in the lens and have been linked to cataract formation due to their roles 
in Ca2+ homeostasis (Liu et al., 1999). Analysis of alternative splicing of these 
isoforms in DM1 LECs could therefore be very interesting. This study has also 
highlighted the role of signalling pathways in the survival of DM1 LECs. We 
have shown that the DM1 LECs release factors into the medium which are 
capable of activating the Akt pathway and increasing growth in FHL124 cells. 
Activation of Akt was found to be upregulated in DM1 LECs which was critical 
to their survival. PTEN, the negative regulator of the Akt pathway was also found 
to be downregulated. During culture the levels of pAkt declined in the cell lines 
which coincided with a decline in cell numbers. A decline in cell number in the 
lens could lead to cataract formation due to a loss of homeostasis in levels of ions 
and water. 
 
6.3 Future directions 
 
 In order to build upon this project, further replicates are required for a 
number of the experiments and confirming the results in all eight cell lines would 
be of great benefit. Many of the interesting results could then be followed up and 
investigated further. Establishing the identity of the factor(s) released by DM1 
LECs which activates the Akt pathway and increases growth in FHL124 cells is a 
key area for future studies. Cytokines, such as interferons, are strong candidates 
and these could be investigated using multianalyte ELISAs. Identification of the 
pathways which lead to the release of factors by the DM1 LECs is also of great 
importance. Microarrays could be used to examine expression levels of thousands 
of genes at once which could highlight pathways that are aberrantly activated in 
DM1 LECs. Pathways that are either up or downregulated in the DM1 LECs 
compared to controls may be direct or indirect effects of the triplet repeat 
mutation and may therefore cause or contribute to the symptoms of the disease. 
This project has laid the groundwork for a new focus for DM1 cataract research. 
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